-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CJqaBrO3hdzw/iQaLax3RfTYOYpZ/YB8Qq7Fynrx55o8wZgOkJ0QqQbdL+AsyhkA Nc4w7yODmJUtQPH3qr9Wbw== 0000950144-06-002233.txt : 20060314 0000950144-06-002233.hdr.sgml : 20060314 20060314172313 ACCESSION NUMBER: 0000950144-06-002233 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20051231 FILED AS OF DATE: 20060314 DATE AS OF CHANGE: 20060314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HCA INC/TN CENTRAL INDEX KEY: 0000860730 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 752497104 STATE OF INCORPORATION: DE FISCAL YEAR END: 0324 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11239 FILM NUMBER: 06685897 BUSINESS ADDRESS: STREET 1: ONE PARK PLZ CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6153449551 MAIL ADDRESS: STREET 1: ONE PARK PLAZA CITY: NASHVILLE STATE: TN ZIP: 37203 FORMER COMPANY: FORMER CONFORMED NAME: HCA THE HEALTHCARE CO DATE OF NAME CHANGE: 20010419 FORMER COMPANY: FORMER CONFORMED NAME: COLUMBIA HCA HEALTHCARE CORP DATE OF NAME CHANGE: 20000502 FORMER COMPANY: FORMER CONFORMED NAME: COLUMBIA HCA HEALTHCARE CORP/ DATE OF NAME CHANGE: 19940314 10-K 1 g99681e10vk.htm HCA INC. - FORM 10-K HCA INC. - FORM 10-K
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K
     
(Mark One)
   
x
  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
    For the fiscal year ended December 31, 2005
OR
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from                 to 
Commission File Number 1-11239
 
HCA INC.
(Exact Name of Registrant as Specified in its Charter)
 
     
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
  75-2497104
(I.R.S. Employer Identification No.)
 
One Park Plaza
Nashville, Tennessee
(Address of Principal Executive Offices)
  37203
(Zip Code)
Registrant’s telephone number, Including Area Code: (615) 344-9551
Securities Registered Pursuant to Section 12(b) of the Act:
         
        Name of Each Exchange
Title of Each Class       on Which Registered
         
Common Stock, $.01 Par Value       New York Stock Exchange
Securities Registered Pursuant to Section 12(g) of the Act: None
      Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.     Yes  x     No  o
      Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.     Yes  o     No  x
      Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes  x     No  o
      Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.     o
      Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer  x     Accelerated filer  o     Non-accelerated filer  o
      Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  o     No  x
      As of February 28, 2006, there were 386,931,100 outstanding shares of the Registrant’s Voting Common Stock and 21,000,000 shares of the Registrant’s Nonvoting Common Stock. As of June 30, 2005, the aggregate market value of the Common Stock held by nonaffiliates was approximately $23.5 billion. For purposes of the foregoing calculation only, the Registrant’s directors, executive officers and the HCA 401(k) Plan have been deemed to be affiliates.
DOCUMENTS INCORPORATED BY REFERENCE
      Portions of the Registrant’s definitive Proxy Statement for its 2006 Annual Meeting of Stockholders are incorporated by reference into Part III hereof.
 
 


 

INDEX
             
        Page
        Reference
         
 Part I
   Business     3  
   Risk Factors     22  
   Unresolved Staff Comments     30  
   Properties     30  
   Legal Proceedings     31  
   Submission of Matters to a Vote of Security Holders     32  
 Part II
   Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities     33  
   Selected Financial Data     34  
   Management’s Discussion and Analysis of Financial Condition and Results of Operations     36  
   Quantitative and Qualitative Disclosures about Market Risk     57  
   Financial Statements and Supplementary Data     57  
   Changes in and Disagreements with Accountants on Accounting and Financial Disclosure     57  
   Controls and Procedures     57  
   Other Information     58  
 Part III
   Directors and Executive Officers of the Registrant     59  
   Executive Compensation     59  
   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters     60  
   Certain Relationships and Related Transactions     60  
   Principal Accountant Fees and Services     60  
 Part IV
   Exhibits and Financial Statement Schedules     61  
 Signatures     67  
 EX-12 STATEMENT RE COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
 EX-21 LIST OF SUBSIDIARIES
 EX-23.1 CONSENT OF ERNST & YOUNG LLP
 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO
 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO
 EX-32 SECTION 906 CERTIFICATIONS OF THE CEO & CFO

2


Table of Contents

PART I
Item 1. Business
General
      HCA Inc. is one of the leading health care services companies in the United States. At December 31, 2005, we operated 182 hospitals, comprised of 175 general, acute care hospitals; six psychiatric hospitals; and one rehabilitation hospital. The 182 hospital total includes seven hospitals (six general, acute care hospitals and one rehabilitation hospital) owned by joint ventures in which an affiliate of HCA is a partner, and these joint ventures are accounted for using the equity method. In addition, we operated 94 freestanding surgery centers, seven of which are owned by joint ventures in which an affiliate of HCA is a partner and these joint ventures are accounted for using the equity method. Our facilities are located in 22 states, England and Switzerland. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein, refer to HCA Inc. and its affiliates unless otherwise stated or indicated by context. The term “affiliates” means direct and indirect subsidiaries of HCA Inc. and partnerships and joint ventures in which such subsidiaries are partners. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and references to “employees” refer to employees of affiliates of HCA.
      HCA’s primary objective is to provide the communities we serve a comprehensive array of quality health care services in the most cost-effective manner possible. Our general, acute care hospitals typically provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by our general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Our psychiatric hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings.
      The Company was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. HCA’s principal executive offices are located at One Park Plaza, Nashville, Tennessee 37203, and our telephone number is (615) 344-9551.
Available Information
      HCA files reports with the Securities and Exchange Commission (“SEC”), including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The public may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. HCA is an electronic filer and the SEC maintains an Internet site at http://www.sec.gov that contains the reports, proxy and information statements, and other information filed electronically. Our website address is www.hcahealthcare.com. Please note that our website address is provided as an inactive textual reference only. HCA makes available free of charge through our website the annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. The information provided on our website is not part of this report, and is therefore not incorporated by reference unless such information is specifically referenced elsewhere in this report.
      We have posted our Corporate Governance Guidelines; our Code of Conduct for directors, officers and employees; and the charters of our Audit; Compensation; Ethics, Compliance and Quality of Care; Finance and Investments; and Nominating and Corporate Governance Committees of the Board of Directors on our website at www.hcahealthcare.com (Corporate Governance page). Our corporate governance materials are available free of charge upon request to HCA’s Corporate Secretary, HCA Inc., One Park Plaza, Nashville, Tennessee 37203.

3


Table of Contents

Business Strategy
      HCA is committed to providing the communities we serve high quality, cost-effective health care while maintaining consistency with our ethics and compliance program, governmental regulations and guidelines, and industry standards. As a part of this strategy, management focuses on the following areas:
  •  commitment to the care and improvement of human life;
 
  •  commitment to ethics and compliance;
 
  •  focus on core communities;
 
  •  physician recruitment and retention;
 
  •  becoming the health care employer of choice;
 
  •  continuing to strive for operational excellence; and
 
  •  allocating capital to strategically complement our operational strategy and enhance stockholder value.
Health Care Facilities
      HCA currently owns, manages or operates hospitals; freestanding surgery centers; diagnostic and imaging centers; radiation and oncology therapy centers; comprehensive rehabilitation and physical therapy centers; and various other facilities.
      At December 31, 2005, HCA owned and operated 169 general, acute care hospitals with 40,665 licensed beds, and an additional six general, acute care hospitals with 2,127 licensed beds are operated through joint ventures, which are accounted for using the equity method. Most of our general, acute care hospitals provide medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services and emergency services. The general, acute care hospitals also provide outpatient services such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy. Each hospital has an organized medical staff and a local board of trustees or governing board, made up of members of the local community.
      Our hospitals do not typically engage in extensive medical research and education programs. However, some of our hospitals are affiliated with medical schools and may participate in the clinical rotation of medical interns and residents and other education programs.
      At December 31, 2005, HCA operated six psychiatric hospitals with 600 licensed beds. Our psychiatric hospitals provide therapeutic programs including child, adolescent and adult psychiatric care, adult and adolescent alcohol and drug abuse treatment and counseling.
      Outpatient health care facilities operated by HCA include freestanding surgery centers, diagnostic and imaging centers, comprehensive outpatient rehabilitation and physical therapy centers, outpatient radiation and oncology therapy centers and various other facilities. These outpatient services are an integral component of our strategy to develop comprehensive health care networks in select communities.
      In addition to providing capital resources, HCA affiliates provide a variety of management services to our health care facilities, including patient safety programs; ethics and compliance programs; national supply contracts; equipment purchasing and leasing contracts; accounting, financial and clinical systems; governmental reimbursement assistance; construction planning and coordination; information technology systems and solutions; legal counsel; human resources services; and internal audit services.
Sources of Revenue
      Hospital revenues depend upon inpatient occupancy levels, the medical and ancillary services ordered by physicians and provided to patients, the volume of outpatient procedures and the charges or payment rates for such services. Charges and reimbursement rates for inpatient services vary significantly depending on the type of service (e.g., medical/surgical, intensive care or psychiatric) and the geographic location of the hospital. Inpatient occupancy levels fluctuate for various reasons, many of which are beyond our control.

4


Table of Contents

      HCA receives payment for patient services from the federal government primarily under the Medicare program, state governments under their respective Medicaid or similar programs, managed care plans, private insurers and directly from patients. The approximate percentages of our patient revenues from such sources were as follows:
                           
    Year Ended December 31,
     
    2005   2004(a)   2003
             
Medicare
    27 %     28 %     28 %
Medicaid
    5       5       7  
Managed Medicaid
    3       3       (a )
Managed care and other insurers
    57       54       55  
Uninsured(b)
    8       10       10  
                   
 
Total
    100 %     100 %     100 %
                   
 
(a)  Prior to 2004, managed Medicaid revenues were classified as either Medicaid or managed care and certain 2004 amounts have been reclassified to conform to the 2005 presentation.
 
(b)  Uninsured revenues for the year ended December 31, 2005 were reduced by $769 million of discounts to the uninsured, related to the uninsured discount program implemented January 1, 2005.
      Medicare is a federal program that provides certain hospital and medical insurance benefits to persons age 65 and over, some disabled persons and persons with end-stage renal disease. Medicaid is a federal-state program, administered by the states, which provides hospital and medical benefits to qualifying individuals who are unable to afford health care. All of our general, acute care hospitals located in the United States are certified as health care services providers for persons covered under Medicare and Medicaid programs. Amounts received under Medicare and Medicaid programs are generally significantly less than established hospital gross charges for the services provided.
      Our hospitals generally offer discounts from established charges to certain group purchasers of health care services, including private insurance companies, employers, HMOs, PPOs and other managed care plans. These discount programs limit our ability to increase revenues in response to increasing costs. See Item 1, “Business — Competition.” Patients are generally not responsible for the total difference between established hospital gross charges and amounts reimbursed for such services under Medicare, Medicaid, HMOs or PPOs and other managed care plans, but are responsible to the extent of any exclusions, deductibles or coinsurance features of their coverage. The amount of such exclusions, deductibles and coinsurance has been increasing each year. Collection of amounts due from individuals is typically more difficult than from governmental or third-party payers. In 2003, we implemented changes to our uninsured care policies to provide financial relief to more of our uninsured patients. On January 1, 2005, we modified our policies to provide a discount to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. In implementing the discount policy, we attempt to qualify uninsured patients for Medicaid, other federal or state assistance or charity care. If an uninsured patient does not qualify for these programs, the uninsured discount is applied. See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Results of Operations — Revenue/ Volume Trends.”
Medicare
Inpatient Acute Care
      Under the Medicare program, we receive reimbursement under a prospective payment system (“PPS”) for general, acute care hospital inpatient services. Under hospital inpatient PPS, fixed payment amounts per inpatient discharge are established based on the patient’s assigned diagnosis related group (“DRG”). DRGs classify treatments for illnesses according to the estimated intensity of hospital resources necessary to furnish care for each principal diagnosis. DRG weights represent the average resources for a given DRG relative to the average resources for all DRGs. When the cost to treat certain patients falls well outside the normal

5


Table of Contents

distribution, providers typically receive additional “outlier” payments. DRG payments do not consider a specific hospital’s cost, but are adjusted for area wage differentials. Hospitals, other than those defined as “new,” receive PPS reimbursement for inpatient capital costs based on DRG weights multiplied by a geographically adjusted federal rate.
      DRG rates are updated and DRG weights are recalibrated each federal fiscal year. The index used to update the DRG rates (the “market basket”) gives consideration to the inflation experienced by hospitals and entities outside the health care industry in purchasing goods and services. However, for several years the percentage increases to the DRG rates have been lower than the percentage increases in the costs of goods and services purchased by hospitals. In federal fiscal year 2005, the DRG rate increase was market basket of 3.3%. For federal fiscal year 2006, the Centers for Medicare and Medicaid Services (“CMS”) set the DRG rate increase at full market basket of 3.7%. Through recent legislation, including the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (“MMA”), Congress equalized the DRG payment rate for urban and rural hospitals at the large urban rate for all hospitals, for discharges on or after April 1, 2003. MMA provides for DRG rate increases for federal fiscal years 2005, 2006, and 2007 at full market basket, if data for ten patient care quality indicators is submitted to the Secretary of the Department of Health and Human Services (“HHS”). Those hospitals not submitting data on the ten quality indicators will receive an increase equal to the market basket rate minus 0.4 percentage points. All HCA hospitals paid under Medicare inpatient DRG PPS are participating in the quality initiative by the Secretary of HHS by submitting the quality data requested for federal fiscal year 2006. For federal fiscal year 2007, MMA provides for a full market basket update. The Medicare Payment Advisory Commission (“MedPAC”) has adopted a recommendation that Congress update inpatient PPS payments for fiscal year 2007 by the market basket minus 0.45 percentage points. It is uncertain whether Congress will adopt this recommendation. On February 8, 2006, the Deficit Reduction Act of 2005 (“DEFRA 2005”) was enacted by Congress and expanded the number of quality measures that must be reported to receive a full market basket update for federal fiscal year 2007. Failure to submit the required quality indicators will result in a two percentage point reduction to the market basket update. We will attempt to comply with the DEFRA 2005 reporting requirements, but we are unable to predict if all our hospitals will be able to comply.
      Historically, the Medicare program has set aside 5.1% of Medicare inpatient payments to pay for outlier cases. In June 2003, CMS adopted significant regulatory changes to outlier payments. Included in the regulatory changes were provisions to: (1) use the most recent settled cost report to establish the hospital’s cost-to-charge ratio, (2) eliminate the use of the statewide average when the hospital’s cost-to-charge ratio falls three standard deviations below the national average, and (3) permit CMS to reconcile outlier payments in the Medicare cost report for hospitals meeting CMS defined audit criteria. As a result of these changes, CMS set the outlier threshold at $31,000 and $25,800 for federal fiscal years 2004 and 2005, respectively. CMS estimates that outlier payments were 3.5% and 4.1% of total operating DRG payments for federal fiscal years 2004 and 2005, respectively. For federal fiscal year 2006, CMS has established an outlier threshold of $23,600. Decreasing the outlier threshold in federal fiscal year 2006 will increase both the number of cases that qualify for outlier payments and the amount of payments for qualifying outlier cases; however, outlier payments are not expected to return to federal fiscal year 2003 and prior payment levels.
      HCA recorded $148 million, $124 million and $221 million of revenues related to Medicare operating outlier cases for 2005, 2004, and 2003, respectively. These amounts represent 2.2%, 1.9% and 3.7% of our Medicare revenues and 0.6%, 0.5% and 1.0% of our total revenues for 2005, 2004, and 2003, respectively.
Outpatient
      CMS reimburses hospital outpatient services (and certain Medicare Part B services furnished to hospital inpatients who have no Part A coverage) on a PPS basis. CMS has continued to use existing fee schedules to pay for physical, occupational and speech therapies, durable medical equipment, clinical diagnostic laboratory services and nonimplantable orthotics and prosthetics. Freestanding surgery centers and independent diagnostic testing facilities are reimbursed on a fee schedule.

6


Table of Contents

      Hospital outpatient services paid under PPS are classified into groups called ambulatory payment classifications (“APCs”). Services for each APC are similar clinically and in terms of the resources they require. A payment rate is established for each APC. Depending on the services provided, a hospital may be paid for more than one APC for a patient visit. The APC payment rates were updated for calendar years 2004 and 2005 by market basket of 3.4% and 3.3%, respectively. The update for calendar year 2006 is market basket of 3.7%. However, as a result of the expiration of additional payments for drugs that were being paid in calendar year 2005, for calendar year 2006 there has been an effective 2.25% reduction to the market basket of 3.7%. For calendar year 2007, MMA provides for a full market basket update. MedPAC has adopted a recommendation that Congress update outpatient PPS payments for fiscal year 2007 by the market basket minus 0.45 percentage points. It is uncertain whether Congress will adopt this recommendation.
Rehabilitation
      CMS reimburses inpatient rehabilitation facilities (“IRFs”) on a PPS basis. Under IRF PPS, patients are classified into case mix groups based upon impairment, age, comorbidities and functional capability. IRFs are paid a predetermined amount per discharge that reflects the patient’s case mix group and is adjusted for area wage levels, low-income patients, rural areas and high-cost outliers. For federal fiscal years 2004 and 2005, CMS updated the PPS rate for rehabilitation hospitals and units by market basket of 3.2% and 3.1%, respectively. For federal fiscal year 2006, CMS has updated the PPS rate for IRFs by market basket of 3.6%. However, CMS also applied a reduction to the standard payment amount of 1.9% to account for improved coding under IRF PPS. For fiscal year 2007, IRF PPS rates are to be updated by full market basket under current law. As of December 31, 2005, we had one rehabilitation hospital, which is operated through a joint venture, and 53 hospital rehabilitation units.
      On May 7, 2004, CMS published a final rule to change the criteria for being classified as an IRF, commonly known as the “75 percent rule”. CMS revised the medical conditions for patients served by rehabilitation facilities from ten medical conditions to 13 conditions. The final rule provides for a transition to targeting payments to facilities that treat a large share of patients with diagnoses likely to require intensive rehabilitation. For cost reporting periods that began on or after July 1, 2004, and before July 1, 2005, the compliance threshold was set at 50% of the IRF’s total patient population. For cost reporting periods beginning on or after July 1, 2005, and before July 1, 2006, the compliance threshold is set at 60% of the IRF’s total patient population. For cost reporting periods beginning on or after July 1, 2006, and before July 1, 2007, the compliance threshold is set at 65% of the IRF’s total patient population. The compliance threshold will be set at 75% for cost reporting periods beginning on or after July 1, 2007. In 2004, Congress enacted legislation preventing CMS from enforcing the final rule until the Government Accountability Office (“GAO”) completed a study on the rule’s impact on IRFs and patients. The GAO has issued their report and CMS has proceeded with implementation of the “75 percent rule”. DEFRA 2005 revised the phase-in period for the “75 percent rule” to retain the 60% threshold for cost reporting periods beginning on or after July 1, 2006 and before July 1, 2007 with the threshold increasing to 65% in 2007 and 75% in 2008. Implementation of the “75 percent rule” has started to reduce our IRF admissions and can be expected to continue to significantly restrict the treatment of patients whose medical conditions do not meet any of the 13 approved conditions.
      Medicare fiscal intermediaries have been given the authority to develop and implement Local Coverage Determinations (“LCD”) to determine the medical necessity of care rendered to Medicare patients where there is no national coverage determination. Some intermediaries have finalized their LCDs for rehabilitation services. A restrictive rehabilitation LCD has the potential to significantly impact Medicare rehabilitation payments. The financial impact to HCA of any final rehabilitation LCD is uncertain.
Psychiatric
      Payments to PPS-exempt psychiatric hospitals and units are based upon reasonable cost, subject to a cost-per-discharge target (the TEFRA limits) for cost reporting periods that began before January 1, 2005. These limits are updated annually by a market basket index. The update to a hospital’s target amount for its cost reporting periods beginning in federal fiscal years 2004 and 2005 was market basket of 3.4% and 3.3%, respectively. Caps had been established for the cost-per-discharge target at the 75th percentile for each category of PPS-exempt hospitals and units. For cost reporting periods beginning on or after October 1, 2002,

7


Table of Contents

payments to these PPS-exempt hospitals and units are no longer subject to these caps. However, if a PPS-exempt hospital or unit was subject to the cap in the cost report for the year prior to October 1, 2002, such limitation will be included in its future target amount. The cost-per-discharge for new hospitals and hospital units cannot exceed 110% of the national median target rate for hospitals in the same category. The target amount for federal fiscal year 2006 is subject to a market basket update of 3.8% for psychiatric hospitals and units that are being paid under the three year transition to the inpatient psychiatric PPS.
      On November 15, 2004, CMS published a final regulation to implement a PPS for inpatient hospital services furnished in psychiatric hospitals and psychiatric units of general, acute care hospitals and critical access hospitals (“IPF PPS”). The new prospective payment system replaces the cost-based system for reporting periods beginning on or after January 1, 2005. IPF PPS is a per diem prospective payment system, with adjustments to account for certain patient and facility characteristics. IPF PPS contains an “outlier” policy for extraordinarily costly cases and an adjustment to a facility’s base payment if it maintains a full-service emergency department. IPF PPS is being implemented over a three-year transition period with full payment under IPF PPS to begin in the fourth year. Also, CMS has included a stop-loss provision to ensure that hospitals avoid significant losses during the transition. CMS has established the IPF PPS payment rate in a manner intended to be budget neutral and has adopted a July 1 update cycle. Thus, the initial IPF PPS per diem payment rate will be effective for the 18-month period January 1, 2005 through June 30, 2006. On January 23, 2006, CMS published a proposed rule to update the IPF PPS for rate year 2007(July 1, 2006 to June 30, 2007) that would result in a 4.7% increase in overall payments to IPFs (reflecting the blend of the 4.8% update for IPF TEFRA and the 4.5% update for IPF PPS payments). The market basket update accounts for moving from a calendar year to a rate year (the annual market basket is estimated to be 3.6%). This rule has not yet been finalized. As of December 31, 2005, HCA had six psychiatric hospitals and 37 hospital psychiatric units.
Other
      Under PPS, the prospective payment rates are adjusted for the area differences in wage levels by a factor (“wage index”) reflecting the relative wage level in the geographic area compared to the national average wage level. Effective October 1, 2004 for inpatient PPS and January 1, 2005 for outpatient PPS, CMS implemented a number of changes to the wage index calculation. These changes included the adoption of standards for defining labor market geographic areas based on standards for defining Core-Based Statistical Areas (“CBSA”) issued by the Office of Management and Budget (“OMB”). Hospitals that were adversely impacted by this new definition received a blended (50/50) wage index based on the old and new wage geographic definitions for one year. Further, CMS has applied an occupational mix adjustment factor to the wage index amounts for the first time, but has limited the adjustment to 10% of the wage index. MMA lowered the labor share for inpatient PPS payments from 71.1% to 62%, effective October 1, 2004, unless the lower percentage would result in lower payments to the hospital. This change, in effect, increases payments for all hospitals whose wage index is less than or equal to 1.0. For all other hospitals, CMS lowered the 71.1% labor share to 69.7%, effective October 1, 2005. Also, effective October 1, 2005, IRF PPS adopted the CBSA definition of labor market geographic areas but have not adopted an occupational mix adjustment. For federal fiscal year 2006, IRFs will receive a blended (50/50) wage index based on the old and new wage geographic definitions. The geographic definition changes and the occupational mix adjustment have not been applied to IPF PPS at this time. However, in the proposed rule published on January 23, 2006, CMS has proposed to adopt the CBSA definition of labor market geographic areas for IPF PPS effective July 1, 2006. The financial impact, if any, that these changes will have on the Company beyond 2006 is uncertain.
      CMS has a significant initiative underway that could affect the administration of the Medicare program and impact how hospitals bill and receive payment for covered Medicare services. In accordance with MMA, CMS will implement contractor reform whereby CMS will competitively bid the Medicare fiscal intermediary and Medicare carrier functions to Medicare Administrative Contractors (“MACs”). CMS plans to award the first of 15 multi-state jurisdictions in June 2006. Seven jurisdictions are planned to be awarded in September 2007 and the remaining seven jurisdictions are planned to be awarded in September 2008. All of these changes

8


Table of Contents

could impact claim processing functions and the resulting cash flow. The Company is unable to predict the impact that these changes could have, if any, to cash flow.
Medicaid
      Medicaid programs are funded jointly by the federal government and the states and are administered by states under approved plans. Most state Medicaid program payments are made under a PPS or are based on negotiated payment levels with individual hospitals. Medicaid reimbursement is often less than a hospital’s cost of services. The federal government and many states are currently considering altering the level of Medicaid funding (including upper payment limits) or program eligibility that could adversely affect future levels of Medicaid reimbursement received by our hospitals. As permitted by law, certain states in which we operate have adopted broad-based provider taxes to fund their Medicaid programs.
Managed Medicaid
      Managed Medicaid programs relate to situations where states contract with one or more entities for patient enrollment, care management and claims adjudication. The states usually do not abdicate program responsibilities for financing, eligibility criteria and core benefit plan design. We generally contract directly with one of the designated entities, usually a managed care organization. The provisions of these programs are state specific.
Annual Cost Reports
      All hospitals participating in the Medicare, Medicaid and TRICARE programs, whether paid on a reasonable cost basis or under a PPS, are required to meet certain financial reporting requirements. Federal and, where applicable, state regulations require the submission of annual cost reports covering the revenue, costs and expenses associated with the services provided by each hospital to Medicare beneficiaries and Medicaid recipients.
      Annual cost reports required under the Medicare and Medicaid programs are subject to routine audits, which may result in adjustments to the amounts ultimately determined to be due to us under these reimbursement programs. These audits often require several years to reach the final determination of amounts due to or from us under these programs. Providers also have rights of appeal, and it is common to contest issues raised in audits of prior years’ reports.
      In June 2003, HCA announced that the Company and the Civil Division of the Department of Justice (“DOJ”) had signed agreements whereby the United States would dismiss the various claims it had brought related to physician relations, cost reports and wound care issues (the “DOJ Agreement”). The DOJ Agreement received court approval in July 2003, and we paid the DOJ $641 million (including accrued interest of $10 million) during July 2003. HCA also finalized an agreement with a negotiating team representing states that may have claims against HCA. Under this agreement, we paid $17.7 million in July 2003 to state Medicaid agencies to resolve these claims. We also paid $33 million for legal fees of the private parties.
Managed Care and Other Discounted Plans
      Most of our hospitals offer discounts from established charges to certain large group purchasers of health care services, including managed care plan and private insurance companies. Admissions reimbursed by managed care and other insurers were 42%, 42% and 44% of our total admissions for the years ended December 31, 2005, 2004 and 2003, respectively. Managed care contracts are typically negotiated for one-year or two-year terms. While we generally received annual average yield increases of six to seven percent from managed care payers during 2005, there can be no assurance that we will continue to receive increases in the future.

9


Table of Contents

Hospital Utilization
      HCA believes that the most important factors relating to the overall utilization of a hospital are the quality and market position of the hospital and the number and quality of physicians and other health care professionals providing patient care within the facility. Generally, we believe the ability of a hospital to be a market leader is determined by its breadth of services, level of technology, emphasis on quality of care and convenience for patients and physicians. Other factors that impact utilization include the growth in local population, local economic conditions and market penetration of managed care programs.
      The following table sets forth certain operating statistics for our hospitals. Hospital operations are subject to certain seasonal fluctuations, including decreases in patient utilization during holiday periods and increases in the cold weather months.
                                         
    Years Ended December 31,
     
    2005   2004   2003   2002   2001
                     
Number of hospitals at end of period(a)
    175       182       184       173       178  
Number of freestanding outpatient surgery centers at end of period(b)
    87       84       79       74       76  
Number of licensed beds at end of period(c)
    41,265       41,852       42,108       39,932       40,112  
Weighted average licensed beds(d)
    41,902       41,997       41,568       39,985       40,645  
Admissions(e)
    1,647,800       1,659,200       1,635,200       1,582,800       1,564,100  
Equivalent admissions(f)
    2,476,600       2,454,000       2,405,400       2,339,400       2,311,700  
Average length of stay (days)(g)
    4.9       5.0       5.0       5.0       4.9  
Average daily census(h)
    22,225       22,493       22,234       21,509       21,160  
Occupancy rate(i)
    53 %     54 %     54 %     54 %     52 %
Emergency room visits(j)
    5,415,200       5,219,500       5,160,200       4,802,800       4,676,800  
Outpatient surgeries(k)
    836,600       834,800       814,300       809,900       804,300  
Inpatient surgeries(l)
    541,400       541,000       528,600       518,100       507,800  
 
(a) Excludes seven facilities in 2005, 2004 and 2003, and six facilities in 2002 and 2001 that are not consolidated (accounted for using the equity method) for financial reporting purposes. Three hospitals located on the same campus were consolidated and counted as one hospital in 2005.
(b) Excludes seven facilities in 2005, eight facilities in 2004, four facilities in 2003 and 2002 and three facilities in 2001 that are not consolidated (accounted for using the equity method) for financial reporting purposes.
(c) Licensed beds are those beds for which a facility has been granted approval to operate from the applicable state licensing agency.
(d) Represents the average number of licensed beds, weighted based on periods owned.
(e) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.
(f) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue. The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume. Equivalent admissions for 2004 were reclassified to conform to the 2005 presentation.
(g) Represents the average number of days admitted patients stay in our hospitals.
(h) Represents the average number of patients in our hospital beds each day.
(i) Represents the percentage of hospital licensed beds occupied by patients. Both average daily census and occupancy rate provide measures of the utilization of inpatient rooms.
(j) Represents the number of patients treated in our emergency rooms.
(k) Represents the number of surgeries performed on patients who were not admitted to our hospitals. Pain management and endoscopy procedures are not included in outpatient surgeries.
(l) Represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management and endoscopy procedures are not included in inpatient surgeries.

10


Table of Contents

Competition
      Generally, other hospitals in the local communities served by most of HCA’s hospitals provide services similar to those offered by our hospitals. Additionally, in the past several years the number of freestanding surgery centers and diagnostic centers (including facilities owned by physicians) in the geographic areas in which we operate has increased significantly. As a result, most of our hospitals operate in a highly competitive environment. The rates charged by our hospitals are intended to be competitive with those charged by other local hospitals for similar services. In some cases, competing hospitals are more established than our hospitals. Some competing hospitals are owned by tax-supported government agencies and many others are owned by not-for-profit entities that may be supported by endowments, charitable contributions and/or tax revenues and are exempt from sales, property and income taxes. Such exemptions and support are not available to our hospitals. In addition, in certain localities there are large teaching hospitals that provide highly specialized facilities, equipment and services which may not be available at most of our hospitals. We are facing increasing competition from physician-owned specialty hospitals and freestanding surgery centers for market share in high margin services. Psychiatric hospitals frequently attract patients from areas outside their immediate locale and, therefore, our psychiatric hospitals compete with both local and regional hospitals, including the psychiatric units of general, acute care hospitals.
      Our strategies are designed to ensure our hospitals are competitive. We believe our hospitals compete within local communities on the basis of many factors, including the quality of care, ability to attract and retain quality physicians, skilled clinical personnel and other health care professionals, location, breadth of services, technology offered and prices charged. We have increased our focus on operating outpatient services with improved accessibility and more convenient service for patients, and increased predictability and efficiency for physicians.
      Two of the most significant factors to the competitive position of a hospital are the number and quality of physicians affiliated with the hospital. Although physicians may at any time terminate their affiliation with a hospital operated by HCA, our hospitals seek to retain physicians with varied specialties on the hospitals’ medical staffs and to attract other qualified physicians. We believe that physicians refer patients to a hospital on the basis of the quality and scope of services it renders to patients and physicians, the quality of physicians on the medical staff, the location of the hospital and the quality of the hospital’s facilities, equipment and employees. Accordingly, we strive to maintain and provide quality facilities, equipment, employees and services for physicians and patients.
      Another major factor in the competitive position of a hospital is management’s ability to negotiate service contracts with purchasers of group health care services. Managed care plans attempt to direct and control the use of hospital services and obtain discounts from hospitals’ established gross charges. In addition, employers and traditional health insurers are increasingly interested in containing costs through negotiations with hospitals for managed care programs and discounts from established gross charges. Generally, hospitals compete for service contracts with group health care services purchasers on the basis of price, market reputation, geographic location, quality and range of services, quality of the medical staff and convenience. The importance of obtaining contracts with managed care organizations varies from community to community, depending on the market strength of such organizations.
      State certificate of need (“CON”) laws, which place limitations on a hospital’s ability to expand hospital services and facilities, make capital expenditures and otherwise make changes in operations, may also have the effect of restricting competition. In those states which have no CON laws or which set relatively high levels of expenditures before they become reviewable by state authorities, competition in the form of new services, facilities and capital spending is more prevalent. See Item 1, “Business — Regulation and Other Factors.”
      HCA, and the health care industry as a whole, face the challenge of continuing to provide quality patient care while dealing with rising costs and strong competition for patients. Changes in medical technology, existing and future legislation, regulations and interpretations and competitive contracting for provider services by private and government payers remain ongoing challenges. These challenges may require changes in our operations in the future.

11


Table of Contents

      Admissions and average lengths of stay continue to be negatively affected by payer-required pre-admission authorization, utilization review and payer pressure to maximize outpatient and alternative health care delivery services for less acutely ill patients. Increased competition, admission constraints and payer pressures are expected to continue. To meet these challenges, we intend to expand many of our facilities or acquire or construct new facilities, to better enable the provision of a comprehensive array of outpatient services, offer discounts to private payer groups, upgrade facilities and equipment, and offer new or expanded programs and services.
Regulation and Other Factors
Licensure, Certification and Accreditation
      Health care facility construction and operation are subject to numerous federal, state and local regulations relating to the adequacy of medical care, equipment, personnel, operating policies and procedures, maintenance of adequate records, fire prevention, rate-setting and compliance with building codes and environmental protection laws. Facilities are subject to periodic inspection by governmental and other authorities to assure continued compliance with the various standards necessary for licensing and accreditation. We believe that our health care facilities are properly licensed under applicable state laws. All of our general, acute care hospitals are certified for participation in the Medicare and Medicaid programs and are accredited by the Joint Commission on Accreditation of Healthcare Organizations (“Joint Commission”). If any facility were to lose its Joint Commission accreditation or otherwise lose its certification under the Medicare and Medicaid programs, the facility would be unable to receive reimbursement from the Medicare and Medicaid programs. Management believes our facilities are in substantial compliance with current applicable federal, state, local and independent review body regulations and standards. The requirements for licensure, certification and accreditation are subject to change and, in order to remain qualified, it may become necessary for us to make changes in our facilities, equipment, personnel and services.
Certificates of Need
      In some states where HCA operates hospitals, the construction or expansion of health care facilities, the acquisition of existing facilities, the transfer or change of ownership and the addition of new beds or services may be subject to review by and prior approval of state regulatory agencies under a CON program. Such laws generally require the reviewing state agency to determine the public need for additional or expanded health care facilities and services. Failure to obtain necessary state approval can result in the inability to expand facilities, complete an acquisition or change ownership.
State Rate Review
      Some states where we operate hospitals have adopted legislation mandating rate or budget review for hospitals or have adopted taxes on hospital revenues, assessments or licensure fees to fund indigent health care within the state. In the aggregate, state rate reviews and indigent tax provisions have not materially, adversely affected our results of operations.
Utilization Review
      Federal law contains numerous provisions designed to ensure that services rendered by hospitals to Medicare and Medicaid patients meet professionally recognized standards and are medically necessary and that claims for reimbursement are properly filed. These provisions include a requirement that a sampling of admissions of Medicare and Medicaid patients must be reviewed by quality improvement organizations to assess the appropriateness of Medicare and Medicaid patient admissions and discharges, the quality of care provided, the validity of DRG classifications and the appropriateness of cases of extraordinary length of stay or cost. Quality improvement organizations may deny payment for services provided, may assess fines and also have the authority to recommend to HHS that a provider, which is in substantial noncompliance with the appropriate standards, be excluded from participating in the Medicare program. Most nongovernmental managed care organizations also require utilization review.

12


Table of Contents

Federal Health Care Program Regulations
      Participation in any federal health care program, including the Medicare and Medicaid programs, is heavily regulated by statute and regulation. If a hospital fails to substantially comply with the numerous conditions of participation in the Medicare and Medicaid programs or performs certain prohibited acts, the hospital’s participation in the federal health care programs may be terminated, or civil or criminal penalties may be imposed under certain provisions of the Social Security Act, or both.
Anti-kickback Statute
      A section of the Social Security Act known as the “Anti-kickback Statute” prohibits providers and others from directly or indirectly soliciting, receiving, offering or paying any remuneration with the intent of generating referrals or orders for services or items covered by a federal health care program. Courts have interpreted this statute broadly. Violations of the Anti-kickback Statute may be punished by a criminal fine of up to $25,000 for each violation or imprisonment, civil money penalties of up to $50,000 per violation and damages of up to three times the total amount of the remuneration and/or exclusion from participation in federal health care programs, including Medicare and Medicaid.
      The Office of Inspector General at HHS (“OIG”), among other regulatory agencies, is responsible for identifying and eliminating fraud, abuse and waste. The OIG carries out this mission through a nationwide program of audits, investigations and inspections. As one means of providing guidance to health care providers, the OIG issues “Special Fraud Alerts.” These alerts do not have the force of law, but identify features of arrangements or transactions that may indicate that the arrangements or transactions violate the Anti-kickback Statute or other federal health care laws. The OIG has identified several incentive arrangements, which, if accompanied by inappropriate intent, constitute suspect practices, including: (a) payment of any incentive by the hospital each time a physician refers a patient to the hospital, (b) the use of free or significantly discounted office space or equipment in facilities usually located close to the hospital, (c) provision of free or significantly discounted billing, nursing or other staff services, (d) free training for a physician’s office staff in areas such as management techniques and laboratory techniques, (e) guarantees which provide that, if the physician’s income fails to reach a predetermined level, the hospital will pay any portion of the remainder, (f) low-interest or interest-free loans, or loans which may be forgiven if a physician refers patients to the hospital, (g) payment of the costs of a physician’s travel and expenses for conferences, (h) coverage on the hospital’s group health insurance plans at an inappropriately low cost to the physician, (i) payment for services (which may include consultations at the hospital) which require few, if any, substantive duties by the physician, (j) purchasing goods or services from physicians at prices in excess of their fair market value, (k) rental of space in physician offices, at other than fair market value terms, by persons or entities to which physicians refer, and (l) certain “gainsharing” arrangements, i.e., the practice of giving physicians a share of any reduction in a hospital’s costs for patient care attributable in part to the physician’s efforts. The OIG has encouraged persons having information about hospitals who offer the above types of incentives to physicians to report such information to the OIG.
      The OIG also issues “Special Advisory Bulletins” as a means of providing guidance to health care providers. These bulletins, along with the “Special Fraud Alerts,” have focused on certain arrangements that could be subject to heightened scrutiny by government enforcement authorities, including contractual joint venture arrangements and other joint venture arrangements between those in a position to refer business, such as physicians, and those providing items or services for which Medicare or Medicaid pays.
      In addition to issuing fraud alerts and special advisory bulletins, the OIG from time to time issues compliance program guidance for certain types of health care providers. In January 2005, the OIG published Supplemental Compliance Guidance for Hospitals, supplementing its 1998 guidance for the hospital industry. In the supplemental guidance, the OIG identifies a number of risk areas under federal fraud and abuse statutes and regulations. These areas of risk include compensation arrangements with physicians, recruitment arrangements with physicians and joint venture relationships with physicians.
      As authorized by Congress, the OIG has published safe harbor regulations that outline categories of activities that are deemed protected from prosecution under the Anti-kickback Statute. Currently, there are

13


Table of Contents

statutory exceptions and safe harbors for various activities, including the following: investment interests, space rental, equipment rental, practitioner recruitment, personnel services and management contracts, sale of practice, referral services, warranties, discounts, employees, group purchasing organizations, waiver of beneficiary coinsurance and deductible amounts, managed care arrangements, obstetrical malpractice insurance subsidies, investments in group practices, freestanding surgery centers, ambulance replenishing, and referral agreements for specialty services. The fact that conduct or a business arrangement does not fall within a safe harbor, or that it is identified in a fraud alert or as a risk area in the Supplemental Compliance Guidelines for Hospitals, does not automatically render the conduct or business arrangement illegal under the Anti-kickback Statute. However, such conduct and business arrangements may lead to increased scrutiny by government enforcement authorities. Although the Company believes that its arrangements with physicians have been structured to comply with current law and available interpretations, there can be no assurance that regulatory authorities enforcing these laws will determine these financial arrangements do not violate the Anti-kickback Statute or other applicable laws. An adverse determination could subject the Company to liabilities under the Social Security Act, including criminal penalties, civil monetary penalties and exclusion from participation in Medicare, Medicaid or other federal health care programs.
Stark Law
      The Social Security Act also includes a provision commonly known as the “Stark Law.” This law effectively prohibits physicians from referring Medicare and Medicaid patients to entities with which they or any of their immediate family members have a financial relationship, if these entities provide certain designated health services that are reimbursable by Medicare, including inpatient and outpatient hospital services. Sanctions for violating the Stark Law include denial of payment, refunding amounts received for services provided pursuant to prohibited referrals, civil monetary penalties of up to $15,000 per prohibited service provided, and exclusion from the Medicare and Medicaid programs. The statute also provides for a penalty of up to $100,000 for a circumvention scheme. There are exceptions to the self-referral prohibition for many of the customary financial arrangements between physicians and providers, including employment contracts, leases and recruitment agreements. There is also an exception for a physician’s ownership interest in an entire hospital, as opposed to an ownership interest in a hospital department.
      CMS has issued two phases of final regulations implementing the Stark Law, which became effective on January 4, 2002 and July 26, 2004, respectively. While these regulations help clarify the requirements of the exceptions to the Stark Law, it is unclear how the government will interpret them for enforcement purposes.
      In 2003, Congress passed legislation that modified the hospital ownership exception to the Stark Law by creating an 18-month moratorium on allowing physicians to own interests in new specialty hospitals. During the moratorium, HHS was required to conduct an analysis of specialty hospitals, including quality of care provided and physician referral patterns to these facilities. MedPAC was also required to study cost and payment issues related to specialty hospitals. The moratorium applied to hospitals that primarily or exclusively treat cardiac, orthopedic or surgical conditions or any other specialized category of patients or cases designated by regulation, unless the hospitals were in operation or development before November 18, 2003, did not increase the number of physician investors, and met certain other requirements. The moratorium expired on June 8, 2005. In March 2005, MedPAC issued its report on specialty hospitals, in which it recommended that Congress extend the moratorium until January 1, 2007, modify payments to hospitals to reflect more closely the cost of care, and allow certain types of gainsharing arrangements. In May 2005, HHS issued the required report of its analysis of specialty hospitals in which it recommended reforming certain inpatient hospital services and ambulatory surgery center services payment rates that may currently encourage the establishment of specialty hospitals and implementation of closer scrutiny of the processes for approving new specialty hospitals for participation in Medicare. Further, HHS suspended processing new provider enrollment applications for specialty hospitals until January 2006, creating in effect a moratorium on new specialty hospitals. DEFRA 2005, signed into law February 8, 2006, directed HHS to extend this enrollment suspension until the earlier of six months from the enactment of DEFRA 2005 or the release of a report regarding physician owned specialty hospitals by HHS.

14


Table of Contents

Similar State Laws
      Many states in which HCA operates also have laws that prohibit payments to physicians for patient referrals similar to the Anti-kickback Statute and self-referral legislation similar to the Stark Law. The scope of these state laws is broad, since they can often apply regardless of the source of payment for care, and little precedent exists for their interpretation or enforcement. These statutes typically provide for criminal and civil penalties as well as loss of facility licensure.
HIPAA and BBA-97
      The Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) broadened the scope of certain fraud and abuse laws by adding several criminal provisions for health care fraud offenses that apply to all health benefit programs. HIPAA also added a prohibition against incentives intended to influence decisions by Medicare beneficiaries as to the provider from which they will receive services. In addition, HIPAA created new enforcement mechanisms to combat fraud and abuse, including the Medicare Integrity Program, and an incentive program under which individuals can receive up to $1,000 for providing information on Medicare fraud and abuse that leads to the recovery of at least $100 of Medicare funds. Federal enforcement officials now have the ability to exclude from Medicare and Medicaid any investors, officers and managing employees associated with business entities that have committed health care fraud, even if the officer or managing employee had no knowledge of the fraud. HIPAA was followed by the Balanced Budget Act of 1997 (“BBA-97”), which created additional fraud and abuse provisions, including civil penalties for contracting with an individual or entity that the provider knows or should know is excluded from a federal health care program.
Other Fraud and Abuse Provisions
      The Social Security Act also imposes criminal and civil penalties for making false claims and statements to Medicare and Medicaid. False claims include, but are not limited to, billing for services not rendered or for misrepresenting actual services rendered in order to obtain higher reimbursement, billing for unnecessary goods and services, and cost report fraud. Criminal and civil penalties may be imposed for a number of other prohibited activities, including failure to return known overpayments, certain gainsharing arrangements, and offering remuneration to influence a Medicare or Medicaid beneficiary’s selection of a health care provider. Like the Anti-kickback Statute, these provisions are very broad. Careful and accurate coding of claims for reimbursement, as well as accurately preparing cost reports, must be performed to avoid liability.
The Federal False Claims Act and Similar State Laws
      A factor affecting the health care industry is the use of the federal False Claims Act and, in particular, actions brought by individuals on the government’s behalf under the False Claims Act’s “qui tam,” or whistleblower, provisions. Whistleblower provisions allow private individuals to bring actions on behalf of the government alleging that the defendant has defrauded the federal government.
      When a defendant is determined by a court of law to be liable under the False Claims Act, the defendant may be required to pay three times the actual damages sustained by the government, plus mandatory civil penalties of between $5,500 and $11,000 for each separate false claim. There are many potential bases for liability under the False Claims Act. Liability often arises when an entity knowingly submits a false claim for reimbursement to the federal government. The False Claims Act defines the term “knowingly” broadly. Though simple negligence will not give rise to liability under the False Claims Act, submitting a claim with reckless disregard to its truth or falsity constitutes a “knowing” submission under the False Claims Act and, therefore, will qualify for liability.
      In some cases, whistleblowers and the federal government have taken the position that providers who allegedly have violated other statutes, such as the Anti-kickback Statute and the Stark Law, have thereby submitted false claims under the False Claims Act. A number of states in which HCA operates have adopted their own false claims provisions as well as their own whistleblower provisions whereby a private party may file a civil lawsuit in state court.

15


Table of Contents

HIPAA Administrative Simplification and Privacy Requirements
      The Administrative Simplification Provisions of HIPAA require the use of uniform electronic data transmission standards for certain health care claims and payment transactions submitted or received electronically. These provisions are intended to encourage electronic commerce in the health care industry. HHS has issued regulations implementing the HIPAA Administrative Simplification Provisions and compliance with these regulations became mandatory for HCA’s facilities in October 2003, although CMS accepted noncompliant claims through September 30, 2005. HHS recently proposed a rule that would establish standards for electronic health care claims attachments. We believe that the cost of compliance with these regulations has not had and is not expected to have a material adverse effect on our business, financial position or results of operations.
      HIPAA also requires HHS to adopt standards to protect the privacy and security of individually identifiable health-related information. HHS issued regulations containing privacy standards and compliance with these regulations became mandatory during April 2003. The privacy regulations regulate the use and disclosure of individually identifiable health-related information, whether communicated electronically, on paper or orally. The regulations also provide patients with significant new rights related to understanding and controlling how their health information is used or disclosed. HHS released final security regulations that became mandatory during April 2005 and require health care providers to implement administrative, physical and technical practices to protect the security of individually identifiable health information that is maintained or transmitted electronically. The privacy regulations and security regulations have and will continue to impose significant costs on our facilities in order to comply with these standards.
      Violations of HIPAA could result in civil penalties of up to $25,000 per type of violation in each calendar year and criminal penalties of up to $250,000 per violation. In addition, there are numerous legislative and regulatory initiatives at the federal and state levels addressing patient privacy concerns. Facilities will continue to remain subject to any federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA. These statutes vary and could impose additional penalties.
EMTALA
      All of HCA’s hospitals are subject to the Emergency Medical Treatment and Active Labor Act (“EMTALA”). This federal law requires any hospital that participates in the Medicare program to conduct an appropriate medical screening examination of every individual who presents to the hospital’s emergency room for treatment and, if the individual is suffering from an emergency medical condition, to either stabilize that condition or make an appropriate transfer of the individual to a facility that can handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of an individual’s ability to pay for treatment. There are severe penalties under EMTALA if a hospital fails to screen or appropriately stabilize or transfer an individual or if the hospital delays appropriate treatment in order to first inquire about the individual’s ability to pay. Penalties for violations of EMTALA include civil monetary penalties and exclusion from participation in the Medicare program. In addition, an injured individual, the individual’s family or a medical facility that suffers a financial loss as a direct result of another hospital’s violation of the law can bring a civil suit against the hospital.
      The government broadly interprets EMTALA to cover situations in which individuals do not actually present to a hospital’s emergency room, but present for emergency examination or treatment to the hospital’s campus, generally, or to a hospital-based clinic that treats emergency medical conditions or are transported in a hospital-owned ambulance, subject to certain exceptions. EMTALA does not generally apply to individuals admitted for inpatient services. The government also has expressed its intent to investigate and enforce EMTALA violations actively in the future. We believe our hospitals operate in substantial compliance with EMTALA.
Corporate Practice of Medicine/Fee Splitting
      Some of the states in which we operate have laws that prohibit corporations and other entities from employing physicians and practicing medicine for a profit or that prohibit certain direct and indirect payments or fee-splitting arrangements between health care providers that are designed to induce or encourage the

16


Table of Contents

referral of patients to, or the recommendation of, particular providers for medical products and services. Possible sanctions for violation of these restrictions include loss of license and civil and criminal penalties. In addition, agreements between the corporation and the physician may be considered void and unenforceable. These statutes vary from state to state, are often vague and have seldom been interpreted by the courts or regulatory agencies.
Health Care Industry Investigations
      Significant media and public attention has focused in recent years on the hospital industry. While we are currently not aware of any material investigations of the Company, under federal or state health care laws or regulations, it is possible that governmental entities could initiate investigations or litigation in the future at facilities we operate and that such matters could result in significant penalties as well as adverse publicity. It is also possible that HCA’s executives and managers could be included in governmental investigations or litigation or named as defendants in private litigation.
      The Company’s substantial Medicare, Medicaid and other governmental billings result in heightened scrutiny of its operations. We continue to monitor all aspects of our business and have developed a comprehensive ethics and compliance program that is designed to meet or exceed applicable federal guidelines and industry standards. Because the law in this area is complex and constantly evolving, governmental investigations or litigation may result in interpretations that are inconsistent with industry practices, including the Company’s.
      In public statements surrounding current investigations, governmental authorities have taken positions on a number of issues, including some for which little official interpretation previously has been available, that appear to be inconsistent with practices that have been common within the industry and that previously have not been challenged in this manner. In some instances, government investigations that have in the past been conducted under the civil provisions of federal law may now be conducted as criminal investigations.
      Both federal and state government agencies have increased their focus on and coordination of civil and criminal enforcement efforts in the health care area. The OIG and the Department of Justice have, from time to time, established national enforcement initiatives, targeting all hospital providers, that focus on specific billing practices or other suspected areas of abuse. Further, under the federal False Claims Act, private parties have the right to bring “qui tam” whistleblower lawsuits against companies that submit false claims for payments to the government. Some states have adopted similar state whistleblower and false claims provisions.
      In addition to national enforcement initiatives, federal and state investigations relate to a wide variety of routine health care operations such as: cost reporting and billing practices, including for Medicare outliers; financial arrangements with referral sources; physician recruitment activities; physician joint ventures; and hospital charges and collection practices for self-pay patients. We engage in many of these routine health care operations and other activities that could be the subject of governmental investigations or inquiries from time to time. For example, we have significant Medicare and Medicaid billings, we have numerous financial arrangements with physicians who are referral sources to our hospitals and we have joint venture arrangements involving physician investors. Any additional investigations of the Company, our executives or managers could result in significant liabilities or penalties to us, as well as adverse publicity.
Health Care Reform
      Health care is one of the largest industries in the United States and continues to attract much legislative interest and public attention. In recent years, various legislative proposals have been introduced or proposed in Congress and in some state legislatures that would effect major changes in the health care system, either nationally or at the state level. Many states have enacted, or are considering enacting, measures designed to reduce their Medicaid expenditures and change private health care insurance. DEFRA 2005, signed into law on February 8, 2006, included Medicaid cuts of approximately $4.8 billion over five years. In addition, proposed regulatory changes would, if implemented, reduce federal Medicaid funding by an additional $12.2 billion over five years. Most states, including the states in which HCA operates, have applied for and

17


Table of Contents

have been granted federal waivers from current Medicaid regulations to allow them to serve some or all of their Medicaid participants through managed care providers.
Compliance Program and Corporate Integrity Agreement
      HCA maintains a comprehensive ethics and compliance program that is designed to meet or exceed applicable federal guidelines and industry standards. The program is intended to monitor and raise awareness of various regulatory issues among employees and to emphasize the importance of complying with governmental laws and regulations. As part of the ethics and compliance program, we provide annual ethics and compliance training to our employees and encourage all employees to report any violations to their supervisor, an ethics and compliance officer or a toll-free telephone ethics line.
      In January 2001, HCA entered into an eight-year Corporate Integrity Agreement (“CIA”) with the OIG. The CIA is structured to assure the federal government of our overall federal health care program compliance and specifically covers DRG coding, outpatient PPS billing and physician relations. The CIA also included testing for outpatient laboratory billing in 2001, which was replaced with skilled nursing facilities billing in 2003. Under the CIA, we have an affirmative obligation to report potential violations of applicable federal heath care laws and regulations and have, pursuant to this obligation, reported a number of potential violations of the Stark, EMTALA and other laws, most of which we consider to be technical violations. This obligation could result in greater scrutiny by regulatory authorities. Breach of the CIA could subject us to substantial monetary penalties and/or exclusion from participation in the Medicare and Medicaid programs.
Antitrust Laws
      The federal government and most states have enacted antitrust laws that prohibit certain types of conduct deemed to be anti-competitive. These laws prohibit price fixing, concerted refusal to deal, market monopolization, price discrimination, tying arrangements, acquisitions of competitors and other practices that have, or may have, an adverse effect on competition. Violations of federal or state antitrust laws can result in various sanctions, including criminal and civil penalties. Antitrust enforcement in the health care industry is currently a priority of the Federal Trade Commission. We believe we are in compliance with such federal and state laws, but there can be no assurance that a review of our practices by courts or regulatory authorities will not result in a determination that could adversely affect our operations.
Environmental Matters
      HCA is subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. Management does not believe that we will be required to expend any material amounts in order to comply with these laws and regulations or that compliance will materially affect our capital expenditures, results of operations or financial condition.
Insurance
      As is typical in the health care industry, HCA is subject to claims and legal actions by patients in the ordinary course of business. Through a wholly-owned insurance subsidiary, we insure a substantial portion of our professional liability risks. Our facilities are insured by the insurance subsidiary for losses of up to $50 million per occurrence. The insurance subsidiary has obtained reinsurance for professional liability risks generally above a rentention level of $15 million per occurrence. We also maintain professional liability insurance with unrelated commercial carriers for losses in excess of amounts insured by our insurance subsidiary. HCA and its insurance subsidiary maintain reserves for professional liability risks (net of $43 million receivable under reinsurance contracts) that totaled $1.578 billion at December 31, 2005. Management considers such reserves, which are based on actuarially determined estimates, to be adequate for such liability risks.
      We purchase, from unrelated insurance companies, coverage for directors and officers liability and property loss in amounts that we believe are adequate. The directors and officers liability coverage includes a $25 million corporate deductible. The property coverage includes varying deductibles depending on the cause of the property damage. These deductibles range from $500,000 per claim up to 5% of the affected property values for certain flood and wind and earthquake related incidents.

18


Table of Contents

Employees and Medical Staffs
      At December 31, 2005, HCA had approximately 191,100 employees, including approximately 51,300 part-time employees. References herein to “employees” refer to employees of affiliates of HCA. HCA is subject to various state and federal laws that regulate wages, hours, benefits and other terms and conditions relating to employment. Employees at 16 hospitals are represented by various labor unions. We consider our employee relations to be satisfactory. Our hospitals are experiencing some union organizational activity, and we anticipate that we will have elections at six hospitals in Florida in the second quarter of 2006, and an election at one hospital in Nevada in the fourth quarter of 2006. However, we do not expect such efforts to materially affect our future operations. HCA’s hospitals, like most hospitals, have experienced labor costs rising faster than the general inflation rate. In some markets, nurse and medical support personnel availability has become a significant operating issue to health care providers. To address this challenge, we have implemented several initiatives to improve retention, recruiting, compensation programs and productivity. This shortage may also require an increase in the utilization of more expensive temporary personnel.
      Licensed physicians, who have been accepted to the medical staff of individual hospitals, staff our hospitals. With certain exceptions, physicians generally are not employees of our hospitals. However, some physicians provide services in our hospitals under contracts which generally describe a term of service, provide and establish the duties and obligations of such physicians, require the maintenance of certain performance criteria and fix compensation for such services. Any licensed physician may apply to be accepted to the medical staff of any of our hospitals, but the hospital’s medical staff and the appropriate governing board of the hospital, in accordance with established credentialing criteria, must approve acceptance to the staff. Members of the medical staffs of our hospitals often also serve on the medical staffs of other hospitals and may terminate their affiliation with one of our hospitals at any time.
Executive Officers of the Registrant
      The executive officers of HCA as of March 13, 2006, were as follows:
             
Name   Age   Position(s)
         
Jack O. Bovender, Jr. 
    60     Chairman of the Board and Chief Executive Officer
Richard M. Bracken
    53     President, Chief Operating Officer and Director
R. Milton Johnson
    49     Executive Vice President and Chief Financial Officer
David G. Anderson
    58     Senior Vice President — Finance and Treasurer
Victor L. Campbell
    59     Senior Vice President
Rosalyn S. Elton
    44     Senior Vice President — Operations Finance
Charles R. Evans
    58     President — Eastern Group
V. Carl George
    61     Senior Vice President — Development
R. Sam Hankins, Jr. 
    55     Chief Financial Officer — Outpatient Services Group
Russell K. Harms
    48     Chief Financial Officer — Central Group
Samuel N. Hazen
    45     President — Western Group
Frank M. Houser, M.D. 
    65     Senior Vice President — Quality and Medical Director
Patricia T. Lindler
    58     Senior Vice President — Government Programs
A. Bruce Moore, Jr. 
    46     President — Outpatient Services Group
W. Paul Rutledge
    51     President — Central Group
Richard J. Shallcross
    47     Chief Financial Officer — Western Group
Joseph N. Steakley
    51     Senior Vice President — Internal Audit Services
John M. Steele
    50     Senior Vice President — Human Resources
Donald W. Stinnett
    49     Chief Financial Officer — Eastern Group
Beverly B. Wallace
    55     President — Shared Services Group
Robert A. Waterman
    52     Senior Vice President and General Counsel
Noel Brown Williams
    50     Senior Vice President and Chief Information Officer
Alan R. Yuspeh
    56     Senior Vice President — Ethics, Compliance and Corporate Responsibility

19


Table of Contents

      Jack O. Bovender, Jr. was appointed Chairman of the Board and Chief Executive Officer effective January 2002. Mr. Bovender served as President and Chief Executive Officer from January 2001 until December 2001. Mr. Bovender served as President and Chief Operating Officer of the Company from August 1997 to January 2001 and was appointed a Director of the Company in July 1999. From April 1994 to August 1997, he was retired after serving as Chief Operating Officer of HCA-Hospital Corporation of America from 1992 until 1994. Prior to 1992, Mr. Bovender held several senior level positions with HCA-Hospital Corporation of America.
      Richard M. Bracken was appointed to the Company’s Board of Directors in November 2002. Mr. Bracken was appointed President and Chief Operating Officer in January 2002, after being appointed Chief Operating Officer in July 2001. Mr. Bracken served as President — Western Group of the Company from August 1997 until July 2001. From January 1995 to August 1997, Mr. Bracken served as President of the Pacific Division of the Company. Prior to 1995 he served in various hospital Chief Executive Officer and Administrator positions with HCA-Hospital Corporation of America.
      R. Milton Johnson has served as Executive Vice President and Chief Financial Officer of the Company since July 2004. Mr. Johnson served as Senior Vice President and Controller of the Company from July 1999 until July 2004. Mr. Johnson served as Vice President and Controller of the Company from November 1998 to July 1999. Prior to that time, Mr. Johnson served as Vice President — Tax of the Company from April 1995 to October 1998. Prior to that time, Mr. Johnson served as Director of Tax for Healthtrust from September 1987 to April 1995.
      David G. Anderson has served as Senior Vice President — Finance and Treasurer of the Company since July 1999. Mr. Anderson served as Vice President  — Finance of the Company from September 1993 to July 1999 and was elected to the additional position of Treasurer in November 1996. From March 1993 until September 1993, Mr. Anderson served as Vice President — Finance and Treasurer of Galen Health Care, Inc. From July 1988 to March 1993, Mr. Anderson served as Vice President — Finance and Treasurer of Humana Inc.
      Victor L. Campbell has served as Senior Vice President of the Company since February 1994. Prior to that time, Mr. Campbell served as HCA-Hospital Corporation of America’s Vice President for Investor, Corporate and Government Relations. Mr. Campbell joined HCA-Hospital Corporation of America in 1972. Mr. Campbell is the chairman of the Board of the Federation of American Hospitals and serves on the Board of HRET, a subsidiary of the American Hospital Association.
      Rosalyn S. Elton has served as Senior Vice President — Operations Finance of the Company since July 1999. Ms. Elton served as Vice President — Operations Finance of the Company from August 1993 to July 1999. From October 1990 to August 1993, Ms. Elton served as Vice President — Financial Planning and Treasury for the Company.
      Charles R. Evans was appointed President — Eastern Group of the Company in May 2004. Mr. Evans served as President — Southeast Division from January 2001 until May 2004. Mr. Evans served as President — Mid America Division from January 1998 until December 2000. Prior to that time, Mr. Evans served as President — North Carolina Division from April 1996 until December 1997, and as President — First Coast Health Network from January 1995 until March 1996. Prior to that time, Mr. Evans served in various positions with Community Hospitals Indianapolis.
      V. Carl George has served as Senior Vice President — Development of the Company since July 1999. Mr. George served as Vice President — Development of the Company from April 1995 to July 1999. From September 1987 to April 1995, Mr. George served as Director of Development for Healthtrust. Prior to working for Healthtrust, Mr. George served with HCA-Hospital Corporation of America in various positions.
      R. Sam Hankins, Jr. was appointed Chief Financial Officer — Outpatient Services Group in May 2004. Mr. Hankins served as Chief Financial Officer — West Florida Division from January 1998 until May 2004. Prior to that time, Mr. Hankins served as Chief Financial Officer — Northeast Division from March 1997 until December 1997, and as Chief Financial Officer — Richmond Division from March 1996 until February

20


Table of Contents

1997. Prior to that time, Mr. Hankins served in various positions with CJW Medical Center in Richmond, Virginia and with several hospitals.
      Russell K. Harms was appointed Chief Financial Officer — Central Group in October 2005. From January 2001 to October 2005, Mr. Harms served as Chief Financial Officer of HCA’s MidAmerica Division. From December 1997 to December 2000, Mr. Harms served as Chief Financial Officer of Presbyterian/St. Lukes Medical Center.
      Samuel N. Hazen was appointed President — Western Group of the Company in July 2001. Mr. Hazen served as Chief Financial Officer — Western Group of the Company from August 1995 to July 2001. Mr. Hazen served as Chief Financial Officer — North Texas Division of the Company from February 1994 to July 1995. Prior to that time, Mr. Hazen served in various hospital and regional Chief Financial Officer positions with Humana Inc. and Galen Health Care, Inc.
      Frank M. Houser, M.D. has served as Senior Vice President — Quality and Medical Director of the Company since November 1997. Dr. Houser served as President — Physician Management Services of the Company from May 1996 to November 1997. Dr. Houser served as President of the Georgia Division of the Company from December 1994 to May 1996. From May 1993 to December 1994, Dr. Houser served as the Medical Director of External Operations at The Emory Clinic, Inc. in Atlanta, Georgia. Dr. Houser served as State Public Health Director, Georgia Department of Human Resources from July 1991 to May 1993.
      Patricia T. Lindler has served as Senior Vice President — Government Programs of the Company since July 1999. Ms. Lindler served as Vice President  — Reimbursement of the Company from September 1998 to July 1999. Prior to that time, Ms. Lindler was the President of Health Financial Directions, Inc. from March 1995 to November 1998. From September 1980 to February 1995, Ms. Lindler served as Director of Reimbursement of the Company’s Florida Group.
      A. Bruce Moore, Jr. was appointed President — Outpatient Services Group in January 2006. Mr. Moore had served as Senior Vice President and as Chief Operating Officer — Outpatient Services Group since July 2004 and as Senior Vice President — Operations Administration from July 1999 until July 2004. Mr. Moore served as Vice President — Operations Administration of the Company from September 1997 to July 1999, as Vice President — Benefits from October 1996 to September 1997, and as Vice President — Compensation from March 1995 until October 1996.
      W. Paul Rutledge was appointed as President — Central Group in October 2005. Mr. Rutledge had served as President of the MidAmerica Division since January 2001. He served as President of TriStar Health System from June 1996 to January 2001 and served as president of Centennial Medical Center from May 1993 to June 1996. He has served in leadership capacities with HCA for more than 20 years, working with hospitals in New Orleans, La., Rome, Ga. and Nashville Tn.
      Richard J. Shallcross was appointed Chief Financial Officer — Western Group of the Company in August 2001. Mr. Shallcross served as Chief Financial Officer — Continental Division of the Company from September 1997 to August 2001. From October 1996 to August 1997, Mr. Shallcross served as Chief Financial Officer — Utah/ Idaho Division of the Company. From November 1995 until September 1996, Mr. Shallcross served as Vice President of Finance and Managed Care for the Colorado Division of the Company.
      Joseph N. Steakley has served as Senior Vice President — Internal Audit Services of the Company since July 1999. Mr. Steakley served as Vice President  — Internal Audit Services from November 1997 to July 1999. From October 1989 until October 1997, Mr. Steakley was a partner with Ernst & Young LLP.
      John M. Steele has served as Senior Vice President — Human Resources of the Company since November 2003. Mr. Steele served as Vice President — Compensation and Recruitment of the Company from November 1997 to October 2003. From September 1995 to November 1997, Mr. Steele served as Assistant Vice President — Recruitment.
      Donald W. Stinnett was appointed Chief Financial Officer — Eastern Group in October 2005. Mr. Stinnett had served as Chief Financial Officer of the Far West Division since July 1999. Mr. Stinnett

21


Table of Contents

served as Chief Financial Officer and Vice President of Finance of Franciscan Health System of the Ohio Valley from 1995 until 1999, and served in various capacities with Franciscan Health System of Cincinnati and Providence Hospital in Cincinnati prior to that time.
      Beverly B. Wallace was appointed President — Shared Services Group in March 2006. From January 2003 until March 2006, Ms. Wallace served as President — Financial Services Group. Ms. Wallace served as Senior Vice President — Revenue Cycle Operations Management of the Company from July 1999 to January 2003. Ms. Wallace served as Vice President — Managed Care of the Company from July 1998 to July 1999. From 1997 to 1998, Ms. Wallace served as President — Homecare Division of the Company. From 1996 to 1997, Ms. Wallace served as Chief Financial Officer — Nashville Division of the Company. From 1994 to 1996, Ms. Wallace served as Chief Financial Officer — Mid-America Division of the Company.
      Robert A. Waterman has served as Senior Vice President and General Counsel of the Company since November 1997. Mr. Waterman served as a partner in the law firm of Latham & Watkins from September 1993 to October 1997; he was also Chair of the firm’s healthcare group during 1997.
      Noel Brown Williams has served as Senior Vice President and Chief Information Officer of the Company since October 1997. From October 1996 to September 1997, Ms. Williams served as Chief Information Officer for American Service Group/ Prison Health Services, Inc. From September 1995 to September 1996, Ms. Williams worked as an independent consultant. From June 1993 to June 1995, Ms. Williams served as Vice President, Information Services for HCA Information Services. From February 1979 to June 1993, she held various positions with HCA-Hospital Corporation of America Information Services.
      Alan R. Yuspeh has served as Senior Vice President — Ethics, Compliance and Corporate Responsibility of the Company since October 1997. From September 1991 until October 1997, Mr. Yuspeh was a partner with the law firm of Howrey & Simon. As a part of his law practice, Mr. Yuspeh served from 1987 to 1997 as Coordinator of the Defense Industry Initiative on Business Ethics and Conduct.
Item 1A. Risk Factors
Risk Factors
      If any of the events discussed in the following risk factors were to occur, HCA’s business, financial position, results of operations, cash flows or prospects could be materially, adversely affected. Additional risks and uncertainties not presently known, or currently deemed immaterial, may also constrain its business and operations. In either case, the trading price of our common stock could decline and stockholders could lose all or part of their investment.
Our Hospitals Face Competition For Patients From Other Hospitals And Health Care Providers.
      The health care business is highly competitive and competition among hospitals and other health care providers for patients has intensified in recent years. Generally, other hospitals in the local communities served by most of our hospitals provide services similar to those offered by our hospitals. In 2005, CMS began making public performance data related to ten quality measures that hospitals submit in connection with their Medicare reimbursement. If any of our hospitals achieve poor results (or results that are lower than our competitors) on these ten quality measures, patient volumes could decline. In the future, other trends toward clinical transparency may have an unanticipated impact on our competitive position and patient volumes. In addition, the number of freestanding specialty hospitals, surgery centers and diagnostic and imaging centers in the geographic areas in which we operate has increased significantly. As a result, most of our hospitals operate in a highly competitive environment. Some of the hospitals that compete with our hospitals are owned by governmental agencies or not-for-profit corporations supported by endowments, charitable contributions and/or tax revenues and can finance capital expenditures and operations on a tax-exempt basis. We are facing increasing competition from physician-owned specialty hospitals and freestanding surgery centers for market share in high margin services and for quality physicians and personnel. If our competitors are better able to attract patients, recruit physicians, expand services or obtain favorable managed care contracts at their facilities, we may experience a decline in patient volume. See Item 1, “Business — Competition.”

22


Table of Contents

      Section 507 of MMA provided for an 18-month moratorium on the establishment of new specialty hospitals. Congress also required that MedPAC and HHS conduct studies on specialty hospitals with reports to be completed no later than 15 months after the date of enactment of MMA. The moratorium expired on June 8, 2005. In March 2005, MedPAC issued its report on specialty hospitals, in which it recommended that Congress extend the moratorium until January 1, 2007, modify payments to hospitals to reflect more closely the cost of care, and allow certain types of gainsharing arrangements. In May 2005, HHS issued the required report of its analysis of specialty hospitals in which it recommended reforming certain inpatient hospital services and ambulatory surgery center services payment rates that may currently encourage the establishment of specialty hospitals and implementation of closer scrutiny of the processes for approving new specialty hospitals for participation in Medicare. Further, HHS suspended processing new provider enrollment applications for specialty hospitals until January 2006, creating in effect a moratorium on new specialty hospitals. DEFRA 2005 directed HHS to extend this enrollment suspension until the earlier of six months from the enactment of DEFRA 2005 or the release of a report regarding physician owned specialty hospitals by HHS. We cannot predict whether the moratorium will be extended beyond this date. If the moratorium expires, we may face additional competition from an increased number of specialty hospitals, including hospitals owned by physicians currently on staff at our hospitals.
The Growth Of Uninsured And Patient Due Accounts And A Deterioration In The Collectibility Of These Accounts Could Adversely Affect Our Results Of Operations.
      The primary collection risks of our accounts receivable relate to the uninsured patient accounts and patient accounts for which the primary insurance carrier has paid the amounts covered by the applicable agreement, but patient responsibility amounts (deductibles and copayments) remain outstanding. The provision for doubtful accounts relates primarily to amounts due directly from patients.
      On December 29, 2004, CMS issued guidance that has enabled hospitals to provide discounts to any uninsured patient without placing the hospital’s Medicare payments at risk. Based on this guidance, in 2005 we implemented modifications to our self-pay policies, the effect of which was to provide a discount to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. In implementing the discount policy, hospitals first attempt to qualify uninsured patients for Medicaid, other federal or state assistance or charity care. If an uninsured patient does not qualify for these programs, the uninsured discount is applied.
      The amount of the provision for doubtful accounts is based upon management’s assessment of historical writeoffs and expected net collections, business and economic conditions, trends in federal and state governmental and private employer health care coverage and other collection indicators. At December 31, 2005, our allowance for doubtful accounts represented approximately 85% of the $3.404 billion patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage was being evaluated (“pending Medicaid accounts”). For the year ended December 31, 2005, the provision for doubtful accounts decreased to 9.6% of revenues compared to 11.4% of revenues in 2004. Adjusting for the effect of the uninsured discount policy implemented January 1, 2005, the provision for doubtful accounts was 12.4% of revenues for the year ended December 31, 2005.
      A continuation of the trends that have resulted in an increasing proportion of accounts receivable being comprised of uninsured accounts and a deterioration in the collectibility of these accounts will adversely affect our collection of accounts receivable, cash flows and results of operations.
Changes In Governmental Programs May Reduce Our Revenues.
      A significant portion of our patient volumes is derived from government health care programs, principally Medicare and Medicaid, which are highly regulated and subject to frequent and substantial changes. We derived approximately 53% of our admissions from the Medicare and Medicaid programs in 2005. In recent years, legislative changes have resulted in limitations on and, in some cases, reductions in levels of payments to health care providers for certain services under these government programs.

23


Table of Contents

      Congress has directed MedPAC to make recommendations regarding the levels of payments to health care providers under the Medicare program. For inpatient services for fiscal year 2007, MedPAC has recommended that Congress update inpatient PPS payments by the market basket minus 0.45 percentage points. For outpatient services for calendar year 2007, MedPAC has recommended that Congress update outpatient PPS payments by the market basket minus 0.45 percentage points. It is uncertain whether Congress will adopt these recommendations. If Congress adopts these recommendations, HCA’s revenues may be reduced. Other Medicare payment changes may also reduce HCA’s revenues. See Item 1, “Business — Sources of Revenue.”
      A number of states are experiencing budget problems and have adopted, or are considering, legislation designed to reduce their Medicaid expenditures. DEFRA 2005, signed into law on February 8, 2006, includes Medicaid cuts of approximately $4.8 billion over five years. In addition, proposed regulatory changes, if implemented, would reduce federal Medicaid funding by an additional $12.2 billion over five years. States have also adopted, or are considering, legislation designed to reduce coverage and program eligibility, enroll Medicaid recipients in managed care programs and/or impose additional taxes on hospitals to help finance or expand the states’ Medicaid systems. Hospital operating margins have been, and may continue to be, under significant pressure because of deterioration in pricing flexibility and payer mix, and growth in operating expenses in excess of the increase in PPS payments under the Medicare program. Future legislation or other changes in the administration or interpretation of government health programs could have a material, adverse effect on our financial position and results of operations.
Demands Of Nongovernment Payers May Adversely Affect Our Growth In Revenues.
      Our ability to negotiate favorable contracts with nongovernment payers, including managed care plans, significantly affects the revenues and operating results of most of our hospitals. Admissions derived from managed care and other insurers accounted for approximately 42% of our admissions in 2005. Nongovernment payers, including managed care payers, increasingly are demanding discounted fee structures. Reductions in price increases or the amounts received from managed care, commercial insurance or other payers could have a material, adverse effect on our financial position and results of operations.
Our Performance Depends On Our Ability To Recruit And Retain Quality Physicians.
      Physicians generally direct the majority of hospital admissions and, therefore, the success of our hospitals depend, in part, on the number and quality of the physicians on the medical staffs of our hospitals, the admitting practices of those physicians and maintaining good relations with those physicians. Physicians are generally not employees of the hospitals at which they practice and, in many of the markets that HCA serves, most physicians have admitting privileges at other hospitals in addition to our hospitals. Such physicians may terminate their affiliation with our hospitals at any time. If we are unable to provide adequate support personnel or technologically advanced equipment and hospital facilities that meet the needs of those physicians, they may be discouraged from referring patients to our facilities, admissions may decrease and our operating performance may decline.
If We Fail To Comply With Extensive Laws And Government Regulations, We Could Suffer Penalties Or Be Required To Make Significant Changes To Our Operations.
      The health care industry is required to comply with extensive and complex laws and regulations at the federal, state and local government levels relating to, among other things:
  •  billing for services;
 
  •  relationships with physicians and other referral sources;
 
  •  adequacy of medical care;
 
  •  quality of medical equipment and services;
 
  •  qualifications of medical and support personnel;

24


Table of Contents

  •  confidentiality, maintenance and security issues associated with health-related information and medical records;
 
  •  the screening, stabilization and transfer of individuals who have emergency medical conditions;
 
  •  licensure;
 
  •  hospital rate or budget review;
 
  •  operating policies and procedures; and
 
  •  addition of facilities and services.
      Among these laws are the Anti-kickback Statute and the Stark Law. These laws impact the relationships that we may have with physicians and other referral sources. We have a variety of financial relationships with physicians who refer patients to our hospitals, including employment contracts, leases and professional service agreements. We also provide financial incentives, including minimum revenue guarantees, to recruit physicians into the communities served by our hospitals. The OIG has enacted safe harbor regulations that outline practices that are deemed protected from prosecution under the Anti-kickback Statute. While we endeavor to comply with the applicable safe harbors, certain of our current arrangements, including joint ventures and financial relationships with physicians and other referral sources, do not qualify for safe harbor protection. Failure to meet a safe harbor does not mean that the arrangement necessarily violates the Anti-kickback Statute, but may subject the arrangement to greater scrutiny. We cannot assure that practices that are outside of a safe harbor will not be found to violate the Anti-kickback Statute.
      Our financial relationships with physicians and their immediate family members must comply with the Stark Law by meeting an exception. We attempt to structure our relationships to meet an exception to the Stark Law, but the regulations implementing the exceptions are detailed and complex, and we cannot assure that every relationship complies fully with the Stark Law. Unlike the Anti-kickback Statute, failure to meet an exception under the Stark Law results in a violation of the Stark Law, even if such violation is technical in nature.
      If we fail to comply with the Anti-kickback Statute, the Stark Law or other applicable laws and regulations, we could be subjected to liabilities, including criminal penalties, civil penalties (including the loss of our licenses to operate one or more facilities), and exclusion of one or more facilities from participation in the Medicare, Medicaid and other federal and state health care programs. See Item 1, “Business — Regulation and Other Factors.”
      Because many of these laws and their implementation regulations are relatively new, we do not always have the benefit of significant regulatory or judicial interpretation of these laws and regulations. In the future, different interpretations or enforcement of these laws and regulations could subject our current or past practices to allegations of impropriety or illegality, or could require us to make changes in our facilities, equipment, personnel, services, capital expenditure programs and operating expenses. A determination that we have violated these laws, or the public announcement that we are being investigated for possible violations of these laws, could have a material adverse effect our business, financial condition, results of operations or prospects and our business reputation could suffer significantly. In addition, we are unable to predict whether other legislation or regulations at the federal or state level will be adopted, what form such legislation or regulations may take or their impact.
Our Hospitals Face Competition For Staffing, Which May Increase Labor Costs And Reduce Profitability.
      Our operations are dependent on the efforts, abilities and experience of our management and medical support personnel, such as nurses, pharmacists and lab technicians, as well as our physicians. We compete with other health care providers in recruiting and retaining qualified management and support personnel responsible for the daily operations of each of our hospitals, including nurses and other nonphysician health care professionals. In some markets, the availability of nurses and other medical support personnel has become a significant operating issue to health care providers. This shortage may require us to continue to enhance

25


Table of Contents

wages and benefits to recruit and retain nurses and other medical support personnel or to hire more expensive temporary personnel. We also depend on the available labor pool of semiskilled and unskilled employees in each of the markets in which we operate. In addition, to the extent that a significant portion of our employee base unionizes, or attempts to unionize, our labor costs could increase. If our labor costs increase, we may not be able to raise rates to offset these increased costs. Because a significant percentage of our revenues consists of fixed, prospective payments, our ability to pass along increased labor costs is constrained. Our failure to recruit and retain qualified management, nurses and other medical support personnel, or to control labor costs, could have a material, adverse effect on our results of operations.
We Have Been The Subject Of Governmental Investigations, Claims And Litigation That Have Resulted In Significant Charges And Ongoing Reporting Obligations.
      Commencing in 1997, HCA became aware that we were the subject of governmental investigations and litigation relating to our business practices. The investigations were concluded through a series of agreements executed in 2000 and 2003. In January 2001, we entered into an eight-year CIA with the OIG. If we were found to be in violation of the CIA, we could be subject to substantial monetary fines, civil and criminal penalties and/or exclusion from participation in the Medicare and Medicaid programs. Any such sanctions or expenses could have a material adverse effect on our financial position, results of operations and liquidity.
      In September 2005, we received a subpoena from the Office of the United States Attorney for the Southern District of New York seeking the production of documents. Also in September 2005, we were informed that the SEC had issued a formal order of investigation. Both the subpoena and the formal order of investigation relate to trading in our securities. We are cooperating fully with these investigations.
      Subsequently, HCA and certain of our executive officers and directors were named in various federal securities law class actions and several shareholders have filed derivative lawsuits purportedly on behalf of the Company. Additionally, a former employee of HCA filed a complaint against certain of our executive officers pursuant to the Employee Retirement Income Security Act and we have been served with a shareholder demand letter addressed to our Board of Directors. We cannot predict the results of the investigations or any related lawsuits or the effect that findings in such investigations or lawsuits adverse to us may have on us. These proceedings are described in greater detail in Item 3, “Legal Proceedings.”
      Controls Designed To Reduce Inpatient Services May Reduce Our Revenues.
      Controls imposed by third-party payers designed to reduce admissions and lengths of stay, commonly referred to as “utilization review,” have affected and are expected to continue to affect our facilities. Utilization review entails the review of the admission and course of treatment of a patient by managed care plans. Inpatient utilization, average lengths of stay and occupancy rates continue to be negatively affected by payer-required preadmission authorization and utilization review and by payer pressure to maximize outpatient and alternative health care delivery services for less acutely ill patients. Efforts to impose more stringent cost controls are expected to continue. Although we are unable to predict the effect these changes will have on our operations, significant limits on the scope of services reimbursed and on reimbursement rates and fees could have a material, adverse effect on our business, financial position and results of operations.
Our Operations Could Be Impaired By A Failure Of Our Information Systems.
      The performance of our sophisticated information technology and systems is critical to our business operations. In addition to our shared services initiatives, our information systems are essential to a number of critical areas of our operations, including:
  •  accounting and financial reporting;
 
  •  billing and collecting accounts;
 
  •  coding and compliance;
 
  •  clinical systems;

26


Table of Contents

  •  medical records and document storage;
 
  •  inventory management; and
 
  •  negotiating, pricing and administering managed care contracts and supply contracts.
      We are in the process of implementing projects to replace our payroll and human resources information systems. Management estimates that the payroll and human resources system projects will require total expenditures of approximately $332 million to develop and install. At December 31, 2005, project-to-date costs incurred were $278 million ($158 million of the costs incurred have been capitalized and $120 million have been expensed). Management expects that the system development, testing, data conversion and installation will continue through 2006. There can be no assurance that the development and implementation of those systems will not be delayed, that the total cost will not be significantly more than currently anticipated, that business processes will not be interrupted during implementation or that we will realize the expected benefits and efficiencies from the developed products.
      Any system failure that causes an interruption in service or availability of our systems could adversely affect operations or delay the collection of revenue. Even though we have implemented network security measures, our servers are vulnerable to computer viruses, break-ins and similar disruptions from unauthorized tampering. The occurrence of any of these events could result in interruptions, delays, the loss or corruption of data, or cessations in the availability of systems, all of which could have a material, adverse effect on our financial position and results of operations and harm our business reputation.
State Efforts To Regulate The Construction Or Expansion Of Hospitals Could Impair Our Ability To Operate And Expand Our Operations.
      Some states require health care providers to obtain prior approval, known as a certificate of need, or CON, for the purchase, construction or expansion of health care facilities, to make certain capital expenditures or to make changes in services or bed capacity. In giving approval, these states consider the need for additional or expanded health care facilities or services. We currently operate hospitals in a number of states with CON laws. The failure to obtain any requested CON could impair our ability to operate or expand operations.
Our Facilities Are Heavily Concentrated In Florida And Texas, Which Makes Us Sensitive To Regulatory, Economic, Environmental And Competitive Changes In Those States.
      HCA operated 182 hospitals at December 31, 2005, and 74 of those hospitals are located in Florida and Texas. This situation makes us particularly sensitive to regulatory, economic, environmental and competition changes in those states.
      Any material change in the current payment programs or regulatory, economic, environmental or competitive conditions in those states could have a disproportionate effect on our overall business results.
      In addition, both Florida and Texas are located in hurricane-prone areas. In the recent past, hurricanes have had a disruptive effect on the operations of our hospitals in Florida, Texas, and other coastal states, and the patient populations in those states. Our business activities could be harmed by a particularly active hurricane season or even a single storm.
We May Be Subject To Liabilities From Claims By The IRS.
      HCA is currently contesting claims for income taxes, interest and penalties proposed by the IRS for prior years aggregating approximately $776 million through December 31, 2005. The disputed items include the deductibility of a portion of the 2001 government settlement payment, the timing of recognition of certain patient service revenues in 2000 through 2002, the method for calculating the tax allowance for uncollectible accounts in 2002, and the amount of insurance expense deducted in 1999 through 2002.
      During February 2006, the IRS began an examination of our 2003 through 2004 federal income tax returns. The IRS has not determined the amount of any additional income tax, interest and penalties that it

27


Table of Contents

may claim upon completion of this examination or any future examinations that may be initiated. See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — IRS Disputes.”
We May Be Subject To Liabilities From Claims Brought Against Our Facilities.
      HCA is subject to litigation relating to our business practices, including claims and legal actions by patients and others in the ordinary course of business alleging malpractice, product liability or other legal theories. See Item 3, “Legal Proceedings.” Many of these actions involve large claims and significant defense costs. We insure a substantial portion of our professional liability risks through a wholly-owned subsidiary. Management believes our insurance coverage is sufficient to cover claims arising out of the operation of our facilities. HCA’s wholly-owned insurance subsidiary has entered into certain reinsurance contracts, and the obligations covered by the reinsurance contracts are included in its reserves for professional liability risks, as the subsidiary remains liable to the extent that the reinsurers do not meet their obligations under the reinsurance contracts. If payments for claims exceed actuarially determined estimates, are not covered by insurance or reinsurers, if any, fail to meet their obligations, our results of operations and financial position could be adversely affected.
We Are Exposed to Market Risks Related to Changes in the Market Values of Securities and Interest Rate Changes
      HCA is exposed to market risk related to changes in market values of securities. The investments in debt and equity securities of our wholly-owned insurance subsidiary were $1.419 billion and $965 million, respectively, at December 31, 2005. These investments are carried at fair value, with changes in unrealized gains and losses being recorded as adjustments to other comprehensive income. The fair value of investments is generally based on quoted market prices. If the insurance subsidiary were to experience significant declines in the fair value of its investments, this could require additional investment by us to allow the insurance subsidiary to satisfy its minimum capital requirements. At December 31, 2005, we had a net unrealized gain of $184 million on the insurance subsidiary’s investment securities.
      We are also exposed to market risk related to changes in interest rates, and periodically enter into interest rate swap agreements to manage our exposure to these fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts and interest payments in these agreements match the cash flows of the related liabilities. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not assets or liabilities of HCA. Any market risk or opportunity associated with these swap agreements is offset by the opposite market impact on the related debt. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Market Risk”.
Fluctuations In Operating Results And Other Factors May Result In Decreases In Our Stock Price.
      There is significant volatility in the market price of HCA’s common stock. If we are unable to operate our hospitals as profitably as we have in the past, investors could sell shares of HCA’s common stock when it becomes apparent that the expectations of the market may not be realized, resulting in a decrease in the market price of HCA’s common stock.
      In addition to our operating results, the operating results of other hospital companies, changes in financial estimates or recommendations by analysts, changes in government health care programs, governmental investigations and litigation, speculation in the press or investment community, the possible effects of war, terrorist and other hostilities, adverse weather conditions, the level of seasonal illnesses, changes in general conditions in the economy or the financial markets, or other developments affecting the health care industry, could cause substantial fluctuations in the market price of our common stock.

28


Table of Contents

We Have Increased Leverage As A Result Of Financing Our Recently Completed “Dutch” Auction Tender Offer.
      In October 2005, we commenced a modified “Dutch” auction tender offer to purchase up to $2.5 billion of our common stock. To finance the tender offer, we used approximately $600 million of cash on hand and borrowed $800 million under a $1.0 billion short term loan facility. In connection with the tender offer, we amended our existing revolving credit facility and the related senior term loan to modify the compliance levels for our required ratio of consolidated total debt to consolidated total capitalization. Our total long-term debt, including amounts due within one year, was $10.475 billion at December 31, 2005. In February 2006, we issued $1.0 billion of 6.5% notes due in February 2016. The proceeds from the notes and the proceeds from the sales of hospitals were used to repay amounts under the $800 million term loan and to pay down amounts advanced under the existing revolving credit facility. The authorization permits us to repurchase additional shares in an amount up to the remainder of the $2.5 billion authorization from time to time through open market purchases, or in private or other transactions. During 2005, we repurchased 8.0 million shares of our common stock for $412 million through open market purchases. See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources” and “— Market Risk” and Note 8 — Long-Term Debt in the notes to consolidated financial statements for additional information on our debt obligations.
      We may continue to make borrowings under our existing revolving credit facility, and we have issued debt securities, from time to time, including $1.0 billion of 6.5% Notes due 2016 issued in February 2006. We may issue additional debt securities in the future. Our ability to make payments on our debt and fund planned capital expenditures and the operation of our business will depend on cash flow from operations, amounts available under our existing revolving credit facility and our access to public and private debt markets. Our increased debt service obligations could, among other things:
  •  limit our ability to borrow money or raise capital to fund our working capital, capital expenditures and debt service, or for other purposes;
 
  •  increase our vulnerability to adverse economic and industry conditions;
 
  •  limit our ability to pay dividends and to obtain additional financing and limit our flexibility in planning for, or reacting to, changes in our business or the industry; and
 
  •  require the dedication of a substantial portion of our cash flow from operating activities to the payment of principal and interest on our debt.

29


Table of Contents

Item 1B. Unresolved Staff Comments
      None.
Item 2. Properties
      The following table lists, by state, the number of hospitals (general, acute care, psychiatric and rehabilitation) directly or indirectly owned and operated by the Company as of December 31, 2005:
                 
State   Hospitals   Beds
         
Alaska
    1       254  
California
    5       1,513  
Colorado
    7       2,249  
Florida
    40       10,424  
Georgia
    14       2,383  
Idaho
    2       476  
Indiana
    1       282  
Kansas
    4       1,286  
Kentucky
    2       384  
Louisiana
    11       1,682  
Mississippi
    1       130  
Missouri
    8       1,672  
Nevada
    3       1,075  
New Hampshire
    2       295  
North Carolina
    1       60  
Oklahoma
    2       937  
South Carolina
    3       740  
Tennessee
    11       1,986  
Texas
    34       9,596  
Utah
    6       922  
Virginia
    12       3,327  
West Virginia
    4       917  
 
International                
Switzerland
    2       220  
England
    6       704  
             
      182       43,514  
             
      In addition to the hospitals listed in the above table, we directly or indirectly operate 94 freestanding surgery centers. We also operate medical office buildings in conjunction with some of our hospitals. These office buildings are primarily occupied by physicians who practice at our hospitals.
      We maintain our headquarters in approximately 919,000 square feet of space in the Nashville, Tennessee area. In addition to the headquarters in Nashville, we maintain service centers related to our shared services initiatives. These service centers are located in markets in which we operate hospitals.
      HCA’s headquarters, hospitals and other facilities are suitable for their respective uses and are, in general, adequate for our present needs. Our properties are subject to various federal, state and local statutes and ordinances regulating their operation. Management does not believe that compliance with such statutes and ordinances will materially affect our financial position or results of operations.

30


Table of Contents

Item 3. Legal Proceedings
      HCA operates in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against the Company. The resolution of any such lawsuits, claims or legal and regulatory proceedings could materially, adversely affect our results of operations and financial position in a given period.
Government Investigation, Claims and Litigation
      Commencing in 1997, we became aware we were the subject of governmental investigations and litigation relating to our business practices. The investigations were concluded through a series of agreements executed in 2000 and 2003. In January 2001, we entered into an eight-year Corporate Integrity Agreement (“CIA”) with the Office of Inspector General of the Department of Health and Human Services. Violation or breach of the CIA, or other violation of federal or state laws relating to Medicare, Medicaid or similar programs, could subject the Company to substantial monetary fines, civil and criminal penalties and/or exclusion from participation in the Medicare and Medicaid programs. Alleged violations may be pursued by the government or through private qui tam actions. Sanctions imposed against us as a result of such actions could have a material, adverse effect on our results of operations and financial position.
Governmental Investigations
      In September 2005, we received a subpoena from the Office of the United States Attorney for the Southern District of New York seeking the production of documents. Also in September 2005, we were informed that the SEC had issued a formal order of investigation. Both the subpoena and the formal order of investigation relate to trading in our securities. We are cooperating fully with these investigations.
Securities Class Action Litigation
      In November 2005, two putative federal securities law class actions were filed in the United States District Court for the Middle District of Tennessee on behalf of persons who purchased our stock between January 12, 2005 and July 13, 2005. These substantially similar lawsuits assert claims pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, against us and our Chairman and Chief Executive Officer, President and Chief Operating Officer, and Executive Vice President and Chief Financial Officer, related to our July 13, 2005 announcement of preliminary results of operations for the second quarter ended June 30, 2005.
      On January 4, 2006, the court consolidated these actions under the caption In re HCA Inc. Securities Litigation, case number 3:05-CV-00981. Pursuant to federal statute, on January 25, 2006, the court appointed co-lead plaintiffs to represent the interests of the putative class members in this litigation. Co-lead plaintiffs must file a consolidated amended complaint no later than March 27, 2006. We believe that the allegations contained within these class action lawsuits are without merit and intend to vigorously defend the litigation.
Shareholder Derivative Lawsuits in Federal Court
      In November 2005, two current shareholders each filed a derivative lawsuit, purportedly on behalf of the Company, in the United States District Court for the Middle District of Tennessee against our Chairman and Chief Executive Officer, President and Chief Operating Officer, Executive Vice President and Chief Financial Officer, other executives, and certain members of our Board of Directors. Each lawsuit asserts claims for breaches of fiduciary duty, abuse of control, gross mismanagement, waste of corporate assets, and unjust enrichment in connection with the Company’s July 13, 2005 announcement of preliminary results of operations for the quarter ended June 30, 2005.
      On January 23, 2006, the court consolidated these actions as In re HCA Inc. Derivative Litigation, lead case number 3:05-CV-0968, and ordered that a consolidated derivative complaint be filed no later than March 24, 2006.

31


Table of Contents

      On December 27, 2005, we were served with a shareholder demand letter demanding that our Board of Directors take action to remedy alleged breaches of fiduciary duty by certain of our directors and executive officers. The letter claims that certain officers and directors knew, but failed to publicly disclose, certain matters concerning trends relating to uninsured patient accounts receivable.
Shareholder Derivative Lawsuit in State Court
      On January 18, 2006, a current shareholder filed a derivative lawsuit, purportedly on behalf of the Company, in the Circuit Court for the State of Tennessee (Nashville District), against our Chairman and Chief Executive Officer, President and Chief Operating Officer, Executive Vice President and Chief Financial Officer, other executives, and certain members of our Board of Directors. This lawsuit is substantially identical to the previously described “Shareholder Derivative Lawsuits in Federal Court,” in all material respects. Although the action has been filed, the plaintiff has not yet served the complaint on the named defendants.
ERISA Litigation
      On November 22, 2005, Brenda Thurman, a former employee of an HCA affiliate, filed a complaint in the United States District Court for the Middle District of Tennessee on behalf of herself, the HCA Savings and Retirement Program (the “Plan”), and a class of participants in the Plan who held an interest in our common stock, against our Chairman and Chief Executive Officer, President and Chief Operating Officer, Executive Vice President and Chief Financial Officer, and other unnamed individuals. The lawsuit, filed under sections 502(a)(2) and 502(a)(3) of the Employee Retirement Income Security Act (“ERISA”), 29 U.S.C. §§ 1132(a)(2) and (3), alleges that defendants breached their fiduciary duties owed to the Plan and to plan participants.
      On January 13, 2006, the court signed an order staying all proceedings and discovery in this matter, pending resolution of a motion to dismiss the consolidated amended complaint in the related federal securities class action against HCA. On January 18, 2006, the magistrate judge signed an order (i) consolidating Thurman’s cause of action with all other future actions making the same claims and arising out of the same operative facts, (ii) appointing Thurman as lead plaintiff, and (iii) appointing Thurman’s attorneys as lead counsel and liaison counsel in the case. On January 26, 2006, the court issued an order reassigning the case to United States District Court Judge William J. Haynes, Jr., who has been presiding over the federal securities class action and federal derivative lawsuits.
General Liability and Other Claims
      The Company is a party to certain proceedings relating to claims for income taxes and related interest in the United States Tax Court, and the United States Court of Federal Claims. For a description of those proceedings, see Note 4 — Income Taxes in the notes to consolidated financial statements.
      We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or for wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants have asked for punitive damages against us, which may not be covered by insurance. In the opinion of management, the ultimate resolution of these pending claims and legal proceedings will not have a material, adverse effect on our results of operations or financial position.
Item 4. Submission of Matters to a Vote of Security Holders
      No matters were submitted to a vote of security holders during the fourth quarter of 2005.

32


Table of Contents

PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
      HCA’s common stock is traded on the New York Stock Exchange, Inc. (the “NYSE”) (symbol “HCA”). The table below sets forth, for the calendar quarters indicated, the high and low sales prices per share reported on the NYSE composite tape for our common stock.
                           
    Sales Price   Cash
        Dividend
    High   Low   Declared
             
2005
                       
 
First Quarter
  $ 54.10     $ 38.97     $ 0.15  
 
Second Quarter
    58.60       52.14       0.15  
 
Third Quarter
    57.17       45.59       0.15  
 
Fourth Quarter
    52.74       45.30       0.15  
2004
                       
 
First Quarter
  $ 46.60     $ 38.98     $ 0.13  
 
Second Quarter
    43.24       38.00       0.13  
 
Third Quarter
    42.30       36.44       0.13  
 
Fourth Quarter
    41.64       34.70       0.13  
      At the close of business on February 28, 2006, there were approximately 12,400 holders of record of our common stock and one holder of record of our nonvoting common stock.
      In January 2005, our Board of Directors approved an increase in our quarterly dividend from $0.13 per share to $0.15 per share. The Board declared the initial $0.15 per share dividend payable on June 1, 2005 to shareholders of record at May 1, 2005. In January 2006, our Board of Directors approved an increase in our quarterly dividend from $0.15 per share to $0.17 per share. The Board declared the initial $0.17 per share dividend payable on June 1, 2006 to shareholders of record at May 1, 2006. The declaration and payment of future dividends will depend upon many factors, including earnings, financial position, business needs, capital and surplus and regulatory considerations.
      On October 13, 2005, we announced the authorization of a modified “Dutch” auction tender offer to purchase up to $2.500 billion of our common stock. In November 2005, we closed the tender offer and repurchased 28.7 million shares for an aggregate purchase price of $1.437 billion ($50.00 per share). We are authorized to repurchase additional shares in an amount up to the remainder of the $2.5 billion authorization through open market purchases or in private or other transactions. As of December 31, 2005, we had repurchased 8.0 million additional shares for $412 million pursuant to the authorization. This table provides certain information as of December 31, 2005 with respect to our repurchases of our common stock.
                                 
                Approximate Dollar
            Total Number of   Value of Shares That
            Shares Purchased   May Yet Be Purchased
        Average   as Part of Publicly   Under Publicly
    Total Number of   Price Paid   Announced Plans   Announced Plans or
Period   Shares Repurchased   per Share   or Programs   Programs
                 
October 1, 2005 through October 31, 2005
                    $ 2.500 billion  
November 1, 2005 through November 30, 2005
    28.7 million     $ 50.00       28.7 million     $ 1.063 billion  
December 1, 2005 through December 31, 2005
    8.0 million     $ 51.80       36.7 million     $ 0.651 billion  
                         
Total for Fourth Quarter 2005
    36.7 million     $ 50.39       36.7 million     $ 0.651 billion  
                         

33


Table of Contents

Item 6. Selected Financial Data
HCA INC.
SELECTED FINANCIAL DATA
AS OF AND FOR THE YEARS ENDED DECEMBER 31
(Dollars in millions, except per share amounts)
                                             
    2005   2004   2003   2002   2001
                     
Summary of Operations:
                                       
Revenues
  $ 24,455     $ 23,502     $ 21,808     $ 19,729     $ 17,953  
Salaries and benefits
    9,928       9,419       8,682       7,952       7,279  
Supplies
    4,126       3,901       3,522       3,158       2,860  
Other operating expenses
    4,039       3,797       3,676       3,341       3,238  
Provision for doubtful accounts
    2,358       2,669       2,207       1,581       1,376  
(Gains) losses on investments
    (53 )     (56 )     (1 )     2       (63 )
Equity in earnings of affiliates
    (221 )     (194 )     (199 )     (206 )     (158 )
Depreciation and amortization
    1,374       1,250       1,112       1,010       1,048  
Interest expense
    655       563       491       446       536  
Gains on sales of facilities
    (78 )           (85 )     (6 )     (131 )
Impairment of long-lived assets
          12       130       19       17  
Government settlement and investigation related costs
                (33 )     661       327  
Impairment of investment securities
                      168        
Loss on retirement of debt
                            28  
                               
      22,128       21,361       19,502       18,126       16,357  
                               
Income before minority interests and income taxes
    2,327       2,141       2,306       1,603       1,596  
Minority interests in earnings of consolidated entities
    178       168       150       148       119  
                               
Income before income taxes
    2,149       1,973       2,156       1,455       1,477  
Provision for income taxes
    725       727       824       622       591  
                               
Reported net income
    1,424       1,246       1,332       833       886  
Goodwill amortization, net of income taxes
                            69  
                               
   
Adjusted net income
  $ 1,424     $ 1,246     $ 1,332     $ 833     $ 955  
                               
Basic earnings per share:
                                       
 
Reported net income
  $ 3.25     $ 2.62     $ 2.66     $ 1.63     $ 1.69  
 
Goodwill amortization, net of income taxes
                            0.13  
                               
   
Adjusted net income
  $ 3.25     $ 2.62     $ 2.66     $ 1.63     $ 1.82  
                               
Shares used in computing basic earnings per share (in thousands)
    438,619       475,620       501,799       511,824       524,112  
Diluted earnings per share:
                                       
 
Reported net income
  $ 3.19     $ 2.58     $ 2.61     $ 1.59     $ 1.65  
 
Goodwill amortization, net of income taxes
                            0.13  
                               
   
Adjusted net income
  $ 3.19     $ 2.58     $ 2.61     $ 1.59     $ 1.78  
                               
Shares used in computing diluted earnings per share (in thousands)
    445,785       483,663       510,874       525,219       538,177  
Cash dividends declared per common share
  $ 0.60     $ 0.52     $ 0.08     $ 0.08     $ 0.08  
Financial Position:
                                       
 
Assets
  $ 22,225     $ 21,840     $ 21,400     $ 19,059     $ 18,073  
 
Working capital
    1,320       1,509       1,654       766       957  
 
Long-term debt, including amounts due within one year
    10,475       10,530       8,707       6,943       7,360  
 
Minority interests in equity of consolidated entities
    828       809       680       611       563  
 
Company-obligated mandatorily redeemable securities of affiliate holding solely Company securities
                            400  
 
Stockholders’ equity
    4,863       4,407       6,209       5,702       4,762  

34


Table of Contents

HCA INC.
SELECTED FINANCIAL DATA
AS OF AND FOR THE YEARS ENDED DECEMBER 31 — (Continued)
(Dollars in millions, except per share amounts)
                                           
    2005   2004   2003   2002   2001
                     
Cash Flow Data:
                                       
 
Cash provided by operating activities
  $ 3,159     $ 2,954     $ 2,292     $ 2,648     $ 1,352  
 
Cash used in investing activities
    (1,681 )     (1,688 )     (2,862 )     (1,740 )     (1,300 )
 
Cash (used in) provided by financing activities
    (1,400 )     (1,347 )     650       (934 )     (342 )
Operating Data:
                                       
 
Number of hospitals at end of period(a)
    175       182       184       173       178  
 
Number of freestanding outpatient surgical centers at end of period(b)
    87       84       79       74       76  
 
Number of licensed beds at end of period(c)
    41,265       41,852       42,108       39,932       40,112  
 
Weighted average licensed beds(d)
    41,902       41,997       41,568       39,985       40,645  
 
Admissions(e)
    1,647,800       1,659,200       1,635,200       1,582,800       1,564,100  
 
Equivalent admissions(f)
    2,476,600       2,454,000       2,405,400       2,339,400       2,311,700  
 
Average length of stay (days)(g)
    4.9       5.0       5.0       5.0       4.9  
 
Average daily census(h)
    22,225       22,493       22,234       21,509       21,160  
 
Occupancy(i)
    53 %     54 %     54 %     54 %     52 %
 
Emergency room visits(j)
    5,415,200       5,219,500       5,160,200       4,802,800       4,676,800  
 
Outpatient surgeries(k)
    836,600       834,800       814,300       809,900       804,300  
 
Inpatient surgeries(l)
    541,400       541,000       528,600       518,100       507,800  
 
Days revenues in accounts receivable(m)
    50       48       52       52       49  
 
Gross patient revenues(n)
  $ 78,662     $ 71,279     $ 62,626     $ 53,542     $ 44,947  
 
Outpatient revenues as a % of patient revenues(o)
    36 %     37 %     37 %     37 %     37 %
 
(a) Excludes seven facilities in 2005, 2004, and 2003; and six facilities in 2002 and 2001 that are not consolidated (accounted for using the equity method) for financial reporting purposes. Three hospitals located on the same campus were consolidated and counted as one hospital in 2005.
(b) Excludes seven facilities in 2005, eight facilities in 2004, four facilities in 2003 and 2002 and three facilities in 2001 that are not consolidated (accounted for using the equity method) for financial reporting purposes.
(c) Licensed beds are those beds for which a facility has been granted approval to operate from the applicable state licensing agency.
(d) Weighted average licensed beds represents the average number of licensed beds, weighted based on periods owned.
(e) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.
(f) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue. The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume. Equivalent admissions for 2004 were reclassified to conform to the 2005 presentation.
(g) Represents the average number of days admitted patients stay in our hospitals.
(h) Represents the average number of patients in our hospital beds each day.
(i) Represents the percentage of hospital licensed beds occupied by patients. Both average daily census and occupancy rate provide measures of the utilization of inpatient rooms.
(j) Represents the number of patients treated in our emergency rooms.
(k) Represents the number of surgeries performed on patients who were not admitted to our hospitals. Pain management and endoscopy procedures are not included in outpatient surgeries.
(l) Represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management and endoscopy procedures are not included in inpatient surgeries.
(m) Revenues per day is calculated by dividing the revenues for the period by the days in the period. Days revenues in accounts receivable is then calculated as accounts receivable, net of the allowance for doubtful accounts, at the end of the period divided by revenues per day.
(n) Gross patient revenues are based upon our standard charge listing. Gross charges/ revenues typically do not reflect what our hospital facilities are paid. Gross charges/ revenues are reduced by contractual adjustments, discounts and charity care to determine reported revenues.
(o) Represents the percentage of patient revenues related to patients who are not admitted to our hospitals. Patient revenues for 2004 were reclassified to conform to the 2005 presentation.

35


Table of Contents

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
      The selected financial data and the accompanying consolidated financial statements present certain information with respect to the financial position, results of operations and cash flows of HCA Inc. which should be read in conjunction with the following discussion and analysis. The terms “HCA,” “Company,” “we,” “our,” or “us” as used herein, refer to HCA Inc. and our affiliates unless otherwise stated or indicated by context. The term “affiliates” means direct and indirect subsidiaries of HCA Inc. and partnerships and joint ventures in which such subsidiaries are partners.
Forward-Looking Statements
      This “Annual Report on Form 10-K” includes certain disclosures which contain “forward-looking statements.” Forward-looking statements include all statements that do not relate solely to historical or current facts, and can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, that could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) increases in the amount and risk of collectibility of uninsured accounts and deductibles and copayment amounts for insured accounts, (2) the ability to achieve operating and financial targets and achieve expected levels of patient volumes and control the costs of providing services, (3) possible changes in the Medicare, Medicaid and other state programs that may impact reimbursements to health care providers and insurers, (4) the highly competitive nature of the health care business, (5) changes in revenue mix and the ability to enter into and renew managed care provider agreements on acceptable terms, (6) the efforts of insurers, health care providers and others to contain health care costs, (7) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures and our corporate integrity agreement with the government, (8) changes in federal, state or local regulations affecting the health care industry, (9) the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical support personnel, (10) the outcome of governmental investigations by the United States Attorney for the Southern District of New York and the Securities and Exchange Commission, (“SEC”), (11) the outcome of certain class action and derivative litigation filed with respect to us, (12) the impact of our charity care and uninsured discounting policies, (13) the possible enactment of federal or state health care reform, (14) the increased leverage resulting from the financing of the our modified “Dutch” auction tender offer, (15) the availability and terms of capital to fund the expansion of our business, (16) our ability to successfully consummate the hospital divestitures to LifePoint Hospitals Inc. on a timely basis and in accordance with the definitive agreement, (17) the continuing impact of hurricanes on our facilities and the ability to obtain recoveries under our insurance policies, (18) fluctuations in the market value of our common stock, (19) changes in accounting practices, (20) changes in general economic conditions, (21) future divestitures which may result in charges, (22) changes in business strategy or development plans, (23) delays in receiving payments for services provided, (24) the outcome of pending and any future tax audits, appeals and litigation associated with our tax positions (25) potential liabilities and other claims that may be asserted against us, (26) the ability to develop and implement the payroll and human resources information systems within the expected time and cost projections and, upon implementation, to realize the expected benefits and efficiencies, and (27) other risk factors described in this Annual Report on Form 10-K. As a consequence, current plans, anticipated actions and future financial position and results may differ from those expressed in any forward-looking statements made by or on behalf of HCA. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this report.

36


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
2005 Operations Summary
      Net income totaled $1.424 billion, or $3.19 per diluted share, for the year ended December 31, 2005 compared to $1.246 billion, or $2.58 per diluted share, for the year ended December 31, 2004. The 2005 results include gains on sales of facilities of $78 million, or $0.08 per diluted share, reductions to estimated professional liability reserves of $83 million, or $0.12 per diluted share, a favorable tax settlement of $48 million, or $0.11 per diluted share, and a tax benefit of $24 million, or $0.05 per diluted share, related to the repatriation of foreign earnings. During 2005, we incurred expenses, net of recoveries, associated with hurricanes of $60 million, or $0.08 per diluted share. The 2004 results include a favorable change in the estimated provision for doubtful accounts totaling $46 million, or $0.06 per diluted share, based upon refinements to the allowance for doubtful accounts estimation process related to estimated recoveries associated with Medicare copays and deductibles and collection agency placements, and a $59 million, or $0.07 per diluted share, reduction to the estimated professional liability insurance reserves. During 2004, we incurred expenses, net of recoveries, associated with hurricanes of $40 million, or $0.05 per diluted share and recognized an asset impairment charge of $12 million, or $0.02 per diluted share. We repurchased 36.7 million shares of our common stock during the fourth quarter of 2005 and 62.9 million shares of our common stock during the fourth quarter of 2004. Shares used for diluted earnings per share for the year ended December 31, 2005 were 445.8 million shares, compared to 483.7 million shares for the year ended December 31, 2004.
      Same facility revenue per equivalent admission increased 3.2% for the year ended December 31, 2005 compared to the year ended December 31, 2004. Our uninsured discount policy, which became effective January 1, 2005, resulted in $756 million in same facility discounts to the uninsured being recorded during 2005. Adjusting for the effect of the uninsured discounts, same facility revenue per equivalent admission increased 6.5% for the year ended December 31, 2005 compared to the year ended December 31, 2004. See “Supplemental Non-GAAP Disclosures, Operating Measures Adjusted for the Impact of Discounts for the Uninsured.”
      During the year ended December 31, 2005, same facility admissions increased 0.1%, compared to the year ended December 31, 2004. Same facility inpatient surgeries increased 0.9% and same facility outpatient surgeries increased 0.3% during the year ended December 31, 2005 compared to the year ended December 31, 2004.
      For the year ended December 31, 2005, the provision for doubtful accounts declined to 9.6% of revenues from 11.4% of revenues for the year ended December 31, 2004. Adjusting for the effect of the uninsured discounts, the provision for doubtful accounts for the year ended December 31, 2005 was 12.4% of revenues. Same facility uninsured admissions increased 9.5% and same facility uninsured emergency room visits increased 11.0% for the year ended December 31, 2005 compared to the year ended December 31, 2004.
Business Strategy
      We are committed to providing the communities we serve high quality, cost-effective, health care while maintaining consistency with our ethics and compliance program, governmental regulations and guidelines, and industry standards. As a part of this strategy, management focuses on the following areas:
  •  Commitment to the care and improvement of human life: Our foundation is built on putting patients first and providing quality health care services in the communities we serve. We continue to increase efforts and funding for our patient safety agenda. Management believes patient outcomes will increasingly influence physician and patient choices concerning health care delivery.
 
  •  Commitment to ethics and compliance: We are committed to a corporate culture highlighted by the following values — compassion, honesty, integrity, fairness, loyalty, respect and kindness. Our comprehensive ethics and compliance program reinforces our dedication to these values.

37


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Business Strategy (Continued)
  •  Focus on core communities: We strive to maintain market-leading positions in large, growing urban and suburban communities, primarily in the Southern and Western regions of the United States. Effective January 1, 2006, we reorganized our operations management to create a third operating group and created smaller, more focused divisions and markets, along with market-based service line strategies.
 
  •  Physician Recruitment and Retention. We recruit and work to retain both primary care physicians and specialists by strategically employing them or providing incentives for them to establish a practice or join an existing practice where there is a community need and providing support to build their practices. We use joint ventures with physicians in both our outpatient diagnostic centers and our freestanding surgery centers. In certain situations, we extend professional liability insurance coverage to physicians on our medical staffs through our wholly-owned insurance subsidiary. We also develop medical office buildings to provide convenient facilities for physicians to locate their practices and serve the needs of their patients.
 
  •  Becoming the health care employer of choice: We use a number of industry-leading practices to help ensure our hospitals are a health care employer of choice in their communities. Labor initiatives provide strategies to the hospitals for recruiting, compensation and productivity, and include various leadership and career development programs. An internal contract labor agency provides improved quality and reduces costs.
 
  •  Continuing to strive for operational excellence: Our group purchasing organization achieves pricing efficiencies through purchasing and supply contracts. We use a shared services model to process revenue and accounts receivable through regional patient accounting service centers. We have increased our focus on providing outpatient services with improved accessibility and more convenient service for patients and increased predictability and efficiency for physicians. As part of this focus, we may buy or build outpatient facilities to improve our market presence.
 
  •  Allocating capital to strategically complement our operational strategy and enhance stockholder value: Our capital spending is intended to increase bed capacity, provide new or expanded services in existing facilities, maintain or replace equipment and renovate existing facilities or construct replacement facilities. We also selectively evaluate acquisitions that may complement our strategies in existing or new markets. Capital may also be allocated to take advantage of opportunities such as repayment of indebtedness, stock repurchases and payment of dividends.
Critical Accounting Policies and Estimates
      The preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenues and expenses. Our estimates are based on historical experience and various other assumptions that we believe are reasonable under the circumstances. We evaluate our estimates on an ongoing basis and make changes to the estimates and related disclosures as experience develops or new information becomes known. Actual results may differ from these estimates.
      We believe that the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.
Revenues
      Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from payers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Laws and regulations governing the

38


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Critical Accounting Policies and Estimates (Continued)
     Revenues (Continued)
Medicare and Medicaid programs are complex and subject to interpretation. The estimated reimbursement amounts are made on a payer-specific basis and are recorded based on the best information available regarding management’s interpretation of the applicable laws, regulations and contract terms. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms that result from contract renegotiations and renewals. We have invested significant resources to refine and improve the computerized billing system and the information system data used to make contractual allowance estimates. We have developed standardized calculation processes and related training programs to improve the utility of the patient accounting systems.
      The Emergency Medical Treatment and Active Labor Act (“EMTALA”) requires any hospital that participates in the Medicare program to conduct an appropriate medical screening examination of every person who presents to the hospital’s emergency room for treatment and, if the individual is suffering from an emergency medical condition, to either stabilize that condition or make an appropriate transfer of the individual to a facility that can handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of an individual’s ability to pay for treatment. Federal and state laws and regulations, including but not limited to EMTALA, require, and our commitment to providing quality patient care encourages, the provision of services to patients who are financially unable to pay for the health care services they receive.
      We do not pursue collection of amounts related to patients who meet the Company’s guidelines to qualify as charity care; therefore, they are not reported in revenues. The revenues associated with uninsured patients who do not meet our guidelines to qualify as charity care have generally been reported in revenues at gross charges. Patients treated at our hospitals for nonelective care, who have income at or below 200% of the federal poverty level, are eligible for charity care. The federal poverty level is established by the federal government and is based on income and family size. On January 1, 2005, we modified our policies to provide discounts to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans.
      Due to the complexities involved in the classification and documentation of health care services authorized and provided, the estimation of revenues earned and the related reimbursement are often subject to interpretations that could result in payments that are different from our estimates. A hypothetical 1% change in net receivables that are subject to contractual discounts at December 31, 2005 would result in an impact on pretax earnings of approximately $29 million.
Provision for Doubtful Accounts and the Allowance for Doubtful Accounts
      The collection of outstanding receivables from Medicare, managed care payers, other third-party payers and patients is our primary source of cash and is critical to our operating performance. The primary collection risks relate to uninsured patient accounts, including patient accounts for which the primary insurance carrier has paid the amounts covered by the applicable agreement, but patient responsibility amounts (deductibles and copayments) remain outstanding. The provision for doubtful accounts and the allowance for doubtful accounts relate primarily to amounts due directly from patients. An estimated allowance for doubtful accounts is recorded for all uninsured accounts, regardless of the aging of those accounts. Accounts are written off when all reasonable internal and external collection efforts have been performed. We consider the return of an account from the primary external collection agency to be the culmination of our reasonable collection efforts and the timing basis for writing off the account balance. Writeoffs are based upon specific identification and the writeoff process requires a writeoff adjustment entry to the patient accounting system. We do not pursue

39


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Critical Accounting Policies and Estimates (Continued)
     Provision for Doubtful Accounts and the Allowance for Doubtful Accounts (Continued)
collection of amounts related to patients that meet our guidelines to qualify as charity care. Charity care is not reported in revenues and does not have an impact on the provision for doubtful accounts.
      The amount of the provision for doubtful accounts is based upon management’s assessment of historical writeoffs and expected net collections, business and economic conditions, trends in federal, state, and private employer health care coverage and other collection indicators. Management relies on the results of detailed reviews of historical writeoffs and recoveries at facilities that represent a majority of our revenues and accounts receivable (the “hindsight analysis”) as a primary source of information in estimating the collectibility of our accounts receivable. We perform the hindsight analysis quarterly, utilizing rolling twelve-month accounts receivable collection and writeoff data. At December 31, 2005, the allowance for doubtful accounts represented approximately 85% of the $3.404 billion patient due accounts receivable balance, including accounts, net of the related estimated contractual discounts, related to patients for which eligibility for Medicaid assistance or charity was being evaluated (“pending Medicaid accounts”). At December 31, 2004, the allowance for doubtful accounts represented approximately 87% of the $3.382 billion patient due accounts receivable balance, including pending Medicaid accounts, net of the related estimated contractual discounts (the December 31, 2004 allowance for doubtful accounts represented approximately 78% of the $3.762 billion patient due accounts receivable balance, including pending Medicaid accounts, but excluding the related estimated contractual discounts). The provision for doubtful accounts decreased to 9.6% of revenues for 2005, from 11.4% of revenues for 2004 and from 10.1% of revenues in 2003. Our uninsured discount policy, which became effective January 1, 2005, resulted in $769 million in discounts to the uninsured being recorded during 2005. Adjusting for the effect of the uninsured discounts, the provision for doubtful accounts increased to 12.4% of revenues for the year ended December 31, 2005. See “Supplemental Non-GAAP Disclosures, Operating Measures Adjusted for the Impact of Discounts for the Uninsured.” Days revenues in accounts receivable were 50 days, 48 days and 52 days at December 31, 2005, 2004 and 2003, respectively. Management expects a continuation of the challenges related to the collection of the patient due accounts. Adverse changes in general economic conditions, patient accounting service center operations, payer mix, or trends in federal, state, and private employer health care coverage could affect the collection of accounts receivable, cash flows and results of operations.
      The approximate breakdown of accounts receivable by payer classification as of December 31, 2005 and 2004 is set forth in the following table:
                             
    % of Accounts Receivable
     
    Under 91 Days   91 — 180 Days   Over 180 Days
             
Accounts receivable aging at December 31, 2005:
                       
 
Medicare and Medicaid
    13 %     2 %     2 %
 
Managed care and other insurers
    21       4       4  
 
Uninsured
    21       11       22  
                   
   
Total
    55 %     17 %     28 %
                   
Accounts receivable aging at December 31, 2004:
                       
 
Medicare and Medicaid
    11 %     1 %     2 %
 
Managed care and other insurers
    20       3       1  
 
Uninsured
    22       13       27  
                   
   
Total
    53 %     17 %     30 %
                   

40


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Critical Accounting Policies and Estimates (Continued)
     Provision for Doubtful Accounts and the Allowance for Doubtful Accounts (Continued)
      The decline in uninsured accounts receivable from 62% of total accounts receivable at December 31, 2004 to 54% of total accounts receivable at December 31, 2005 can be primarily attributed to the reductions in uninsured accounts receivable amounts related to the uninsured discount program that was implemented January 1, 2005.
Investments of Insurance Subsidiary — Other-than-temporary Impairment Considerations
      Our wholly-owned insurance subsidiary holds debt and equity security investments having an aggregate fair value of $2.384 billion at December 31, 2005. The fair value of the investment securities is generally based on quoted market prices. The investment securities are held for the purpose of providing the funding source to pay professional liability claims covered by the insurance subsidiary. Management’s assessment each quarter of whether a decline in fair value is temporary or other-than-temporary involves multiple subjective judgments, often involves estimating the outcome of future events, and requires a significant level of professional judgment in determining whether factors exist that indicate an impairment has occurred. Management evaluates, among other things, the financial position and near term prospects of the issuer, conditions in the issuer’s industry, liquidity of the investment, changes in the amount or timing of expected future cash flows from the investment, and recent downgrades of the issuer by a rating agency to determine if, and when, a decline in the fair value of an investment below amortized cost is considered other-than-temporary. The length of time and extent to which the fair value of the investment is less than amortized cost and the ability and intent to retain the investment to allow for any anticipated recovery of the investment’s fair value are important components of management’s investment securities evaluation process. There were no other-than-temporary declines in fair value during 2003, 2004, or 2005 and at December 31, 2005, the insurance subsidiary’s investment security portfolio had unrealized gains of $193 million and unrealized losses of $9 million.
Professional Liability Claims
      We, along with virtually all health care providers, operate in an environment with professional liability risks. A substantial portion of our professional liability risks is insured through a wholly-owned insurance subsidiary. Reserves for professional liability risks were $1.621 billion and $1.593 billion at December 31, 2005 and December 31, 2004, respectively. The current portion of these reserves, $285 million and $310 million at December 31, 2005 and 2004, respectively, is included in “other accrued expenses.” Obligations covered by reinsurance contracts are included in the reserves for professional liability risks, as the insurance subsidiary remains liable to the extent that reinsurers do not meet their obligations. Reserves for professional liability risks (net of $43 million and $79 million receivable under reinsurance contracts at December 31, 2005 and 2004, respectively) were $1.578 billion and $1.514 billion at December 31, 2005 and 2004, respectively. Reserves and provisions for professional liability risks are based upon actuarially determined estimates. The independent actuaries’ estimated reserve ranges, net of amounts receivable under reinsurance contracts, were $1.373 billion to $1.589 billion at December 31, 2005 and $1.296 billion to $1.530 billion at December 31, 2004. Reserves for professional liability risks represent the estimated ultimate cost of all reported and unreported losses incurred through the respective consolidated balance sheet dates. The reserves are estimated using individual case-basis valuations and actuarial analyses. Those estimates are subject to the effects of trends in loss severity and frequency. The estimates are continually reviewed and adjustments are recorded as experience develops or new information becomes known.

41


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Critical Accounting Policies and Estimates (Continued)
     Professional Liability Claims (Continued)
      The reserves for professional liability risks cover approximately 3,300 and 3,500 individual claims at December 31, 2005 and 2004, respectively, and estimates for potential unreported claims. The time period required to resolve these claims can vary depending upon the jurisdiction and whether the claim is settled or litigated. The estimation of the timing of payments beyond a year can vary significantly. Changes to the estimated reserve amounts are included in current operating results. Due to the considerable variability that is inherent in such estimates, there can be no assurance that the ultimate liability will not exceed management’s estimates.
      Provisions for losses related to professional liability risks were $298 million, $291 million and $380 million for the years ended December 31, 2005, 2004 and 2003, respectively. The Company recognized reductions in its estimated professional liability insurance reserves of $83 million pretax, or $0.12 per diluted share, during 2005. Results of operations for 2004 included a reduction in estimated professional liability reserves of $59 million pretax, or $0.07 per diluted share. The malpractice reserve reductions in 2005 and 2004 reflect the recognition by our external actuaries of improving frequency and severity claim trends at HCA. This improving frequency and moderating severity can be primarily attributed to tort reforms enacted in key states, particularly Texas, and our risk management and patient safety initiatives, particularly in the areas of obstetrics and emergency services.
     Income Taxes
      We calculate our provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized by identifying the temporary differences that arise from the recognition of items in different periods for tax and accounting purposes. Deferred tax assets generally represent the tax effects of amounts expensed in our income statement for which tax deductions will be claimed future periods.
      Although we believe that we have properly reported taxable income and paid taxes in accordance with applicable laws, federal and state taxing authorities may challenge our tax positions upon audit. To reflect the possibility that our positions may not ultimately be sustained, we have established, and when appropriate adjust, provisions for potential adverse tax outcomes, based on our evaluation of the underlying facts and circumstances. Final audit results may vary from our estimates.
Results of Operations
Revenue/ Volume Trends
      Our revenues depend upon inpatient occupancy levels, the ancillary services and therapy programs ordered by physicians and provided to patients, the volume of outpatient procedures and the charge and negotiated payment rates for such services. Gross charges typically do not reflect what our facilities are actually paid. Our facilities have entered into agreements with third-party payers, including government programs and managed care health plans, under which the facilities are paid based upon the cost of providing services, predetermined rates per diagnosis, fixed per diem rates or discounts from gross charges.
      Revenues increased 4.1% to $24.455 billion for the year ended December 31, 2005 from $23.502 billion for the year ended December 31, 2004 and increased 7.8% for the year ended December 31, 2004 from $21.808 billion for the year ended December 31, 2003. The increase in revenues in 2005 can be attributed to a 0.9% increase in equivalent admissions and a 3.1% increase in revenue per equivalent admission compared to the prior year. Our uninsured discount policy, which became effective January 1, 2005, resulted in $769 million in discounts to the uninsured being recorded during 2005. Adjusting for the effect of the

42


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)
     Revenue/Volume Trends (Continued)
uninsured discounts, revenue per equivalent admission increased 6.3% in the year ended December 31, 2005 compared to the year ended December 31, 2004. See “Supplemental Non-GAAP Disclosures, Operating Measures Adjusted for the Impact of Discounts for the Uninsured.” The increase in revenues in 2004 can be primarily attributed to a 1.3% increase in same facility equivalent admissions and a 6.0% increase in same facility revenue per equivalent admission compared to the prior year. For the year ended December 31, 2004, 89.8% of the $1.694 billion increase in revenues, compared to the year ended December 31, 2003, was related to the increase in same facility revenues and the remaining 10.2% of the increase related to acquired facilities.
      Same facility admissions increased 0.1% in 2005 compared to 2004 and increased 0.7% in 2004 compared to 2003. Same facility inpatient surgeries increased 0.9% and same facility outpatient surgeries increased 0.3% during 2005 compared to 2004. Same facility inpatient surgeries increased 2.2% and same facility outpatient surgeries increased 1.4% during 2004 compared to 2003. Same facility emergency room visits increased 4.8% during 2005 compared to 2004 and increased 0.2% during 2004 compared to 2003.
      Admissions related to Medicare, Medicaid, managed Medicaid, managed care and other insurers and the uninsured for the years ended December 31, 2005, 2004 and 2003 are set forth below.
                         
    Years Ended December 31,
     
    2005   2004   2003
             
Medicare
    38 %     39 %     39 %
Medicaid
    10       10       13  
Managed Medicaid
    5       4       (a )
Managed care and other insurers
    42       42       44  
Uninsured
    5       5       4  
                   
      100 %     100 %     100 %
                   
 
(a) Prior to 2004, managed Medicaid admissions were classified as either Medicaid or managed care.
      Same facility uninsured emergency room visits increased 11.0% and same facility uninsured admissions increased 9.5% during 2005 compared to 2004. Same facility uninsured emergency room visits increased 7.6% and same facility uninsured admissions increased 9.7% during 2004 compared to 2003. Management cannot predict whether the current trends in same facility emergency room visits and same facility uninsured admissions will continue.
      Several factors negatively affected patient volumes in 2005. Unit closures and changes in Medicare admission guidelines led to reductions in rehabilitation and skilled nursing admissions. Cardiac admissions have been affected by competition from physician-owned heart hospitals and credentialing decisions made at some of our Florida hospitals. More stringent enforcement of case management guidelines led to certain patient services being classified as outpatient observation visits instead of one-day admissions. We plan to increase physician recruitment, increase available medical office building space on or near our campuses, and continue capital spending devoted to both maintenance of technology and facilities and growth and expansion programs. Effective January 1, 2006, we reorganized our operations management to create a third operating group and created smaller, more focused divisions and markets, along with market-based service line strategies.

43


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)
     Revenue/Volume Trends (Continued)
      At December 31, 2005, we owned and operated 40 hospitals and 28 surgery centers in the state of Florida. Our Florida facilities’ revenues totaled $6.276 billion and $6.036 billion for the years ended December 31, 2005 and 2004, respectively. At December 31, 2005, we owned and operated 34 hospitals and 23 surgery centers in the state of Texas. Our Texas facilities’ revenues totaled $5.900 billion and $5.771 billion for the years ended December 31, 2005 and 2004, respectively.
      Revenues related to Medicare operating outlier cases for the years ended December 31, 2005, 2004 and 2003, respectively, were $148 million, $124 million and $221 million. These amounts represent 2.2%, 1.9% and 3.7% of Medicare revenues and 0.6%, 0.5% and 1.0% of total revenues for the years ended December 31, 2005, 2004 and 2003, respectively. There can be no assurances that we will continue to receive these levels of Medicare outlier payments in future periods.
      We provided $1.138 billion, $926 million and $821 million of charity care during the years ended December 31, 2005, 2004 and 2003, respectively. On January 1, 2005, we modified our policies to provide a discount to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans and totaled $769 million for the year ended December 31, 2005.
      We receive a significant portion of our revenues from government health programs, principally Medicare and Medicaid, which are highly regulated and subject to frequent and substantial changes. Legislative changes have resulted in limitations and even reductions in levels of payments to health care providers for certain services under these government programs.
      The approximate percentages of our inpatient revenues related to Medicare, Medicaid, managed Medicaid, managed care plans and other insurers and the uninsured for the years ended December 31, 2005, 2004 and 2003 are set forth below.
                         
    Years Ended December 31,
     
    2005   2004(a)   2003
             
Medicare
    36 %     37 %     38 %
Medicaid
    7       6       8  
Managed Medicaid
    3       3       (a )
Managed care and other insurers
    49       48       48  
Uninsured(b)
    5       6       6  
                   
      100 %     100 %     100 %
                   
 
(a) Prior to 2004, managed Medicaid revenues were classified as either Medicaid or managed care and certain 2004 amounts have been reclassified to conform to the 2005 presentation.
 
(b) Uninsured revenues for the year ended December 31, 2005 were reduced due to discounts to the uninsured, related to the uninsured discount program implemented January 1, 2005.

44


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)
Operating Results Summary
      The following are comparative summaries of net income for the years ended December 31, 2005, 2004 and 2003 (dollars in millions, except per share amounts):
                                                   
    2005   2004   2003
             
    Amount   Ratio   Amount   Ratio   Amount   Ratio
                         
Revenues
  $ 24,455       100.0     $ 23,502       100.0     $ 21,808       100.0  
Salaries and benefits
    9,928       40.6       9,419       40.1       8,682       39.8  
Supplies
    4,126       16.9       3,901       16.6       3,522       16.2  
Other operating expenses
    4,039       16.5       3,797       16.0       3,676       16.8  
Provision for doubtful accounts
    2,358       9.6       2,669       11.4       2,207       10.1  
Gains on investments
    (53 )     (0.2 )     (56 )     (0.2 )     (1 )      
Equity in earnings of affiliates
    (221 )     (0.9 )     (194 )     (0.8 )     (199 )     (0.9 )
Depreciation and amortization
    1,374       5.6       1,250       5.3       1,112       5.1  
Interest expense
    655       2.7       563       2.4       491       2.3  
Gains on sales of facilities
    (78 )     (0.3 )                 (85 )     (0.4 )
Impairment of long-lived assets
                12       0.1       130       0.6  
Government settlement and investigation related costs
                            (33 )     (0.2 )
                                     
      22,128       90.5       21,361       90.9       19,502       89.4  
                                     
Income before minority interests and income taxes
    2,327       9.5       2,141       9.1       2,306       10.6  
Minority interests in earnings of consolidated entities
    178       0.7       168       0.7       150       0.7  
                                     
Income before income taxes
    2,149       8.8       1,973       8.4       2,156       9.9  
Provision for income taxes
    725       3.0       727       3.1       824       3.8  
                                     
Net income
  $ 1,424       5.8     $ 1,246       5.3     $ 1,332       6.1  
                                     
Earnings per share:
                                               
 
Basic earnings per share
  $ 3.25             $ 2.62             $ 2.66          
 
Diluted earnings per share
  $ 3.19             $ 2.58             $ 2.61          
% changes from prior year:
                                               
 
Revenues
    4.1 %             7.8 %             10.5 %        
 
Income before income taxes
    9.0               (8.5 )             48.2          
 
Net income
    14.2               (6.5 )             59.9          
 
Basic earnings per share
    24.0               (1.5 )             63.2          
 
Diluted earnings per share
    23.6               (1.1 )             64.2          
 
Admissions(a)
    (0.7 )             1.5               3.3          
 
Equivalent admissions(b)
    0.9               2.0               2.8          
 
Revenue per equivalent admission
    3.1               5.6               7.5          
Same facility % changes from prior year(c):
                                               
 
Revenues
    4.7               7.3               7.6          
 
Admissions(a)
    0.1               0.7               0.6          
 
Equivalent admissions(b)
    1.4               1.3                        
 
Revenue per equivalent admission
    3.2               6.0               7.5          
 
(a) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.
(b) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue. The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume. Equivalent admissions for 2004 were reclassified to conform to the 2005 presentation.
(c) Same facility information excludes the operations of hospitals and their related facilities that were either acquired or divested during the current and prior year.

45


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)
Operating Results Summary (Continued)
Supplemental Non-GAAP Disclosures
Operating Measures Adjusted for the Impact of Discounts for the Uninsured
(Dollars in millions, except revenue per equivalent admission)
      The results of operations for the year ended December 31, 2005, adjusted for the impact of our uninsured discount policy, are presented below:
                                                 
    Year Ended December 31, 2005
     
        Non-
            GAAP %
        GAAP % of   of Adjusted
    Reported   Uninsured   Non-GAAP   Revenues   Revenues
    GAAP(a)   Discounts   Adjusted        
    Amounts   Adjustment(b)   Amounts(c)   2005   2004   2005
                         
Revenues
  $ 24,455     $ 769     $ 25,224       100.0 %     100.0 %     100.0 %
Salaries and benefits
    9,928             9,928       40.6       40.1       39.4  
Supplies
    4,126             4,126       16.9       16.6       16.4  
Other operating expenses
    4,039             4,039       16.5       16.0       15.9  
Provision for doubtful accounts
    2,358       769       3,127       9.6       11.4       12.4  
Admissions
    1,647,800               1,647,800                          
Equivalent admissions
    2,476,600               2,476,600                          
Revenue per equivalent admission
  $ 9,874             $ 10,185                          
% change from prior year
    3.1 %             6.3 %                        
Same Facility(d):
                                               
Revenues
  $ 23,686     $ 756     $ 24,442                          
Admissions
    1,610,800               1,610,800                          
Equivalent admissions
    2,409,800               2,409,800                          
Revenue per equivalent admission
  $ 9,829             $ 10,143                          
% change from prior year
    3.2 %             6.5 %                        
 
(a) Generally accepted accounting principles (“GAAP”).
(b) Represents the impact of the discounts for the uninsured for the period. On January 1, 2005, we modified our policies to provide discounts to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. In implementing the discount policy, we first attempt to qualify uninsured patients for Medicaid, other federal or state assistance or charity care. If an uninsured patient does not qualify for these programs, the uninsured discount is applied.
(c) Revenues, the provision for doubtful accounts, certain operating expense categories as a percentage of revenues and revenue per equivalent admission have been adjusted to exclude the discounts under our uninsured discount policy (non-GAAP financial measures). We believe these non-GAAP financial measures are useful to investors and provide disclosures of our results of operations on the same basis as that used by management. Management uses this information to compare revenues, the provision for doubtful accounts, certain operating expense categories as a percentage of revenues and revenue per equivalent admission for periods prior and subsequent to the January 1, 2005 implementation of the uninsured discount policy. Management finds this information to be useful to enable the evaluation of revenue and certain expense category trends that are influenced by patient volumes and are generally analyzed as a percentage of net revenues. These non-GAAP financial measures should not be considered an alternative to GAAP financial measures. We believe this supplemental information provides management and the users of our financial statements with useful information for period-to-period comparisons. Investors are encouraged to use GAAP measures when evaluating our overall financial performance.
(d) Same facility information excludes the operations of hospitals and their related facilities which were either acquired, divested or removed from service during the current and prior period.
Years Ended December 31, 2005 and 2004
      Net income increased 14.2%, from $1.246 billion, or $2.58 per diluted share, for the year ended December 31, 2004 to $1.424 billion, or $3.19 per diluted share, for the year ended December 31, 2005. Financial results for 2005 include gains on sales of facilities of $78 million, or $0.08 per diluted share,

46


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)
Years Ended December 31, 2005 and 2004 (Continued)
reductions to estimated professional liability reserves of $83 million, or $0.12 per diluted share, an adverse financial impact from hurricanes of $60 million, or $0.08 per diluted share, a tax benefit of $24 million, or $0.05 per diluted share, related to the repatriation of foreign earnings, and a favorable tax settlement of $48 million, or $0.11 per diluted share, related to the divestures in 1998 and 2001 of certain noncore business units. The 2004 results include a favorable change in the estimated provision for doubtful accounts totaling $46 million, or $0.06 per diluted share, based upon refinements to our allowance for doubtful accounts estimation process, a $59 million reduction, or $0.07 per diluted share, to estimated professional liability reserves, an adverse financial impact from hurricanes of $40 million, or $0.05 per diluted share, and an impairment of long-lived assets of $12 million, or $0.02 per diluted share.
      Revenues increased 4.1% to $24.455 billion for the year ended December 31, 2005 compared to $23.502 billion for the year ended December 31, 2004. The increase in revenues was due to a 0.9% increase in equivalent admissions and 3.1% increase in revenue per equivalent admission. Adjusting for the effect of the uninsured discount policy, revenues increased 7.3% for the year ended December 31, 2005 compared to 2004. For the year ended December 31, 2005, admissions decreased 0.7% and same facility admissions increased by 0.1% compared to 2004. Outpatient surgical volumes increased 0.2% and increased 0.3% on a same facility basis in 2005 compared to 2004.
      Salaries and benefits, as a percentage of revenues, were 40.6% in 2005 and 40.1% in 2004. Adjusting for the effect of the uninsured discount policy, salaries and benefits were 39.4% of revenues for the year ended December 31, 2005. Labor rate increases averaged approximately 4.2% for the year ended December 31, 2005.
      Supply costs increased, as a percentage of revenues, to 16.9% for the year ended December 31, 2005 from 16.6% for the year ended December 31, 2004. Adjusting for the effect of the uninsured discount policy, supplies were 16.4% of revenues for the year ended December 31, 2005. During 2005, general supply cost trends included a more stable pricing environment for medical devices and pharmacy items and a stabilization in usage rates for drug-eluting stents.
      Other operating expenses (primarily consisting of contract services, professional fees, repairs and maintenance, rents and leases, utilities, insurance and nonincome taxes), as a percentage of revenues, increased to 16.5% in 2005 from 16.0% in 2004. Adjusting for the effect of the uninsured discount policy, other operating expenses were 15.9% of revenues for the year ended December 31, 2005.
      The provision for doubtful accounts, as a percentage of revenues, declined to 9.6% for the year ended December 31, 2005 from 11.4% for the year ended December 31, 2004. Adjusting for the effect of the uninsured discount policy, the provision for doubtful accounts was 12.4% of revenues in the year ended December 31, 2005. The provision for doubtful accounts and the allowance for doubtful accounts relate primarily to uninsured amounts due directly from patients. The increase in the provision for doubtful accounts (adjusted for uninsured discounts), as a percentage of revenues, related to an increasing amount of patient financial responsibility under certain managed care plans, increases in uninsured emergency room visits of 9.9% and increases in uninsured admissions of 8.9% in 2005 compared to 2004. At December 31, 2005, the allowance for doubtful accounts represented approximately 85% of the $3.404 billion total patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage was being evaluated.
      Gains on investments for the year ended December 31, 2005 of $53 million consist primarily of net gains on investment securities held by our wholly-owned insurance subsidiary. Gains on investments for the year

47


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)
Years Ended December 31, 2005 and 2004 (Continued)
ended December 31, 2004 were $56 million. At December 31, 2005, we had net unrealized gains of $184 million on the insurance subsidiary’s investment securities.
      Equity in earnings of affiliates increased to $221 million for the year ended December 31, 2005 compared to $194 million for the year ended December 31, 2004. The increase was primarily due to an increase in profits at the Denver, Colorado market joint venture.
      Depreciation and amortization increased, as a percentage of revenues, to 5.6% in the year ended December 31, 2005 from 5.3% in the year ended December 31, 2004. A portion of the increase is the result of additional depreciation expense of approximately $44 million being recorded during 2005 to correct accumulated depreciation at certain facilities and assure a consistent application of our accounting policy relative to certain short-lived medical equipment.
      Interest expense increased to $655 million for the year ended December 31, 2005 from $563 million for the year ended December 31, 2004. The average debt balance was $9.828 billion for the year ended December 31, 2005 compared to $8.853 billion for the year ended December 31, 2004. The average interest rate for our long-term debt increased from 6.5% at December 31, 2004 to 7.0% at December 31, 2005.
      During 2004, we closed San Jose Medical Center in San Jose, California, resulting in a pretax asset impairment charge of $12 million ($8 million after-tax).
      Minority interests in earnings of consolidated entities increased to $178 million for the year ended December 31, 2005 compared to $168 million for the year ended December 31, 2004.
      The effective tax rate was 33.8% in the year ended December 31, 2005 and 36.8% in the year ended December 31, 2004. During 2005, the effective tax rate was reduced due to a favorable tax settlement of $48 million related to the divestures of certain noncore business units in 1998 and 2001 and a tax benefit of $24 million related to the repatriation of foreign earnings. Excluding the effect of the combined $72 million of tax benefits, the effective tax rate for the year ended December 31, 2005 would have been 37.1%.
Years Ended December 31, 2004 and 2003
      Net income decreased 6.5% from $1.332 billion, or $2.61 per diluted share, for the year ended December 31, 2003 to $1.246 billion, or $2.58 per diluted share, for the year ended December 31, 2004. The 2004 results include a favorable change in the estimated provision for doubtful accounts totaling $46 million, or $0.06 per diluted share, based upon refinements to the allowance for doubtful accounts estimation process related to estimated recoveries associated with Medicare copayments and deductibles and collection agency placements, a $59 million reduction, or $0.07 per diluted share, to the estimated professional liability reserves, an adverse financial impact from hurricanes of $40 million, or $0.05 per diluted share, an impairment of long-lived assets of $12 million, or $0.02 per diluted share, and a favorable $19 million, or $0.04 per diluted share, reduction in the effective income tax rate. The 2003 results include a favorable settlement with the federal government, net of investigation related costs, of $33 million, or $0.04 per diluted share, an asset impairment charge of $130 million, or $0.16 per diluted share, and gains on sales of facilities of $85 million, or $0.10 per diluted share.
      In April 2003, we completed the acquisition of eleven hospitals in Kansas City. During the years ended December 31, 2004 and 2003, respectively, the acquired Kansas City hospitals produced revenues of $885 million and $698 million and losses before income taxes of $31 million and $35 million. The 2003 amounts include operations subsequent to the April 1, 2003 acquisition date.

48


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)
Years Ended December 31, 2004 and 2003 (Continued)
      Revenues increased 7.8% to $23.502 billion for the year ended December 31, 2004 from $21.808 billion for the year ended December 31, 2003. The increase was due to a 2.0% increase in equivalent admissions and an increase in revenue per equivalent admission of 5.6%. For the year ended December 31, 2004, admissions increased 1.5% and same facility admissions increased by 0.7% compared to 2003. Outpatient surgical volumes increased 2.5%, and increased 1.4% on a same facility basis.
      Salaries and benefits, as a percentage of revenues, remained relatively flat at 40.1% in 2004 and 39.8% in 2003.
      Supply costs increased, as a percentage of revenues, to 16.6% for the year ended December 31, 2004 from 16.2% for the year ended December 31, 2003. Supply costs continue to increase, particularly in the cardiac, orthopedic and pharmaceutical areas. Expenditures for drug-eluting stents increased from $49 million for 2003 to $137 million for 2004.
      Other operating expenses (primarily consisting of contract services, professional fees, repairs and maintenance, rents and leases, utilities, insurance and nonincome taxes), as a percentage of revenues, decreased to 16.0% in 2004 from 16.8% in 2003. The decrease, as a percentage of revenues, is primarily due to reductions in the estimated provision for losses related to professional liability risks from $380 million for the year ended December 31, 2003 to $291 million for the year ended December 31, 2004. Other operating expenses were adversely affected during 2004 due to repairs and other miscellaneous expenses which resulted from the hurricanes and are estimated to have cost $18 million, net of insurance recoveries. Other operating expenses also tend to decrease, as a percentage of revenues, when revenue increases, because the majority of these expenses include significant fixed cost components.
      The provision for doubtful accounts, as a percentage of revenues, increased to 11.4% for the year ended December 31, 2004 from 10.1% for the year ended December 31, 2003. The factors influencing this increase include increasing patient financial responsibilities and uninsured accounts, and a deterioration in the collectibility of these accounts. Management believes the increases in uninsured patients and deterioration in the collectibility of these accounts is caused by decreased medical benefits under certain plans, an increasing amount of patient financial responsibility under certain plans, high unemployment levels in certain of our markets, growing numbers of employed individuals choosing not to buy health insurance and reductions in Medicaid benefits in certain states.
      Gains on investments for the year ended December 31, 2004 of $56 million consist primarily of net gains on investment securities held by our wholly-owned insurance subsidiary. Gains on investments for the year ended December 31, 2003 were $1 million. At December 31, 2004, we had net unrealized gains of $231 million on the insurance subsidiary’s investment securities.
      Equity in earnings of affiliates remained relatively flat and were $194 million for the year ended December 31, 2004 compared to $199 million for the year ended December 31, 2003.
      Depreciation and amortization increased, as a percentage of revenues, to 5.3% in the year ended December 31, 2004 from 5.1% in the year ended December 31, 2003. The increase of $138 million of depreciation and amortization is the result of $6.1 billion of capital spending, including acquisitions, during the last three years.
      Interest expense increased from $491 million for the year ended December 31, 2003 to $563 million for the year ended December 31, 2004. Our average debt balance increased from $8.079 billion for the year ended

49


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)
Years Ended December 31, 2004 and 2003 (Continued)
December 31, 2003 to $8.853 billion for the year ended December 31, 2004. The average interest rate for our long-term debt increased from 6.4% at December 31, 2003 to 6.5% at December 31, 2004.
      During 2004, we closed San Jose Medical Center in San Jose, California, resulting in a pretax charge of $12 million ($8 million after-tax). During 2003, we announced plans to discontinue activities associated with the internal development of a patient accounts receivable management system, resulting in a pretax charge of $130 million ($79 million after-tax).
      During 2003, we recognized a pretax gain of $85 million ($49 million after-tax) on the sales of two leased hospitals and two consolidating hospitals, and a working capital settlement related to a sale completed in 2002.
      Minority interests in earnings of consolidated entities increased to $168 million for the year ended December 31, 2004 compared to $150 million for the year ended December 31, 2003 due to improved operations during 2004 at our joint ventures.
      The effective income tax rate was 36.8% in 2004 and 38.2% in 2003. Our effective tax rate was adjusted to reduce estimated state taxes in the fourth quarter of 2004, resulting in a tax expense reduction of $19 million, or $0.04 per diluted share.
Liquidity and Capital Resources
      Cash provided by operating activities totaled $3.159 billion in 2005 compared to $2.954 billion in 2004 and $2.292 billion in 2003. Working capital totaled $1.320 billion at December 31, 2005 and $1.509 billion at December 31, 2004. Cash flows provided by operating activities include income tax benefits related to the exercise of employee stock options which increased from $31 million and $50 million for the years ended December 31, 2003 and 2004, respectively, to $163 million for the year ended December 31, 2005. The lower cash flow from operations in 2003 when compared to both 2005 and 2004 relates, primarily, to government settlement payments of $942 million made in 2003.
      Cash used in investing activities was $1.681 billion, $1.688 billion and $2.862 billion in 2005, 2004 and 2003, respectively. Excluding acquisitions, capital expenditures were $1.592 billion in 2005, $1.513 billion in 2004 and $1.838 billion in 2003. We expended $126 million, $44 million and $908 million for acquisitions of hospitals and health care entities during 2005, 2004 and 2003, respectively. During April 2003, we completed the acquisition of the Health Midwest system in Kansas City. The aggregate cash paid at closing was $855 million. During 2005 and 2004, the cash used for acquisitions was generally for outpatient and ancillary services entities. Capital expenditures in all three years were funded by a combination of cash flows from operations and the issuance of debt. Annual planned capital expenditures are expected to approximate $1.9 billion in 2006. At December 31, 2005, there were projects under construction, which had an estimated additional cost to complete and equip over the next five years of $2.6 billion. We expect to finance capital expenditures with internally generated and borrowed funds. The sale of five hospitals was completed during the fourth quarter of 2005 and we received cash proceeds of approximately $260 million. We have entered into a definitive agreement with LifePoint Hospitals, Inc. (“LifePoint”) for the sale of five hospitals for estimated proceeds of approximately $330 million. Pursuant to the terms of the agreement, the sale is to close on or prior to March 31, 2006. On March 10 and March 14, we received notification in writing from LifePoint asserting that certain conditions required for the closing of the sale transaction, including the issuance of final CONs authorizing the acquisition of the hospitals by LifePoint, cannot be satisfied by March 31, 2006. LifePoint has stated that it will not consummate the transaction unless all conditions have been satisfied. We disagree with

50


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Liquidity and Capital Resources (Continued)
LifePoint’s assertions and are continuing to proceed toward closing. We intend to consider all available remedies in the event that LifePoint does not perform its obligations under the definitive agreement.
      Cash flows used in financing activities totaled $1.400 billion in 2005 and $1.347 billion in 2004, compared to cash provided by financing activities of $650 million in 2003. During 2004 and 2003, we increased amounts outstanding under the Company’s $1.75 billion revolving credit facility (the “Credit Facility”). We also accessed the public debt market to raise capital during 2003 and 2004. We received cash inflows of $943 million related to the exercise of employee stock options during 2005. During 2005, we repurchased 36.7 million shares of our common stock for a total cost of $1.856 billion. During 2004, we repurchased 77.4 million shares of our common stock for a total cost of $3.109 billion. During the second quarter of 2004, we increased our quarterly dividend payment from $0.02 per share to $0.13 per share. In January 2005, our Board of Directors approved an increase in our quarterly dividend from $0.13 per share to $0.15 per share. The Board declared the initial $0.15 per share dividend payable in the second quarter of 2005. In January 2006, our Board of Directors approved an increase in our quarterly dividend from $0.15 per share to $0.17 per share. The Board declared the initial $0.17 per share dividend payable on June 1, 2006 to shareholders of record at May 1, 2006.
      In addition to cash flows from operations, available sources of capital include amounts available under the Credit Facility ($1.218 billion as of December 31, 2005 and $1.056 billion as of February 15, 2006) and anticipated access to public and private debt markets.
      Investments of our professional liability insurance subsidiary, to maintain statutory equity and pay claims, totaled $2.384 billion and $2.322 billion at December 31, 2005 and 2004, respectively. Claims payments, net of reinsurance recoveries, during the next twelve months are expected to approximate $260 million. Our wholly-owned insurance subsidiary has entered into certain reinsurance contracts, and the obligations covered by the reinsurance contracts are included in the reserves for professional liability risks, as the subsidiary remains liable to the extent that the reinsurers do not meet their obligations under the reinsurance contracts. To minimize our exposure to losses from reinsurer insolvencies, we evaluate the financial condition of our reinsurers and monitor concentrations of credit risk arising from similar activities or economic characteristics of the reinsurers. The amounts receivable related to the reinsurance contracts were $43 million and $79 million at December 31, 2005 and 2004, respectively.
Share Repurchase Activities
      On October 14, 2005, we commenced a modified “Dutch” auction tender offer to purchase up to $2.500 billion of our common stock. In November 2005, we closed the tender offer and repurchased 28.7 million shares of our common stock for an aggregate price of $1.437 billion ($50.00 per share). The shares repurchased represented approximately 6% of our outstanding shares at the time of the tender offer. We also repurchased 8.0 million shares of our common stock for $412 million through open market purchases during the fourth quarter of 2005.
      In October 2004, we announced the authorization of a modified “Dutch” auction tender offer to purchase up to $2.501 billion of our common stock. In November 2004, we closed the tender offer and repurchased 62 million shares of our common stock for an aggregate price of $2.466 billion ($39.75 per share). The shares repurchased represented approximately 13% of our outstanding shares at the time of the tender offer. We also repurchased 0.9 million shares of our common stock for $35 million through open market purchases which completed the $2.501 billion share repurchase authorization.
      In April 2003, we announced an authorization to repurchase $1.5 billion of our common stock through open market purchases or privately negotiated transactions. During 2003, we repurchased under this

51


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Liquidity and Capital Resources (Continued)
Share Repurchase Activities (Continued)
authorization 25.3 million shares of its common stock for $900 million, through open market purchases. During 2004, we repurchased 14.5 million shares of our common stock for $600 million, through open market purchases, which completed this authorization.
      In July 2002, we announced an authorization to repurchase up to 12 million shares of our common stock. During 2002, we made open market purchases of 6.2 million shares for $282 million. During 2003, we purchased 5.8 million shares for $214 million, through open market purchases, which completed the repurchases under this authorization.
      During 2005, 2004 and 2003, the share repurchase transactions reduced stockholders’ equity by $1.856 billion, $3.109 billion and $1.114 billion, respectively.
Financing Activities
      Our revolving credit facility (the “Credit Facility”) is a $1.75 billion agreement expiring November 2009. As of December 31, 2005, we had $475 million outstanding under the Credit Facility. As of December 31, 2005, interest is payable generally at either a spread to LIBOR, plus 0.4% to 1.0% (depending on our credit ratings), the prime lending rate or a competitive bid rate. The Credit Facility contains customary covenants which include (i) limitations on debt levels, (ii) limitations on sales of assets, mergers and changes of ownership, and (iii) maintenance of minimum interest coverage ratios. As of December 31, 2005, we were in compliance with all such covenants.
      In February 2006, we issued $1.0 billion of 6.5% notes due February 2016. Proceeds from the notes were used to refinance amounts outstanding under an $800 million term loan entered into in November 2005 and to pay down amounts advanced under the Credit Facility.
      In November 2005, in connection with our modified “Dutch” auction tender offer, we entered into a $1.0 billion credit agreement with several banks, was scheduled to mature in May 2006. Under this agreement, we borrowed $800 million ( the “2005 Term Loan”). Proceeds from the 2005 Term Loan were used to partially fund the repurchase of our common stock. The 2005 Term Loan contained a mandatory prepayment clause which required us to prepay amounts outstanding after receiving proceeds from the issuance of debt or equity securities or from asset sales. Proceeds of $175 million from the sale of hospitals and a portion of the proceeds from the $1.0 billion 6.5% notes issued in February 2006 were used to repay the amounts outstanding under the 2005 Term Loan.
      During the fourth quarter of 2004, in response to our 2004 tender offer to repurchase our common stock, Standard & Poor’s downgraded our senior debt rating from BBB- to BB+ and Fitch Ratings downgraded our senior debt rating from BBB- to BB+. Moody’s Investors Service downgraded our senior debt rating from Bal to Ba2.
      During November 2004, we entered into a $2.5 billion credit agreement (the “2004 Credit Agreement”) with several banks. The 2004 Credit Agreement consists of a $750 million amortizing term loan which matures in 2009 (the “2004 Term Loan”) and the Credit Facility. Proceeds from the 2004 Term Loan were used to refinance a prior bank loan and for general corporate purposes.
      During November 2004, we issued $500 million of 5.5% notes due December 1, 2009 and issued $750 million of 6.375% notes due January 15, 2015. Proceeds from the notes were used to repay amounts outstanding under the term loan entered into in connection with our 2004 tender offer.

52


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Liquidity and Capital Resources (Continued)
Financing Activities (Continued)
      During March 2004, we issued $500 million of 5.75% notes due March 15, 2014. The proceeds from the issuance were used to repay a portion of the amounts outstanding under our prior revolving credit facility and for general corporate purposes.
      During November 2003, we issued $350 million of 5.25% notes due November 6, 2008 and issued $250 million of 7.5% notes due November 6, 2033. Proceeds from the notes were used to repay a portion of the amounts outstanding under a prior revolving credit facility.
      In February 2003, we issued $500 million of 6.25% notes due February 15, 2013. In July 2003, we issued $500 million of 6.75% notes due July 15, 2003. The proceeds from both issuances were used to repay a portion of the amounts outstanding under a prior revolving credit facility and for general corporate purposes.
      Management believes that cash flows from operations, amounts available under the Credit Facility and our anticipated access to public and private debt markets will be sufficient to meet expected liquidity needs during the next twelve months.
Contractual Obligations and Off-Balance Sheet Arrangements
      As of December 31, 2005, maturities of contractual obligations and other commercial commitments are presented in the table below (dollars in millions):
                                         
    Payments Due by Period
     
Contractual Obligations(a)   Total   Current   2-3 years   4-5 years   After 5 years
                     
Long-term debt including interest, excluding the Credit Facility(b)
  $ 17,065     $ 1,270     $ 2,476     $ 3,060     $ 10,259  
Loans outstanding under the Credit Facility including interest(b)
    594       31       62       501        
Operating leases(c)
    1,147       223       358       201       365  
Purchase obligations(c)
    16       3       6       5       2  
                               
Total contractual obligations
  $ 18,822     $ 1,527     $ 2,902     $ 3,767     $ 10,626  
                               
                                         
    Commitment Expiration by Period
Other Commercial Commitments    
Not Recorded on the Consolidated Balance Sheet   Total   Current   2-3 years   4-5 years   After 5 years
                     
Letters of credit(d)
  $ 70     $ 18     $     $ 52     $  
Surety bonds(e)
    71       69       2              
Physician commitments(f)
    46       41       5              
Guarantees(g)
    2                         2  
                               
Total commercial commitments
  $ 189     $ 128     $ 7     $ 52     $ 2  
                               
 
(a) We have not included obligations to pay estimated professional liability claims ($1.621 billion at December 31, 2005) in this table. The estimated professional liability claims are expected to be funded by the designated investment securities that are restricted for this purpose ($2.384 billion at December 31, 2005).
(b) Estimate of interest payments assumes that subsequent to December 31, 2005, there were no changes in interest rates, our credit ratings or associated borrowing spreads or foreign currency exchange rates.
(c) Future operating lease obligations and purchase obligations are not recorded in our consolidated balance sheet.

53


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Contractual Obligations and Off-Balance Sheet Arrangements (Continued)
(d) Amounts relate primarily to instances in which we have letters of credit outstanding with insurance companies that issued workers compensation insurance policies to us in prior years. The letters of credit serve as security to the insurance companies for payment obligations retained by HCA.
(e) Amounts relate primarily to instances in which we have agreed to indemnify various commercial insurers who have provided surety bonds to cover damages for malpractice cases which were awarded to plaintiffs by the courts. These cases are currently under appeal and the bonds will not be released by the courts until the cases are closed.
(f) In consideration for physicians relocating to the communities in which our hospitals are located and agreeing to engage in private practice for the benefit of the respective communities, we make advances to physicians, normally over a period of one year, to assist in establishing the physicians’ practices. The actual amount of these commitments to be advanced often depends upon the financial results of the physicians’ private practices during the recruitment agreement payment period. The physician commitments reflected were estimated based on our historical amounts actually paid to physicians.
(g) We have entered into guarantee agreements related to certain leases.
Market Risk
      HCA is exposed to market risk related to changes in market values of securities. The investments in debt and equity securities of our wholly-owned insurance subsidiary were $1.419 billion and $965 million, respectively, at December 31, 2005. These investments are carried at fair value with changes in unrealized gains and losses being recorded as adjustments to other comprehensive income. The fair value of investments is generally based on quoted market prices. If the insurance subsidiary were to experience significant declines in the fair value of its investments, this could require additional investment by the Company to allow the insurance subsidiary to satisfy its minimum capital requirements.
      Management evaluates, among other things, the financial position and near term prospects of the issuer, conditions in the issuer’s industry, liquidity of the investment, changes in the amount or timing of expected future cash flows from the investment, and recent downgrades of the issuer by a rating agency to determine if and when a decline in the fair value of an investment below amortized cost is considered “other-than-temporary.” The length of time and extent to which the fair value of the investment is less than amortized cost and our ability and intent to retain the investment to allow for any anticipated recovery in the investment’s fair value are important components of management’s investment securities evaluation process. At December 31, 2005, we had a net unrealized gain of $184 million on the insurance subsidiary’s investment securities.
      HCA is also exposed to market risk related to changes in interest rates, and we periodically enter into interest rate swap agreements to manage our exposure to these fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts and interest payments in these agreements match the cash flows of the related liabilities. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Any market risk or opportunity associated with these swap agreements is offset by the opposite market impact on the related debt. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives and the related hedged debt amounts have been recognized in the financial statements at their respective fair values.
      With respect to our interest-bearing liabilities, approximately $3.125 billion of long-term debt at December 31, 2005 is subject to variable rates of interest, while the remaining balance in long-term debt of $7.350 billion at December 31, 2005 is subject to fixed rates of interest. Both the general level of U.S. interest rates and, for the 2004 Credit Agreement, our credit rating affects our variable interest rates. Our variable rate debt is comprised of amounts outstanding under the 2004 Credit Agreement and fixed rate notes on which interest rate swaps have been employed. The 2004 Credit Agreement consists of the Credit Facility, on which interest is payable generally at LIBOR plus 0.4% to 1.0% and the 2004 Term Loan, on which interest is

54


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
Market Risk (Continued)
payable generally at LIBOR plus 0.5% to 1.25%. The fixed rate notes on which interest rate swaps have been employed have interest that is payable at LIBOR plus 1.39% to 2.39%. Due to increases in LIBOR, the average rate for our long-term debt increased from 6.5% at December 31, 2004 to 7.0% at December 31, 2005. The estimated fair value of our total long-term debt was $10.733 billion at December 31, 2005. The estimates of fair value are based upon the quoted market prices for the same or similar issues of long-term debt with the same maturities. Based on a hypothetical 1% increase in interest rates, the potential annualized reduction to future pretax earnings would be approximately $31 million. The impact of such a change in interest rates on the fair value of long-term debt would not be significant. The estimated changes to interest expense and the fair value of long-term debt are determined considering the impact of hypothetical interest rates on our borrowing cost and long-term debt balances. To mitigate the impact of fluctuations in interest rates, we generally target a portion of our debt portfolio to be maintained at fixed rates.
      Foreign operations and the related market risks associated with foreign currency are currently insignificant to our results of operations and financial position.
Effects of Inflation and Changing Prices
      Various federal, state and local laws have been enacted that, in certain cases, limit our ability to increase prices. Revenues for general, acute care hospital services rendered to Medicare patients are established under the federal government’s prospective payment system. Total Medicare revenues approximated 27% in 2005 and 28% in both 2004 and 2003 of our total patient revenues.
      Management believes that hospital industry operating margins have been, and may continue to be, under significant pressure because of changes in payer mix and growth in operating expenses in excess of the increase in prospective payments under the Medicare program. In addition, as a result of increasing regulatory and competitive pressures, our ability to maintain operating margins through price increases to non-Medicare patients is limited.
IRS Disputes
      HCA is currently contesting before the Appeals Division of the Internal Revenue Service (the “IRS”), the United States Tax Court (the “Tax Court”), and the United States Court of Federal Claims, certain claimed deficiencies and adjustments proposed by the IRS in conjunction with its examinations of HCA’s 1994-2002 federal income tax returns, Columbia Healthcare Corporation’s (“CHC”) 1993 and 1994 federal income tax returns, HCA-Hospital Corporation of America’s (“Hospital Corporation of America”) 1991 through 1993 federal income tax returns and Healthtrust, Inc. — The Hospital Company’s (“Healthtrust”) 1990 through 1994 federal income tax returns.
      During 2003, the United States Court of Appeals for the Sixth Circuit affirmed a Tax Court decision received in 1996 related to the IRS examination of Hospital Corporation of America’s 1987 through 1988 Federal income tax returns, in which the IRS contested the method that Hospital Corporation of America used to calculate its tax allowance for doubtful accounts. HCA filed a petition for review by the United States Supreme Court, which was denied in October 2004. Due to the volume and complexity of calculating the tax allowance for doubtful accounts, the IRS has not determined the amount of additional tax and interest that it may claim for taxable years after 1988. In December 2004, HCA made a deposit of $109 million for additional tax and interest, based on its estimate of amounts due for taxable periods through 1998.
      Other disputed items include the deductibility of a portion of the 2001 government settlement payment, the timing of recognition of certain patient service revenues in 2000 through 2002, the method for calculating the tax allowance for uncollectible accounts in 2002, and the amount of insurance expense deducted in 1999

55


Table of Contents

HCA INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS — (Continued)
IRS Disputes (Continued)
through 2002. The IRS has claimed an additional $776 million in income taxes, interest and penalties through December 31, 2005 with respect to these issues.
      During February 2006, the IRS began an examination of HCA’s 2003 through 2004 federal income tax returns. The IRS has not determined the amount of any additional income tax, interest and penalties that it may claim upon completion of this examination.
      Management believes that adequate provisions have been recorded to satisfy final resolution of the disputed issues. Management believes that HCA, CHC, Hospital Corporation of America and Healthtrust properly reported taxable income and paid taxes in accordance with applicable laws and agreements established with the IRS during previous examinations and that final resolution of these disputes will not have a material adverse effect on the results of operations or financial position.

56


Table of Contents

Item 7A. Quantitative and Qualitative Disclosures about Market Risk
      The information called for by this item is provided under the caption “Market Risk” under Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Item 8. Financial Statements and Supplementary Data
      Information with respect to this Item is contained in the Company’s consolidated financial statements indicated in the Index to Consolidated Financial Statements on Page F-1 of this Annual Report on Form 10-K.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
      None.
Item 9A. Controls and Procedures
1. Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures
      Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this annual report.
2. Internal Control Over Financial Reporting
      (a) Management’s Report on Internal Control Over Financial Reporting
      Our management is responsible for establishing and maintaining effective internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.
      Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an assessment of the effectiveness of our internal control over financial reporting based on the framework in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our assessment under the framework in Internal Control — Integrated Framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2005.
      Our management’s assessment of the effectiveness of our internal control over financial reporting as of December 31, 2005 has been audited by Ernst & Young LLP, an independent registered public accounting firm. Ernst & Young’s attestation report is included herein.

57


Table of Contents

(b) Attestation Report of the Independent Registered Public Accounting Firm
Report of Independent Registered Public Accounting Firm
The Board of Directors and Stockholders
HCA Inc.
      We have audited management’s assessment, included in the accompanying Management’s Report on Internal Control Over Financial Reporting, that HCA Inc. maintained effective internal control over financial reporting as of December 31, 2005, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). HCA Inc.’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express an opinion on management’s assessment and an opinion on the effectiveness of the Company’s internal control over financial reporting based on our audit.
      We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
      A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
      Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
      In our opinion, management’s assessment that HCA Inc. maintained effective internal control over financial reporting as of December 31, 2005, is fairly stated, in all material respects, based on the COSO criteria. Also, in our opinion, HCA Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2005, based on the COSO criteria.
      We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of HCA Inc. as of December 31, 2005 and 2004, and the related consolidated statements of income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2005, and our report dated March 8, 2006 expressed an unqualified opinion thereon.
  /s/ ERNST & YOUNG LLP
Nashville, Tennessee
March 8, 2006
Item 9B. Other Information
      None.

58


Table of Contents

PART III
Item 10. Directors and Executive Officers of the Registrant
      The information required by this Item regarding the identity and business experience of HCA’s directors and executive officers is set forth under the heading “Election of Directors” in the definitive proxy materials of HCA to be filed in connection with its 2006 Annual Meeting of Shareholders, with respect to HCA’s directors, and is set forth in Item 1 of Part I of this Annual Report on Form 10-K, with respect to HCA’s executive officers. The information required by this Item contained in such definitive proxy materials is incorporated herein by reference.
      Information on the beneficial ownership reporting for HCA’s directors and executive officers is contained under the caption “Section 16(a) Beneficial Ownership Reporting Compliance” in the definitive proxy materials of HCA to be filed in connection with its 2006 Annual Meeting of Shareholders and is incorporated herein by reference.
      Information on HCA’s Audit Committee and Audit Committee Financial Experts is contained under the caption “Board Structure and Committee Composition” in the definitive proxy materials of HCA to be filed in connection with its 2006 Annual Meeting of Shareholders and is incorporated herein by reference.
      HCA has a Code of Conduct that applies to all directors, officers and employees, including the Company’s chief executive officer, chief financial officer, and chief accounting officer. HCA’s Code of Conduct can be found on the Corporate Governance and Ethics and Compliance pages of HCA’s website, www.hcahealthcare.com. HCA will post any amendments to the Code of Conduct, and any waivers that are required to be disclosed by the rules of either the SEC or the NYSE, on HCA’s website.
Item 11. Executive Compensation
      The information required by this Item is set forth under the heading “Executive Compensation” in the definitive proxy materials of HCA to be filed in connection with its 2006 Annual Meeting of Shareholders, which information is incorporated herein by reference.

59


Table of Contents

  Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
      Information about security ownership of certain beneficial owners is set forth under the heading “Stock Ownership” in the definitive proxy materials of HCA to be filed in connection with its 2006 Annual Meeting of Shareholders, which information is incorporated herein by reference.
      This table provides certain information as of December 31, 2005 with respect to our equity compensation plans (shares in thousands):
EQUITY COMPENSATION PLAN INFORMATION
                         
    (a)   (b)   (c)
             
    Number of securities   Weighted-average   Number of securities remaining
    to be issued   exercise price of   available for future issuance
    upon exercise of   outstanding   under equity compensation
    outstanding options,   options,   plans (excluding securities
    warrants and rights   warrants and rights   reflected in column(a))
             
Equity compensation plans approved by security holders
    27,702     $ 36.49       37,498  
Equity compensation plans not approved by security holders
                 
                   
Total
    27,702     $ 36.49       37,498  
                   
 
For additional information concerning our equity compensation plans, see the discussion in Note 11 — Stock Benefit Plans in the notes to the consolidated financial statements.
Item 13. Certain Relationships and Related Transactions
      The information required by this Item is set forth under the heading “Certain Relationships and Related Transactions” in the definitive proxy materials of HCA to be filed in connection with its 2006 Annual Meeting of Shareholders, which information is incorporated herein by reference.
Item 14. Principal Accountant Fees and Services
      The information required by this Item is set forth under the heading “Ratification of the Appointment of Ernst & Young LLP as our Independent Registered Public Accounting Firm” in the definitive proxy materials of HCA to be filed in connection with its 2006 Annual Meeting of Shareholders, which information is incorporated herein by reference.

60


Table of Contents

PART IV
Item 15. Exhibits and Financial Statement Schedules
      (a) Documents filed as part of the report:
      1. Financial Statements. The accompanying Index to Consolidated Financial Statements on page F-1 of this Annual Report on Form 10-K is provided in response to this item.
      2. List of Financial Statement Schedules. All schedules are omitted because the required information is either not present, not present in material amounts or presented within the consolidated financial statements.
      3. List of Exhibits
             
  3.1       Restated Certificate of Incorporation of the Company, as amended (filed as Exhibit 1 to the Company’s Form 8-A/A, Amendment No. 2 dated March 11, 2004, and incorporated herein by reference).
  3.2       Second Amended and Restated Bylaws of the Company (filed as Exhibit 3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2005, and incorporated herein by reference).
  4.1       Specimen Certificate for shares of Common Stock, par value $0.01 per share, of the Company (filed as Exhibit 3 to the Company’s Form 8-A/A, Amendment No. 2, dated March 11, 2004, and incorporated herein by reference).
  4.2       Registration Rights Agreement, dated as of March 16, 1989, by and among HCA-Hospital Corporation of America and the persons listed on the signature pages thereto (filed as Exhibit (g)(24) to Amendment No. 3 to the Schedule 13E-3 filed by HCA-Hospital Corporation of America, Hospital Corporation of America and The HCA Profit Sharing Plan on March 22, 1989, and incorporated herein by reference).
  4.3       Assignment and Assumption Agreement, dated as of February 10, 1994, between HCA-Hospital Corporation of America and the Company relating to the Registration Rights Agreement, as amended (filed as Exhibit 4.7 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1993, and incorporated herein by reference).
  4.4(a)       Indenture, dated as of December 16, 1993 between the Company and The First National Bank of Chicago, as Trustee (filed as Exhibit 4.11 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1993, and incorporated herein by reference).
  4.4(b)       First Supplemental Indenture, dated as of May 25, 2000 between the Company and Bank One Trust Company, N.A., as Trustee (filed as Exhibit 4.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2000, and incorporated herein by reference).
  4.4(c)       Second Supplemental Indenture, dated as of July 1, 2001 between the Company and Bank One Trust Company, N.A., as Trustee (filed as Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2001, and incorporated herein by reference).
  4.4(d)       Third Supplemental Indenture, dated as of December 5, 2001 between the Company and The Bank of New York, as Trustee (filed as Exhibit 4.5(d) to the Company’s Annual Report of Form 10-K for the fiscal year ended December 31, 2001, and incorporated herein by reference).
  4.5       Form of 7.5% Debentures due 2023 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated December 15, 1993, and incorporated herein by reference).
  4.6       Form of 8.36% Debenture due 2024 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated April 20, 1994, and incorporated herein by reference).
  4.7       Form of Fixed Rate Global Medium Term Note (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated July 11, 1994, and incorporated herein by reference).
  4.8       Form of Floating Rate Global Medium Term Note (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated July 11, 1994, and incorporated herein by reference).
  4.9       Form of 6.91% Note due 2005 (filed as Exhibit 4.9 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004, and incorporated herein by reference).

61


Table of Contents

             
  4.10       Form of 7.69% Note due 2025 (filed as Exhibit 4.10 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004, and incorporated herein by reference).
  4.11       Form of 7.19% Debenture due 2015 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated November 20, 1995, and incorporated herein by reference).
  4.12       Form of 7.50% Debenture due 2095 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated November 20, 1995, and incorporated herein by reference).
  4.13       Form of 7.05% Debenture due 2027 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated December 5, 1995, and incorporated herein by reference).
  4.14       Form of 7.25% Note due 2008 (filed as Exhibit 4 to the Company’s Current Report on Form 8-K dated May 15, 1996, and incorporated herein by reference).
  4.15       Form of Fixed Rate Global Medium Term Note (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated July 2, 1996, and incorporated herein by reference).
  4.16       Form of 7.00% Note Due 2007 (filed as Exhibit 4 to the Company’s Current Report on Form 8-K dated June 27, 1997, and incorporated herein by reference).
  4.17(a)       8.750% Note in the principal amount of $400,000,000 due 2010 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated August 23, 2000, and incorporated herein by reference).
  4.17(b)       8.750% Note in the principal amount of $350,000,000 due 2010 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated August 23, 2000, and incorporated herein by reference).
  4.18       8.75% Note due 2010 in the principal amount of £150,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated October 25, 2000, and incorporated herein by reference).
  4.19(a)       77/8% Note in the principal amount of $100,000,000 due 2011 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated January 23, 2001, and incorporated herein by reference).
  4.19(b)       77/8% Note in the principal amount of $400,000,000 due 2011 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated January 23, 2001, and incorporated herein by reference).
  4.20(a)       7.125% Note in the principal amount of $400,000,000 due 2006 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated May 17, 2001, and incorporated herein by reference).
  4.20(b)       7.125% Note in the principal amount of $100,000,000 due 2006 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated May 17, 2001, and incorporated herein by reference).
  4.21(a)       6.95% Note due 2012 in the principal amount of $400,000,000. (filed as Exhibit 4.5 to the Company’s Current Report on Form 8-K dated April 23, 2002, and incorporated herein by reference).
  4.21(b)       6.95% Note due 2012 in the principal amount of $100,000,000. (filed as Exhibit 4.6 to the Company’s Current Report on Form 8-K dated April 23, 2002, and incorporated herein by reference).
  4.22(a)       6.30% Note due 2012 in the principal amount of $400,000,000. (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated September 18, 2002, and incorporated herein by reference).
  4.22(b)       6.30% Note due 2012 in the principal amount of $100,000,000. (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated September 18, 2002, and incorporated herein by reference).
  4.23(a)       6.25% Note due 2013 in the principal amount of $400,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated February 5, 2003, and incorporated herein by reference).

62


Table of Contents

             
  4.23(b)       6.25% Note due 2013 in the principal amount of $100,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated February 5, 2003, and incorporated herein by reference).
  4.24(a)       63/4% Note due 2013 in the principal amount of $400,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated July 23, 2003, and incorporated herein by reference).
  4.24(b)       63/4% Note due 2013 in the principal amount of $100,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated July 23, 2003, and incorporated herein by reference).
  4.25       5.25% Note due 2008 in the principal amount of $350,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated November 6, 2003, and incorporated herein by reference).
  4.26       7.50% Note due 2033 in the principal amount of $250,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated November 6, 2003, and incorporated herein by reference).
  4.27       5.75% Note due 2014 in the principal amount of $500,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated March 8, 2004, and incorporated herein by reference)
  4.28       5.500% Note due 2009 in the principal amount of $500,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated November 16, 2004, and incorporated herein by reference).
  4.29(a)       6.375% Note due 2015 in the principal amount of $500,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated November 16, 2004, and incorporated herein by reference).
  4.29(b)       6.375% Note due 2015 in the principal amount of $250,000,000 (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K dated November 16, 2004, and incorporated herein by reference).
  4.30(a)       6.500% Note due 2016 in the principal amount of $500,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on February 8, 2006, and incorporated herein by reference).
  4.30(b)       6.500% Note due 2016 in the principal amount of $500,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on February 8, 2006, and incorporated herein by reference).
  4.31       Distribution Agreement dated as of May 11, 1999 by and among the Company, LifePoint Hospitals, Inc. and Triad Hospitals, Inc. (filed as Exhibit 99 to the Company’s Current Report on Form 8-K dated May 11, 1999, and incorporated herein by reference).
  4.32       Loan Agreement among the Company, Lenders party to the agreement and Toronto Dominion (Texas), Inc., as Administrative Agent, dated as of June 28, 2001 and amended and restated as of July 31, 2001 (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-3 (File No. 333-67040), and incorporated herein by reference).
  4.33       Registration Rights Agreement, dated as of June 28, 2001, between the Company and Canadian Investments LLC, a Delaware limited liability Company (filed as Exhibit 10.2 to the Company’s Registration Statement on Form S-3 (File No. 333-67040), and incorporated herein by reference).
  10.1(a)       Amended and Restated Columbia/HCA Healthcare Corporation 1992 Stock and Incentive Plan (filed as Exhibit 10.7(b) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1998, and incorporated herein by reference).*
  10.1(b)       First Amendment to Amended and Restated Columbia/HCA Healthcare Corporation 1992 Stock and Incentive Plan (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1999, and incorporated herein by reference).*
  10.2       Columbia Hospital Corporation Outside Directors Nonqualified Stock Option Plan (filed as Exhibit 28.1 to the Company’s Registration Statement on Form S-8 (File No. 33-55272), and incorporated herein by reference).*

63


Table of Contents

             
  10.3       HCA-Hospital Corporation of America Nonqualified Initial Option Plan (filed as Exhibit 4.6 to the Company’s Registration Statement on Form S-3 (File No. 33-52379), and incorporated herein by reference).*
  10.4       Form of Indemnity Agreement with certain officers and directors (filed as Exhibit 10(kk) to Galen Health Care, Inc.’s Registration Statement on Form 10, as amended, and incorporated herein by reference).
  10.5       Form of Galen Health Care, Inc. 1993 Adjustment Plan (filed as Exhibit 4.15 to the Company’s Registration Statement on Form S-8 (File No. 33-50147), and incorporated herein by reference).*
  10.6       HCA-Hospital Corporation of America 1992 Stock Compensation Plan (filed as Exhibit 10(t) to HCA-Hospital Corporation of America’s Registration Statement on Form S-1 (File No. 33-44906), and incorporated herein by reference).*
  10.7(a)       Columbia/HCA Healthcare Corporation Outside Directors Stock and Incentive Compensation Plan, as amended and restated (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1999, and incorporated herein by reference).*
  10.7(b)       First Amendment to the Columbia/HCA Healthcare Corporation Outside Directors Stock and Incentive Compensation Plan, as amended and restated September 23, 1999, dated as of May 25, 2000 (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2000, and incorporated herein by reference).*
  10.8       HCA Inc. Amended and Restated Management Stock Purchase Plan (filed as Exhibit C to the Company’s Proxy Statement for its Annual Meeting of Stockholders held on May 27, 2004, and incorporated herein by reference).*
  10.9       Letter Agreement between the Company and Robert Waterman dated October 31, 1997 (filed as Exhibit 10.33 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1998, and incorporated herein by reference).*
  10.10       Columbia/HCA Healthcare Corporation 2000 Equity Incentive Plan (filed as Exhibit A to the Company’s Proxy Statement for the Annual Meeting of Stockholders on May 25, 2000, and incorporated herein by reference).*
  10.11(a)       Form of Restricted Share Award Agreement (Officers) (filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K dated February 2, 2005, and incorporated herein by reference).*
  10.11(b)       Form of Non-Qualified Stock Option Award Agreement (Officers) (filed as Exhibit 99.2 to the Company’s Current Report on Form 8-K dated February 2, 2005, and incorporated herein by reference).*
  10.12       HCA 2005 Equity Incentive Plan (filed as Exhibit B to the Company’s Proxy Statement for the Annual Meeting of Shareholders on May 26, 2005, and incorporated herein by reference);.*
  10.13(a)       Form of 2005 Restricted Share Award Agreement (Officers) (filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K dated October 6, 2005, and incorporated herein by reference).*
  10.13(b)       Form of 2005 Non-Qualified Stock Option Agreement (Officers) (filed as Exhibit 99.2 to the Company’s Current Report on Form 8-K dated October 6, 2005, and incorporated herein by reference).*
  10.14(a)       Form of 2006 Restricted Share Award Agreement (Officers) (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K dated February 1, 2006, and incorporated herein by reference).*
  10.14(b)       Form of 2006 Non-Qualified Stock Option Award Agreement (Officers) (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K dated February 1, 2006, and incorporated herein by reference).*
  10.15(a)       Form of Non-Qualified Stock Option Award Agreement (Directors) (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on June 2, 2005, and incorporated herein by reference).
  10.15(b)       Form of Restricted Stock Award Agreement (Directors) (filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on June 2, 2005, and incorporated herein by reference).

64


Table of Contents

             
  10.15(c)       Form of Restricted Share Unit Award Agreement (Directors) (filed as Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on June 2, 2005, and incorporated herein by reference).
  10.16       Civil and Administrative Settlement Agreement, dated December 14, 2000 between the Company, the United States Department of Justice and others (filed as Exhibit 99.2 to the Company’s Current Report on Form 8-K dated December 20, 2000, and incorporated herein by reference).
  10.17       Plea Agreement, dated December 14, 2000 between the Company, Columbia Homecare Group, Inc., Columbia Management Companies, Inc. and the United States Department of Justice (filed as Exhibit 99.3 to the Company’s Current Report on Form 8-K dated December 20, 2000, and incorporated herein by reference).
  10.18       Corporate Integrity Agreement, dated December 14, 2000 between the Company and the Office of Inspector General of the United States Department of Health and Human Services (filed as Exhibit 99.4 to the Company’s Current Report on Form 8-K dated December 20, 2000, and incorporated herein by reference).
  10.19       Limited Liability Company Interest Purchase Agreement, dated as of November 30, 2000, between JV Investor, LLC, Healthtrust, Inc. — The Hospital Company and each of the investors listed therein (filed as Exhibit 10.31 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2000, and incorporated herein by reference).
  10.20       Retirement Agreement between the Company and Thomas F. Frist, Jr., M.D. dated as of January 1, 2002 (filed as Exhibit 10.30 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001, and incorporated herein by reference).*
  10.21(a)       HCA Supplemental Executive Retirement Plan dated as of July 1, 2001 (filed as Exhibit 10.31 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001, and incorporated herein by reference).*
  10.21(b)       First Amendment to the HCA Supplemental Executive Retirement Plan (filed as Exhibit 10.21(b) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2003, and incorporated herein by reference).*
  10.22       HCA Restoration Plan dated as of January 1, 2001 (filed as Exhibit 10.32 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001, and incorporated herein by reference).*
  10.23       HCA Directors’ 2003 Compensation/Fees Policy (filed as Exhibit 10 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2003, and incorporated herein by reference).*
  10.24       HCA Directors’ 2004 Compensation/Fees Policy adopted July 24, 2003 (filed as Exhibit 10.24 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2003, and incorporated herein by reference).*
  10.25       HCA Directors’ 2005 Compensation/Fees Policy (filed as Exhibit 10.24 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004, and incorporated herein by reference).*
  10.26       HCA 2006 Directors Fees Compensation Policy (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed June 2, 2005, and incorporated herein by reference).*
  10.27       HCA Inc. 2003 Performance Equity Incentive Program (filed as Exhibit 10 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2003, and incorporated herein by reference).*
  10.28       HCA Inc. 2004 Performance Excellence Program (filed as Exhibit 10 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2004, and incorporated herein by reference).*
  10.29       HCA Inc. 2005 Senior Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 30, 2005, and incorporated herein by reference).*

65


Table of Contents

             
  10.30       HCA Inc. 2006 Senior Officer Performance Excellence Program (filed as Exhibit 10.3 to the Company’s Current Report on 8-K filed February 1, 2006, and incorporated herein by reference).*
  10.31       Amended and Restated HCA Employee Stock Purchase Plan (filed as Exhibit (d)(12) to the Company’s Schedule TO filed with the Securities and Exchange Commission on October 13, 2004, and incorporated herein by reference).*
  10.32       Amended and Restated Aircraft Hourly Rental Agreement, dated March 28, 2003, by and between Tomco II, LLC and HCA Management Services, L.P. (filed as Exhibit 10.31 to the Company’s Annual Report of Form 10-K for the fiscal year ended December 31, 2003 and incorporated herein by reference).
  10.33       Administrative Settlement Agreement dated June 25, 2003 by and between the United States Department of Health and Human Services, acting through the Centers for Medicare and Medicaid Services, and the Company (filed as Exhibit 10.1 to the Company’s Quarterly Report of Form 10-Q for the quarter ended June 30, 2003, and incorporated herein by reference).
  10.34       Civil Settlement Agreement by and among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General of the Department of Health and Human Services, the TRICARE Management Activity (filed as Exhibit 10.2 to the Company’s Quarterly Report of Form 10-Q for the quarter ended June 30, 2003, and incorporated herein by reference).
  10.35(a)       $2.5 billion Credit Agreement, dated November 9, 2004, by and among the Company, the several banks and other financial institutions from time to time parties hereto, J.P. Morgan Securities Inc., as Sole Advisor, Lead Arranger and Bookrunner, certain other agents and arrangers and JPMorgan Chase Bank, as Administrative Agent (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K dated November 10, 2004, and incorporated herein by reference).
  10.35(b)       First Amendment to $2.5 billion Credit Agreement, dated November 3, 2005 (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed November 3, 2005, and incorporated herein by reference).
  10.36       $1.25 billion Credit Agreement, dated November 9, 2004, by and among the Company, the several banks and other financial institutions from time to time parties thereto, J.P. Morgan Securities Inc. and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, as Joint Lead Arrangers and Joint Bookrunners, Merrill Lynch Capital Corporation, as Syndication Agent, and JPMorgan Chase Bank, as Administrative Agent (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K dated November 10, 2004, and incorporated herein by reference).
  10.37       $1.0 billion Credit Agreement, dated November 3, 2005, by and among the Company, the Several banks and other financial institutions from time to time parties thereto, J.P. Morgan Securities Inc., Merrill Lynch & Co., and Merrill Lynch, Pierce, Fenner & Smith, incorporated, as Joint Lead Arrangers & Joint Bookrunners, Merrill Lynch Capital Corporation, as Syndication Agent, and J.P. Morgan Chase Bank, as Administrative Agent (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on November 3, 2005, and incorporated herein by reference).
  12       Statement re Computation of Ratio of Earnings to Fixed Charges.
  21       List of Subsidiaries.
  23       Consent of Ernst & Young LLP.
  31.1       Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31.2       Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32       Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
Management compensatory plan or arrangement.

66


Table of Contents

SIGNATURES
      Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
  HCA INC.
  By:  /s/ Jack O. Bovender, Jr.
 
 
  Jack O. Bovender, Jr.
  Chief Executive Officer
Dated: March 14, 2006
      Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
             
Signature   Title   Date
         
 
 
/s/ Jack O. Bovender, Jr.

Jack O. Bovender, Jr. 
  Chairman of the Board
and Chief Executive Officer
(Principal Executive Officer)
  March 14, 2006
 
/s/ Richard M. Bracken

Richard M. Bracken
  President, Chief Operating Officer and Director   March 14, 2006
 
 
/s/ R. Milton Johnson

R. Milton Johnson
  Executive Vice President and Chief
Financial Officer (Principal Financial Officer)
  March 14, 2006
 
/s/ C. Michael Armstrong

C. Michael Armstrong
  Director   March 14, 2006
 
/s/ Magdalena H. Averhoff, M.D.

Magdalena H. Averhoff, M.D. 
  Director   March 14, 2006
 
/s/ Martin Feldstein

Martin Feldstein
  Director   March 14, 2006
 
/s/ Thomas F. Frist, Jr., M.D.

Thomas F. Frist, Jr., M.D.
  Director   March 14, 2006
 
/s/ Frederick W. Gluck

Frederick W. Gluck
  Director   March 14, 2006
 
/s/ Glenda A. Hatchett

Glenda A. Hatchett
  Director   March 14, 2006
 
/s/ Charles O. Holliday, Jr.

Charles O. Holliday, Jr.
  Director   March 14, 2006
 
/s/ T. Michael Long

T. Michael Long
  Director   March 14, 2006

67


Table of Contents

             
Signature   Title   Date
         
 
/s/ John H. McArthur

John H. McArthur
  Director   March 14, 2006
 
/s/ Kent C. Nelson

Kent C. Nelson
  Director   March 14, 2006
 
/s/ Frank S. Royal, M.D.

Frank S. Royal, M.D.
  Director   March 14, 2006
 
/s/ Harold T. Shapiro

Harold T. Shapiro
  Director   March 14, 2006

68


Table of Contents

HCA INC.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
           
    Page
     
Report of Independent Registered Public Accounting Firm
    F-2  
Consolidated Financial Statements:
       
 
Consolidated Income Statements for the years ended December 31, 2005, 2004 and 2003
    F-3  
 
Consolidated Balance Sheets, December 31, 2005 and 2004
    F-4  
 
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2005, 2004 and 2003
    F-5  
 
Consolidated Statements of Cash Flows for the years ended December 31, 2005, 2004 and 2003
    F-6  
 
Notes to Consolidated Financial Statements
    F-7  
 
Quarterly Consolidated Financial Information (Unaudited)
    F-32  

F-1


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
HCA Inc.
      We have audited the accompanying consolidated balance sheets of HCA Inc. as of December 31, 2005 and 2004, and the related consolidated statements of income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2005. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.
      We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
      In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of HCA Inc. at December 31, 2005 and 2004, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2005, in conformity with U.S. generally accepted accounting principles.
      We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of HCA Inc.’s internal control over financial reporting as of December 31, 2005, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated March 8, 2006 expressed an unqualified opinion thereon.
  /s/ ERNST & YOUNG LLP
Nashville, Tennessee
March 8, 2006

F-2


Table of Contents

HCA INC.
CONSOLIDATED INCOME STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2005, 2004 AND 2003
(Dollars in millions, except per share amounts)
                             
    2005   2004   2003
             
Revenues
  $ 24,455     $ 23,502     $ 21,808  
Salaries and benefits
    9,928       9,419       8,682  
Supplies
    4,126       3,901       3,522  
Other operating expenses
    4,039       3,797       3,676  
Provision for doubtful accounts
    2,358       2,669       2,207  
Gains on investments
    (53 )     (56 )     (1 )
Equity in earnings of affiliates
    (221 )     (194 )     (199 )
Depreciation and amortization
    1,374       1,250       1,112  
Interest expense
    655       563       491  
Gains on sales of facilities
    (78 )           (85 )
Impairment of long-lived assets
          12       130  
Government settlement and investigation related costs
                (33 )
                   
      22,128       21,361       19,502  
                   
Income before minority interests and income taxes
    2,327       2,141       2,306  
Minority interests in earnings of consolidated entities
    178       168       150  
                   
Income before income taxes
    2,149       1,973       2,156  
Provision for income taxes
    725       727       824  
                   
   
Net income
  $ 1,424     $ 1,246     $ 1,332  
                   
Earnings per share:
                       
 
Basic earnings per share
  $ 3.25     $ 2.62     $ 2.66  
 
Diluted earnings per share
  $ 3.19     $ 2.58     $ 2.61  
The accompanying notes are an integral part of the consolidated financial statements.

F-3


Table of Contents

HCA INC.
CONSOLIDATED BALANCE SHEETS
DECEMBER 31, 2005 AND 2004
(Dollars in millions)
                   
    2005   2004
         
ASSETS
Current assets:
               
 
Cash and cash equivalents
  $ 336     $ 258  
 
Accounts receivable, less allowance for doubtful accounts of $2,897 and $2,942
    3,332       3,083  
 
Inventories
    616       577  
 
Deferred income taxes
    372       467  
 
Other
    559       673  
             
      5,215       5,058  
Property and equipment, at cost:
               
 
Land
    1,212       1,185  
 
Buildings
    8,063       7,981  
 
Equipment
    10,594       10,127  
 
Construction in progress
    949       677  
             
      20,818       19,970  
 
Accumulated depreciation
    (9,439 )     (8,574 )
             
      11,379       11,396  
Investments of insurance subsidiary
    2,134       2,047  
Investments in and advances to affiliates
    627       486  
Goodwill
    2,626       2,540  
Deferred loan costs
    85       99  
Other
    159       214  
             
    $ 22,225     $ 21,840  
             
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
               
 
Accounts payable
  $ 1,484     $ 1,230  
 
Accrued salaries
    561       579  
 
Other accrued expenses
    1,264       1,254  
 
Long-term debt due within one year
    586       486  
             
      3,895       3,549  
Long-term debt
    9,889       10,044  
Professional liability risks
    1,336       1,283  
Deferred income taxes and other liabilities
    1,414       1,748  
Minority interests in equity of consolidated entities
    828       809  
Stockholders’ equity:
               
 
Common stock $0.01 par; authorized 1,600,000,000 voting shares and 50,000,000 nonvoting shares; outstanding 396,512,700 voting shares and 21,000,000 nonvoting shares — 2005 and 401,642,100 voting shares and 21,000,000 nonvoting shares — 2004
    4       4  
 
Accumulated other comprehensive income
    130       193  
 
Retained earnings
    4,729       4,210  
             
      4,863       4,407  
             
    $ 22,225     $ 21,840  
             
The accompanying notes are an integral part of the consolidated financial statements.

F-4


Table of Contents

HCA INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2005, 2004 AND 2003
(Dollars in millions)
                                                                 
    Common Stock   Capital in       Accumulated        
        Excess of       Other        
    Shares   Par   Par       Comprehensive   Retained    
    (000)   Value   Value   Other   Income   Earnings   Total
                             
Balances, December 31, 2002
    514,176     $ 5     $ 93     $ 6     $ 73     $ 5,525     $ 5,702  
 
Comprehensive income:
                                                       
   
Net income
                                            1,332       1,332  
   
Other comprehensive income:
                                                       
     
Net unrealized gains on investment securities
                                    92               92  
     
Foreign currency translation adjustments
                                    11               11  
     
Defined benefit plans
                                    (8 )             (8 )
                                           
       
Total comprehensive income
                                    95       1,332       1,427  
 
Cash dividends declared
                                            (39 )     (39 )
 
Stock repurchases
    (31,144 )             (327 )                     (787 )     (1,114 )
 
Stock options exercised
    4,964               147       (1 )                     146  
 
Employee benefit plan issuances
    2,722               87                               87  
                                           
Balances, December 31, 2003
    490,718       5             5       168       6,031       6,209  
 
Comprehensive income:
                                                       
   
Net income
                                            1,246       1,246  
   
Other comprehensive income:
                                                       
     
Net unrealized gains on investment securities
                                    10               10  
     
Foreign currency translation adjustments
                                    21               21  
     
Defined benefit plans
                                    (6 )             (6 )
                                           
       
Total comprehensive income
                                    25       1,246       1,271  
 
Cash dividends declared
                                            (251 )     (251 )
 
Stock repurchases
    (77,382 )     (1 )     (292 )                     (2,816 )     (3,109 )
 
Stock options exercised
    7,032               224       (5 )                     219  
 
Employee benefit plan issuances
    2,274               68                               68  
                                           
Balances, December 31, 2004
    422,642       4                   193       4,210       4,407  
 
Comprehensive income:
                                                       
   
Net income
                                            1,424       1,424  
   
Other comprehensive income:
                                                       
     
Net unrealized losses on investment securities
                                    (30 )             (30 )
     
Foreign currency translation adjustments
                                    (37 )             (37 )
     
Defined benefit plans
                                    4               4  
                                           
       
Total comprehensive income
                                    (63 )     1,424       1,361  
 
Cash dividends declared
                                            (257 )     (257 )
 
Stock repurchases
    (36,692 )             (1,208 )                     (648 )     (1,856 )
 
Stock options exercised
    27,034               1,106                               1,106  
 
Employee benefit plan issuances
    4,529               102                               102  
                                           
Balances, December 31, 2005
    417,513     $ 4     $  —     $     $ 130     $ 4,729     $ 4,863  
                                           
The accompanying notes are an integral part of the consolidated financial statements.

F-5


Table of Contents

HCA INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 2005, 2004 AND 2003
(Dollars in millions)
                               
    2005   2004   2003
             
Cash flows from operating activities:
                       
 
Net income
  $ 1,424     $ 1,246     $ 1,332  
 
Adjustments to reconcile net income to net cash provided by operating activities:
                       
   
Provision for doubtful accounts
    2,358       2,669       2,207  
   
Depreciation and amortization
    1,374       1,250       1,112  
   
Income taxes
    162       333       496  
   
Gains on sales of facilities
    (78 )           (85 )
   
Impairment of long-lived assets
          12       130  
   
Settlement with government agencies
                (971 )
   
Increase (decrease) in cash from operating assets and liabilities:
                       
     
Accounts receivable
    (2,649 )     (2,648 )     (2,365 )
     
Inventories and other assets
    28       (179 )     140  
     
Accounts payable and accrued expenses
    343       157       215  
   
Other
    197       114       81  
                   
     
Net cash provided by operating activities
    3,159       2,954       2,292  
                   
Cash flows from investing activities:
                       
 
Purchase of property and equipment
    (1,592 )     (1,513 )     (1,838 )
 
Acquisition of hospitals and health care entities
    (126 )     (44 )     (908 )
 
Disposal of hospitals and health care entities
    320       48       163  
 
Change in investments
    (311 )     (178 )     (298 )
 
Other
    28       (1 )     19  
                   
     
Net cash used in investing activities
    (1,681 )     (1,688 )     (2,862 )
                   
Cash flows from financing activities:
                       
 
Issuances of long-term debt
    858       2,500       1,624  
 
Net change in revolving bank credit facility
    (225 )     190       410  
 
Repayment of long-term debt
    (739 )     (912 )     (461 )
 
Repurchases of common stock
    (1,856 )     (3,109 )     (1,114 )
 
Issuances of common stock
    1,009       224       165  
 
Payment of cash dividends
    (258 )     (199 )     (39 )
 
Other
    (189 )     (41 )     65  
                   
     
Net cash (used in) provided by financing activities
    (1,400 )     (1,347 )     650  
                   
 
Change in cash and cash equivalents
    78       (81 )     80  
 
Cash and cash equivalents at beginning of period
    258       339       259  
                   
 
Cash and cash equivalents at end of period
  $ 336     $ 258     $ 339  
                   
 
Interest payments
  $ 624     $ 533     $ 458  
 
Income tax payments, net of refunds
  $ 563     $ 394     $ 328  
The accompanying notes are an integral part of the consolidated financial statements.

F-6


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 — ACCOUNTING POLICIES
Reporting Entity
      HCA Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Inc. and partnerships and joint ventures in which such subsidiaries are partners. At December 31, 2005, these affiliates owned and operated 175 hospitals, 87 freestanding surgery centers and provided extensive outpatient and ancillary services. Affiliates of HCA are also partners in joint ventures that own and operate seven hospitals and seven freestanding surgery centers, which are accounted for using the equity method. The Company’s facilities are located in 22 states, England and Switzerland. The terms “HCA” or the “Company”, as used in this annual report on Form 10-K, refer to HCA Inc. and its affiliates unless otherwise stated or indicated by context.
Basis of Presentation
      The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
      The consolidated financial statements include all subsidiaries and entities controlled by HCA. “Control” is generally defined by HCA as ownership of a majority of the voting interest of an entity. The consolidated financial statements include entities in which HCA absorbs a majority of the entity’s expected losses, receives a majority of the entity’s expected residual returns, or both, as a result of ownership, contractual or other financial interests in the entity. Significant intercompany transactions have been eliminated. Investments in entities that HCA does not control, but in which it has a substantial ownership interest and can exercise significant influence, are accounted for using the equity method.
      HCA has completed various acquisitions and joint venture transactions. The accounts of these entities have been consolidated with those of HCA for periods subsequent to the acquisition of controlling interests. The majority of the Company’s expenses are “cost of revenue” items. Costs that could be classified as general and administrative would include the corporate office costs, which were $185 million, $162 million and $156 million for the years ended December 31, 2005, 2004 and 2003, respectively.
Revenues
      Revenues consist primarily of net patient service revenues that are recorded based upon established billing rates less allowances for contractual adjustments. Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per diagnosis, per diem rates or discounted fee-for-service rates.
      Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. As a result, there is at least a reasonable possibility that recorded estimates will change by a material amount. The estimated reimbursement amounts are adjusted in subsequent periods as cost reports are prepared and filed and as final settlements are determined (in relation to certain government programs, primarily Medicare, this is generally referred to as the “cost report” filing and settlement process). The adjustments to estimated reimbursement amounts, which resulted in net increases to revenues, related to cost reports filed during the respective year were $49 million, $44 million and $70 million in 2005, 2004 and 2003, respectively. The adjustments to estimated reimbursement amounts, which resulted in net increases to

F-7


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 — ACCOUNTING POLICIES (Continued)
     Revenues (Continued)
revenues, related to cost reports filed during previous years were $36 million, $26 million and $26 million in 2005, 2004 and 2003, respectively.
      The Emergency Medical Treatment and Active Labor Act (“EMTALA”) requires any hospital that participates in the Medicare program to conduct an appropriate medical screening examination of every person who presents to the hospital’s emergency room for treatment and, if the individual is suffering from an emergency medical condition, to either stabilize that condition or make an appropriate transfer of the individual to a facility that can handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of an individual’s ability to pay for treatment. Federal and state laws and regulations, including but not limited to EMTALA, require, and HCA’s commitment to providing quality patient care encourages, the Company to provide services to patients who are financially unable to pay for the health care services they receive. Because HCA does not pursue collection of amounts determined to qualify as charity care, they are not reported in revenues. Patients treated at an HCA hospital for nonelective care, who have income at or below 200% of the federal poverty level, are eligible for charity care. The federal poverty level is established by the federal government and is based on income and family size. On January 1, 2005, HCA modified its policies to provide a discount to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. In implementing the discount policy, HCA first attempts to qualify uninsured patients for Medicaid, other federal or state assistance or charity care. If an uninsured patient does not qualify for these programs, the uninsured discount is applied.
Cash and Cash Equivalents
      Cash and cash equivalents include highly liquid investments with a maturity of three months or less when purchased. Carrying values of cash and cash equivalents approximate fair value due to the short-term nature of these instruments.
      The Company’s cash management system provides for daily investment of available balances and the funding of outstanding checks when presented for payment. Outstanding, but unpresented, checks totaling $493 million and $375 million at December 31, 2005 and 2004, respectively, have been included in accounts payable in the consolidated balance sheets. Upon presentation for payment, these checks are funded through available cash balances or the Company’s existing credit facility.
Accounts Receivable
      HCA receives payments for services rendered from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. During the years ended December 31, 2005, 2004 and 2003, approximately 27%, 28% and 28%, respectively, of HCA’s revenues related to patients participating in the Medicare program. HCA recognizes that revenues and receivables from government agencies are significant to its operations, but does not believe that there are significant credit risks associated with these government agencies. HCA does not believe that there are any other significant concentrations of revenues from any particular payer that would subject it to any significant credit risks in the collection of its accounts receivable.
      Additions to the allowance for doubtful accounts are made by means of the provision for doubtful accounts. Accounts written off as uncollectable are deducted from the allowance for doubtful accounts and subsequent recoveries are added. The amount of the provision for doubtful accounts is based upon management’s assessment of historical and expected net collections, business and economic conditions, trends

F-8


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 — ACCOUNTING POLICIES (Continued)
     Accounts Receivable (Continued)
in federal, state, and private employer health care coverage and other collection indicators. The provision for doubtful accounts and the allowance for doubtful accounts relate primarily to “uninsured” amounts (including copayment and deductible amounts from patients who have health care coverage) due directly from patients. Accounts are written off when all reasonable internal and external collection efforts have been performed. HCA considers the return of an account from the primary external collection agency to be the culmination of its reasonable collection efforts and the timing basis for writing off the account balance. Writeoffs are based upon specific identification and the writeoff process requires a writeoff adjustment entry to the patient accounting system. Management relies on the results of detailed reviews of historical writeoffs and recoveries at facilities that represent a majority of HCA’s revenues and accounts receivable (the “hindsight analysis”) as a primary source of information to utilize in estimating the collectability of HCA’s accounts receivable. The Company performs the hindsight analysis quarterly, utilizing rolling twelve-months accounts receivable collection and writeoff data. At December 31, 2005, HCA’s allowance for doubtful accounts represented approximately 85% of the $3.404 billion patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage was being evaluated (“pending Medicaid accounts”). Revenue days in accounts receivable were 50 days, 48 days and 52 days at December 31, 2005, 2004 and 2003, respectively. Adverse changes in general economic conditions, patient accounting service center operations, payer mix, or trends in federal or state governmental health care coverage could affect HCA’s collection of accounts receivable, cash flows and results of operations.
Inventories
      Inventories are stated at the lower of cost (first-in, first-out) or market.
Property and Equipment and Amortizable Intangibles
      Depreciation expense, computed using the straight-line method, was $1.371 billion in 2005, $1.248 billion in 2004, and $1.108 billion in 2003. Buildings and improvements are depreciated over estimated useful lives ranging generally from 10 to 40 years. Estimated useful lives of equipment vary generally from four to 10 years.
      Debt issuance costs are amortized based upon the lives of the respective debt obligations. The gross carrying amount of deferred loan costs at both December 31, 2005 and 2004 was $138 million and accumulated amortization was $53 million and $39 million at December 31, 2005 and 2004, respectively. Amortization of deferred loan costs is included in interest expense and was $14 million, $14 million and $10 million for 2005, 2004 and 2003, respectively.
      When events, circumstances or operating results indicate that the carrying values of certain long-lived assets and related identifiable intangible assets (excluding goodwill) that are expected to be held and used, might be impaired, HCA prepares projections of the undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the projections indicate that the recorded amounts are not expected to be recoverable, such amounts are reduced to estimated fair value. Fair value may be estimated based upon internal evaluations that include quantitative analyses of revenues and cash flows, reviews of recent sales of similar facilities and independent appraisals.
      Long-lived assets to be disposed of are reported at the lower of their carrying amounts or fair value less costs to sell or close. The estimates of fair value are usually based upon recent sales of similar assets and market responses based upon discussions with and offers received from potential buyers.

F-9


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 — ACCOUNTING POLICIES (Continued)
Goodwill
      Goodwill is not amortized, but is subject to annual impairment tests. In addition to the annual impairment reviews, impairment reviews are performed whenever circumstances indicate a possible impairment may exist. Impairment testing for goodwill is done at the reporting unit level. Reporting units are one level below the business segment level, and HCA’s impairment testing is performed at the operating division or market level. The Company compares the fair value of the reporting unit assets to the carrying amount, on at least an annual basis, to determine if there is potential impairment. If the fair value of the reporting unit assets is less than their carrying value, the Company compares the fair value of the goodwill to its carrying value. If the fair value of the goodwill is less than its carrying value, an impairment loss is recognized. Fair value of goodwill is estimated based upon internal evaluations of the related long-lived assets for each reporting unit that include quantitative analyses of revenues and cash flows and reviews of recent sales of similar facilities. No goodwill impairment losses were recognized during 2005, 2004 or 2003.
      During 2005, goodwill increased by $129 million related to acquisitions, decreased by $35 million related to facility sales and decreased by $8 million related to foreign currency translation adjustments. During 2004, goodwill increased by $53 million related to acquisitions and increased by $6 million related to foreign currency translation adjustments.
Professional Liability Claims
      A substantial portion of HCA’s professional liability risks is insured through a wholly-owned insurance subsidiary of HCA, which is funded annually. Reserves for professional liability risks were $1.621 billion and $1.593 billion at December 31, 2005 and 2004, respectively. The current portion of the reserves, $285 million and $310 million at December 31, 2005 and 2004, respectively, is included in “other accrued expenses” in the consolidated balance sheet. Provisions for losses related to professional liability risks were $298 million, $291 million and $380 million for the years ended December 31, 2005, 2004 and 2003, respectively, and are included in “other operating expenses” in the Company’s consolidated income statement. Provisions for losses related to professional liability risks are based upon actuarially determined estimates. Loss and loss expense reserves represent the estimated ultimate net cost of all reported and unreported losses incurred through the respective consolidated balance sheet dates. The reserves for unpaid losses and loss expenses are estimated using individual case-basis valuations and actuarial analyses. Those estimates are subject to the effects of trends in loss severity and frequency. The estimates are continually reviewed and adjustments are recorded as experience develops or new information becomes known. The adjustments to the estimated reserve amounts are included in current operating results. The provision for losses for 2005 and 2004 include reductions of $83 million ($0.12 per diluted share) and $59 million ($0.07 per diluted share), respectively, to the Company’s estimated professional liability insurance reserves. The amount of the changes to the estimated professional liability insurance reserves was determined based upon the semiannual, independent actuarial analyses, which recognized declining frequency and moderating severity claims trends at HCA. HCA believes these favorable trends are primarily attributable to tort reforms enacted in key states, particularly Texas, and HCA’s risk management and patient safety initiatives, particularly in the areas of obstetrics and emergency services. The reserves for professional liability risks cover approximately 3,300 and 3,500 individual claims at December 31, 2005 and 2004, respectively, and estimates for potential unreported claims. The time period required to resolve these claims can vary depending upon the jurisdiction and whether the claim is settled or litigated. During 2005 and 2004, $242 million and $268 million, respectively, of payments (net of reinsurance recoveries of $12 million and $21 million, respectively) were made for professional and general liability claims. The estimation of the timing of payments beyond a year can vary significantly. Although considerable variability is inherent in professional liability reserve estimates, management believes that the reserves for

F-10


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 — ACCOUNTING POLICIES (Continued)
     Professional Liability Claims (Continued)
losses and loss expenses are adequate; however, there can be no assurance that the ultimate liability will not exceed management’s estimates.
      HCA’s facilities are insured by the wholly-owned insurance subsidiary for losses up to $50 million per occurrence. The insurance subsidiary has obtained reinsurance for professional liability risks generally above a retention level of $15 million per occurrence. HCA also maintains professional liability insurance with unrelated commercial carriers for losses in excess of amounts insured by its insurance subsidiary.
      The obligations covered by reinsurance contracts are included in the reserves for professional liability risks, as the subsidiary remains liable to the extent that the reinsurers do not meet their obligations under the reinsurance contracts. The amounts receivable under the reinsurance contracts of $43 million and $79 million at December 31, 2005, and 2004, respectively, are included in other assets (including $25 million at both December 31, 2005 and 2004 included in other current assets). Returns of premiums relating to reinsurance contracts resulted in net increases to the reserves for professional liability risks of $8 million and $14 million during 2005 and 2004, respectively.
Investments of Insurance Subsidiary
      At December 31, 2005 and 2004, the investments of HCA’s wholly-owned insurance subsidiary were classified as “available-for-sale” as defined in Statement of Financial Accounting Standards No. 115, “Accounting for Certain Investments in Debt and Equity Securities” and are recorded at fair value. The investment securities are held for the purpose of providing the funding source to pay professional liability claims covered by the insurance subsidiary. Management performs a quarterly assessment of individual investment securities to determine whether declines in market value are temporary or other-than-temporary. Management’s investment securities evaluation process involves multiple subjective judgments, often involves estimating the outcome of future events, and requires a significant level of professional judgment in determining whether an impairment has occurred. HCA evaluates, among other things, the financial position and near term prospects of the issuer, conditions in the issuer’s industry, liquidity of the investment, changes in the amount or timing of expected future cash flows from the investment, and recent downgrades of the issuer by a rating agency, to determine if, and when, a decline in the fair value of an investment below amortized cost is considered other-than-temporary. The length of time and extent to which the fair value of the investment is less than amortized cost and HCA’s ability and intent to retain the investment, to allow for any anticipated recovery of the investment’s fair value, are important components of management’s investment securities evaluation process.
Minority Interests in Consolidated Entities
      The consolidated financial statements include all assets, liabilities, revenues and expenses of less than 100% owned entities that are controlled by HCA. Accordingly, management has recorded minority interests in the earnings and equity of such entities.
Related Party Transactions
MedCap Properties, LLC (“MedCap”)
      In December 2000, HCA transferred 116 medical office buildings (“MOBs”) to MedCap. HCA received approximately $250 million and a minority interest (approximately 48%) in MedCap in the transaction. MedCap, a private company, was formed by HCA and other investors to acquire the buildings. HCA did not

F-11


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 — ACCOUNTING POLICIES (Continued)
Related Party Transactions (Continued)
MedCap Properties, LLC (“MedCap”) (Continued)
recognize a gain or loss on the transaction. A relative of a director and former executive officer of the Company served as the chief manager of MedCap.
      In October 2003, MedCap was sold to Health Care Property Investors, Inc. (“HCP”). The sale of MedCap to HCP included HCA’s ownership interest in MedCap, and HCA has no ownership interest in HCP. The distribution of the MedCap sale proceeds resulted in HCA recording a deferred gain of $80 million. The transaction was originally accounted for as a financing transaction and the gain amount was deferred due to HCA’s continuing involvement with the MOBs related to certain contingent, protective put and call rights. During the second quarter of 2005, the contingent, protective put and call rights were eliminated and HCA recognized $29 million of the deferred gain and the remaining portion of the deferred gain is being amortized over the applicable lease terms for the MOBs in which HCA leases space from HCP. The former chief manager of MedCap, continues to manage the MOBs as an employee of HCP.
      HCA leased certain office space from MedCap and, during the year ended December 31, 2003 (through September 2003), paid MedCap $16.1 million in rents for such leased office space. HCA continues to lease certain office space from HCP. HCA believes its transactions with MedCap were on terms no less favorable to HCA than those which would have been obtained from an unaffiliated party.
HealthStream, Inc. (“HealthStream”)
      In October 2001, HCA entered into an amended four-year agreement with HealthStream to purchase internet-based education and training services. The agreement expired during 2005. During 2005, 2004 and 2003, the Company paid HealthStream $3.2 million, $3.2 million, and $2.6 million, respectively, which represented approximately 12%, 16% and 15%, respectively, of HealthStream’s net revenues. The chief executive officer, president and chairman of the board of directors of HealthStream is a relative of a director and former executive officer of HCA. HCA believes its transactions with HealthStream are on terms no less favorable to HCA than those which would be obtained from an unaffiliated party.
Share-Based Compensation
      HCA applies Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations in accounting for its employee stock benefit plans. Accordingly, no compensation cost has been recognized for HCA stock options granted under the plans because the exercise prices for options granted were equal to the quoted market prices on the option grant dates and all option grants were to employees or directors.
      As required by Statement of Financial Accounting Standards No. 123, “Accounting for Stock-Based Compensation” (“SFAS 123”), HCA has determined pro forma net income and earnings per share, as if compensation cost for HCA’s employee stock option and stock purchase plans had been determined based

F-12


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 — ACCOUNTING POLICIES (Continued)
Share-Based Compensation (Continued)
upon fair values at the grant dates. These pro forma amounts are as follows (dollars in millions, except per share amounts):
                           
    2005   2004   2003
             
Net income:
                       
 
As reported
  $ 1,424     $ 1,246     $ 1,332  
 
Share-based employee compensation expense determined under a fair value method, net of income taxes
    23       191 (a)     89  
                   
 
Pro forma
  $ 1,401     $ 1,055     $ 1,243  
                   
Basic earnings per share:
                       
 
As reported
  $ 3.25     $ 2.62     $ 2.66  
 
Pro forma
  $ 3.19     $ 2.22     $ 2.48  
Diluted earnings per share:
                       
 
As reported
  $ 3.19     $ 2.58     $ 2.61  
 
Pro forma
  $ 3.14     $ 2.18     $ 2.43  
 
(a)  In December 2004, HCA accelerated the vesting of all unvested stock options awarded to employees and officers which had exercise prices greater than the closing price at December 14, 2004 of $40.89 per share. Options to purchase approximately 19.1 million shares became exercisable immediately as a result of the vesting acceleration. The decision to accelerate vesting of the identified stock options will result in the Company not being required to recognize share-based compensation expense, net of taxes, of approximately $36 million in 2006, $19 million in 2007, and $2 million in 2008, under the provisions of Financial Accounting Standard Board (the “FASB”), Statement of Financial Accounting Standards No. 123R, “Share-Based Payment” (“SFAS 123R”). The elimination of the requirement to recognize compensation expense in future periods related to the unvested stock options was management’s basis for the decision to accelerate the vesting. The effect of accelerating the vesting for all unvested options with exercise prices greater than $40.89 per share was an increase to the pro forma share-based employee compensation expense for the year ended December 31, 2004 of $112 million after-tax ($0.24 per basic share and $0.23 per diluted share).
      For SFAS 123 purposes, the weighted average fair values of HCA’s stock options granted in 2005, 2004 and 2003 were $15.53, $12.90 and $13.49 per share, respectively. The fair values were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:
                         
    2005   2004   2003
             
Risk-free interest rate
    3.99 %     2.56 %     2.62 %
Expected volatility
    33 %     35 %     37 %
Expected life, in years
    5       4       4  
Expected dividend yield
    1.27 %     1.18 %     0.19 %
      The expected volatility is derived using weekly, historical market price data for periods preceding the date of grant. The risk-free interest rate is the approximate yield on United States Treasury Strips, having a term equivalent to the expected life of the stock option, on the date of grant. The expected life is an estimate of the number of years an option will be held before it is exercised. The valuation model was not adjusted for nontransferability, risk of forfeiture or the vesting restrictions of the options, all of which would reduce the value if factored into the calculation.

F-13


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 — ACCOUNTING POLICIES (Continued)
Share-Based Compensation (Continued)
      The pro forma pretax compensation cost related to the shares of common stock issued under HCA’s amended and restated Employee Stock Purchase Plan was $17 million, $15 million and $17 million for the years 2005, 2004 and 2003, respectively. These pro forma costs were determined based on the estimated fair values at the beginning of each subscription period.
Derivatives
      HCA has designated its outstanding interest rate swap agreements as fair value hedges. HCA has determined that the current agreements are highly effective in offsetting the fair value changes in a portion of HCA’s debt portfolio. These derivatives and the related hedged debt amounts have been recognized in the consolidated financial statements at their respective fair values.
Recent Pronouncements
      In December 2004, the FASB issued SFAS 123R, which requires all companies to measure compensation cost for all share-based payments (including employee stock options) at fair value, and is effective for most public companies for annual periods beginning after June 15, 2005. HCA expects to adopt SFAS 123R effective January 1, 2006, using the “modified prospective” method. Under this method, compensation costs will be recognized, beginning with the effective date, based on the requirements of SFAS 123R for all share-based payments granted after the effective date, and based on the requirements of SFAS 123 for all awards granted to employees prior to the effective date that remain unvested on the effective date. The impact on the results of operations of adoption of SFAS 123R will depend on levels of share-based payments granted in the future, and the market value of HCA common stock and other variables that affect the valuation model for options granted. Based upon expected grant levels and values at December 31, 2005, the Company estimates the impact on results of operations, net of income taxes, will approximate $30 million to $40 million in 2006. SFAS 123R requires the benefits of tax deductions in excess of amounts recognized as compensation cost be reported as a financing cash flow, rather than an operating cash flow, as required under prior accounting guidance. This requirement will reduce net operating cash flows and increase net financing cash flows in periods after adoption. While the Company cannot estimate what those amounts will be in the future (because they depend on, among other things, when employees exercise stock options), the amounts of operating cash flows recognized for such excess tax deductions were $163 million, $50 million and $31 million in 2005, 2004 and 2003, respectively.
      In May 2003, the FASB issued Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity” (“SFAS 150”). This statement generally requires liability classification for two broad classes of financial instruments. Under SFAS 150, instruments that represent, or are indexed to, an obligation to buy back the issuer’s shares, regardless of whether the instrument is settled on a net-cash or gross physical basis, are required to be classified as liabilities. Obligations that can be settled in shares, but either derive their value predominately from some other underlying, have a fixed value, or have a value to the counterparty that moves in the opposite direction as the issuer’s shares, are also required to be classified as liabilities under this statement. In October 2003, the FASB voted to defer, for an indefinite period, the application of the SFAS 150 guidance to noncontrolling interests in limited-life subsidiaries. The FASB decided to defer this application of SFAS 150 to allow them the opportunity to consider possible implementation issues that would result from the proposed SFAS 150 guidance regarding measurement and recognition of noncontrolling interests. HCA will assess the impact of the FASB’s reconsiderations, if any, on the Company’s consolidated financial statements when they are finalized.

F-14


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 — ACCOUNTING POLICIES (Continued)
     Recent Pronouncements (Continued)
      In November 2005, the FASB issued FASB Staff Position No. 45-3, “Application of FASB Interpretation No. 45 to Minimum Revenue Guarantees Granted to a Business or Its Owners” (“FSP FIN 45-3”). It served as an amendment to FASB Interpretation No. 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others” (“FIN 45”) by adding minimum revenue guarantees to the list of examples of contracts to which FIN 45 applies. Under FSP FIN 45-3, a guarantor is required to recognize, at the inception of a guarantee, a liability for the fair value of the obligation undertaken in issuing the guarantee. One example cited in FSP FIN 45-3 involves a guarantee provided by a health care entity to a nonemployed physician in order to recruit such physician to move to the entity’s geographical area and establish a private practice, which is an approach HCA uses to recruit physicians.
      FSP FIN 45-3 is effective for new minimum revenue guarantees issued or modified on or after January 1, 2006. For periods before January 1, 2006, HCA expensed the physician recruitment agreement amounts as incurred to the recruited physicians, which was generally over a 12 month period. HCA recorded expenses of approximately $82 million related to physician recruitment agreements for the year ended December 31, 2005. HCA is in the process of evaluating the expected impact of the adoption of FSP FIN 45-3 on results of operations for 2006.
Reclassifications
      Certain prior year amounts have been reclassified to conform to the 2005 presentation.
NOTE 2 — ACQUISITIONS AND DISPOSITIONS
      During 2005, HCA recognized a net pretax gain of $49 million ($19 million after-tax) on the sales of five rural hospitals. Proceeds from the sales were used to repay bank borrowings. During 2004, HCA opened one hospital, sold one hospital, and closed two hospitals. During 2003, HCA recognized a net pretax gain of $85 million ($49 million after-tax) on the sales of two leased hospitals and two consolidating hospitals and a working capital settlement related to a sale completed in 2002. Proceeds from the sales were used to repay bank borrowings.
      During 2005 and 2004, HCA did not acquire any hospitals, but paid $126 million and $44 million, respectively, for other health care entities. During 2003, HCA completed the acquisition of the Health Midwest hospital system in Kansas City. The purchase price was allocated to the related assets acquired and liabilities assumed based upon their respective fair values. The consolidated financial statements include the accounts and operations of the Health Midwest entities subsequent to the April 1, 2003 acquisition date. The pro forma effect of the acquired entities on HCA’s results of operations for periods prior to the acquisition date was not significant.

F-15


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 2 — ACQUISITIONS AND DISPOSITIONS (Continued)
      The following is a summary of hospitals and other health care entities acquired during 2003 (dollars in millions):
               
    2003
     
Number of hospitals
    11  
Number of licensed beds
    2,292  
Purchase price information:
       
 
Hospitals:
       
   
Fair value of assets acquired
  $ 1,183  
   
Liabilities assumed
    (315 )
       
     
Net assets acquired
    868  
 
Other health care entities acquired
    40  
       
     
Net cash paid
  $ 908  
       
      The purchase price paid in excess of the fair value of identifiable net assets of acquired entities aggregated $129 million and $38 million in 2005 and 2004, respectively. In 2004, goodwill increased $15 million related to adjustments to 2003 acquisitions.
NOTE 3 — IMPAIRMENTS OF LONG-LIVED ASSETS
      The carrying value for a hospital HCA closed during 2004 was reduced to fair value of $39 million, based upon estimates of sales value, resulting in a pretax charge of $12 million. The 2004 impairment charge affected HCA’s Western Group.
      During 2003, HCA announced plans to discontinue activities associated with the internal development of a patient accounts receivable management system, resulting in a pretax charge of $130 million. HCA reduced the carrying value for capitalized costs associated with the patient accounts receivable management system components that were discontinued. The 2003 impairment charge affected HCA’s “Corporate and other” operating segment.
      The asset impairment charges did not have a significant impact on the Company’s operations or cash flows and are not expected to significantly impact cash flows for future periods. The impairment charges affected HCA’s asset and liability categories, as follows (dollars in millions):
                 
    2004   2003
         
Property and equipment
  $ 12     $ 105  
Other accrued expenses
          25  
             
    $ 12     $ 130  
             

F-16


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 4 — INCOME TAXES
      The provision for income taxes consists of the following (dollars in millions):
                           
    2005   2004   2003
             
Current:
                       
 
Federal
  $ 668     $ 466     $ 193  
 
State
    63       63       77  
 
Foreign
    37       25       18  
Deferred:
                       
 
Federal
    (43 )     132       513  
 
State
    3       17       50  
 
Foreign
    (3 )     24       12  
 
Change in valuation allowance
                (39 )
                   
    $ 725     $ 727     $ 824  
                   
      A reconciliation of the federal statutory rate to the effective income tax rate follows:
                         
    2005   2004   2003
             
Federal statutory rate
    35.0 %     35.0 %     35.0 %
State income taxes, net of federal income tax benefit
    2.1       2.6       3.8  
Nondeductible intangible assets
    0.6             0.2  
IRS settlement
    (2.2 )            
Valuation allowance
                (1.7 )
Repatriation of foreign earnings
    (1.1 )            
Other items, net
    (0.6 )     (0.8 )     0.9  
                   
Effective income tax rate
    33.8 %     36.8 %     38.2 %
                   
      During 2005, HCA recognized tax benefits of $48 million, or $0.11 per diluted share, related to a favorable tax settlement regarding the Company’s divestiture of certain noncore business units in 1998 and 2001 and $24 million, or $0.05 per diluted share, related to the repatriation of foreign earnings.
      A summary of the items comprising the deferred tax assets and liabilities at December 31 follows (dollars in millions):
                                 
    2005   2004
         
    Assets   Liabilities   Assets   Liabilities
                 
Depreciation and fixed asset basis differences
  $     $ 632     $     $ 788  
Allowances for professional liability and other risks
    124             122        
Doubtful accounts
    155             295        
Compensation
    185             157        
Other
    235       525       291       628  
                         
    $ 699     $ 1,157     $ 865     $ 1,416  
                         
      Deferred income tax benefits of $372 million and $467 million at December 31, 2005 and 2004, respectively, are included in other current assets. Noncurrent deferred income tax liabilities totaled $830 million and $1.018 billion at December 31, 2005 and 2004, respectively.

F-17


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 4 — INCOME TAXES (Continued)
      The tax benefits associated with nonqualified stock options increased the current tax receivable by $163 million, $50 million, and $31 million in 2005, 2004 and 2003, respectively. Such benefits were recorded as increases to stockholders’ equity.
      At December 31, 2005, state net operating loss carryforwards (expiring in years 2006 through 2025) available to offset future taxable income approximated $46 million. Utilization of net operating loss carryforwards in any one year may be limited and, in certain cases, result in an adjustment to intangible assets. Net deferred tax assets related to such carryforwards are not significant.
IRS Disputes
      HCA is currently contesting before the Appeals Division of the Internal Revenue Service (the “IRS”), the United States Tax Court (the “Tax Court”), and the United States Court of Federal Claims, certain claimed deficiencies and adjustments proposed by the IRS in conjunction with its examinations of HCA’s 1994-2002 federal income tax returns, Columbia Healthcare Corporation’s (“CHC”) 1993 and 1994 federal income tax returns, HCA-Hospital Corporation of America’s (“Hospital Corporation of America”) 1991 through 1993 federal income tax returns and Healthtrust, Inc. — The Hospital Company’s (“Healthtrust”) 1990 through 1994 federal income tax returns.
      During 2003, the United States Court of Appeals for the Sixth Circuit affirmed a Tax Court decision received in 1996 related to the IRS examination of Hospital Corporation of America’s 1987 through 1988 federal income tax returns, in which the IRS contested the method that Hospital Corporation of America used to calculate its tax allowance for doubtful accounts. HCA filed a petition for review by the United States Supreme Court, which was denied in October 2004. Due to the volume and complexity of calculating the tax allowance for doubtful accounts, the IRS has not determined the amount of additional tax and interest that it may claim for taxable years after 1988. In December 2004, HCA made a deposit of $109 million for additional tax and interest, based on its estimate of amounts due for taxable periods through 1998.
      Other disputed items include the deductibility of a portion of the 2001 government settlement payment, the timing of recognition of certain patient service revenues in 2000 through 2002, the method for calculating the tax allowance for uncollectable accounts in 2002, and the amount of insurance expense deducted in 1999 through 2002. The IRS has claimed an additional $776 million in income taxes, interest, and penalties through December 31, 2005, with respect to these issues.
      During February 2006, the IRS began an examination of HCA’s 2003 through 2004 federal income tax returns. The IRS has not determined the amount of any additional income tax, interest and penalties that it may claim upon completion of this examination.
      Management believes that adequate provisions have been recorded to satisfy final resolution of the disputed issues. Management believes that HCA, CHC, Hospital Corporation of America and Healthtrust properly reported taxable income and paid taxes in accordance with applicable laws and agreements established with the IRS during previous examinations and that final resolution of these disputes will not have a material adverse effect on results of operations or financial position.
NOTE 5 — EARNINGS PER SHARE
      Basic earnings per share is computed on the basis of the weighted average number of common shares outstanding. Diluted earnings per share is computed on the basis of the weighted average number of common shares outstanding plus the dilutive effect of outstanding stock options and other stock awards, computed using the treasury stock method.

F-18


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 5 — EARNINGS PER SHARE (Continued)
      The following table sets forth the computation of basic and diluted earnings per share (dollars in millions, except per share amounts, and shares in thousands):
                             
    2005   2004   2003
             
Net income
  $ 1,424     $ 1,246     $ 1,332  
Weighted average common shares outstanding
    438,619       475,620       501,799  
 
Effect of dilutive securities:
                       
   
Stock options
    5,841       6,315       7,231  
   
Other
    1,325       1,728       1,844  
                   
Shares used for diluted earnings per share
    445,785       483,663       510,874  
                   
Earnings per share:
                       
 
Basic earnings per share
  $ 3.25     $ 2.62     $ 2.66  
                   
 
Diluted earnings per share
  $ 3.19     $ 2.58     $ 2.61  
                   
NOTE 6 — INVESTMENTS OF INSURANCE SUBSIDIARY
      A summary of the insurance subsidiary’s investments at December 31 follows (dollars in millions):
                                   
    2005
     
        Unrealized    
        Amounts    
    Amortized       Fair
    Cost   Gains   Losses   Value
                 
Debt securities:
                               
 
States and municipalities
  $ 1,199     $ 27     $ (5 )   $ 1,221  
 
Asset-backed securities
    41       4             45  
 
Corporate and other
    22       1             23  
 
Money market funds
    130                   130  
                         
      1,392       32       (5 )     1,419  
                         
Equity securities:
                               
 
Preferred stocks
    10                   10  
 
Common stocks
    798       161       (4 )     955  
                         
      808       161       (4 )     965  
                         
    $ 2,200     $ 193     $ (9 )     2,384  
                         
Amounts classified as current assets
                            (250 )
                         
Investment carrying value
                          $ 2,134  
                         

F-19


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 6 — INVESTMENTS OF INSURANCE SUBSIDIARY (Continued)
                                   
    2004
     
        Unrealized    
        Amounts    
    Amortized       Fair
    Cost   Gains   Losses   Value
                 
Debt securities:
                               
 
States and municipalities
  $ 1,219     $ 50     $ (1 )   $ 1,268  
 
Asset-backed securities
    37       2             39  
 
Corporate and other
    85       1             86  
 
Money market funds
    48                   48  
                         
      1,389       53       (1 )     1,441  
                         
Equity securities:
                               
 
Preferred stocks
    8                   8  
 
Common stocks
    694       180       (1 )     873  
                         
      702       180       (1 )     881  
                         
    $ 2,091     $ 233     $ (2 )     2,322  
                         
Amounts classified as current assets
                            (275 )
                         
Investment carrying value
                          $ 2,047  
                         
      At December 31, 2005 and 2004, the investments of HCA’s insurance subsidiary were classified as “available-for-sale.” The fair value of investment securities is generally based on quoted market prices. Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income. The aggregate common stock investment is comprised of 511 equity positions at December 31, 2005, with 455 positions reflecting unrealized gains and 56 positions reflecting unrealized losses (none of the individual unrealized loss positions exceed $1 million). None of the equity positions with unrealized losses at December 31, 2005 represent situations where there is a continuous decline of more than 20% from cost for more than one year. The equity positions (including those with unrealized losses) at December 31, 2005, are not concentrated in a particular industry.
      Scheduled maturities of investments in debt securities at December 31, 2005 were as follows (dollars in millions):
                 
    Amortized   Fair
    Cost   Value
         
Due in one year or less
  $ 188     $ 188  
Due after one year through five years
    365       371  
Due after five years through ten years
    476       487  
Due after ten years
    322       328  
             
      1,351       1,374  
Asset-backed securities
    41       45  
             
    $ 1,392     $ 1,419  
             
      The average expected maturity of the investments in debt securities approximated 4.1 years at December 31, 2005. Expected and scheduled maturities may differ because the issuers of certain securities may have the right to call, prepay or otherwise redeem such obligations.

F-20


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 6 — INVESTMENTS OF INSURANCE SUBSIDIARY (Continued)
      The cost of securities sold is based on the specific identification method. Sales of securities for the years ended December 31 are summarized below (dollars in millions):
                           
    2005   2004   2003
             
Debt securities:
                       
 
Cash proceeds
  $ 173     $ 181     $ 109  
 
Gross realized gains
    2       6       3  
 
Gross realized losses
    1       2       6  
Equity securities:
                       
 
Cash proceeds
  $ 440     $ 338     $ 36  
 
Gross realized gains
    63       62       9  
 
Gross realized losses
    9       16       7  
NOTE 7 — FINANCIAL INSTRUMENTS
Interest Rate Swap Agreements
      HCA has entered into interest rate swap agreements to manage its exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-floating swaps effectively convert fixed rate obligations to LIBOR indexed variable rate instruments. The notional amounts and timing of interest payments in these agreements match the related liabilities. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not assets or liabilities of HCA. Any market risk or opportunity associated with these swap agreements is offset by the opposite market impact on the related debt. HCA’s credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis.
      The following table sets forth HCA’s interest rate swap agreements at December 31, 2005 (dollars in millions):
                         
    Notional       Fair
    Amount   Termination Date   Value
             
Pay-floating interest rate swap
  $ 500       June 2006     $  
Pay-floating interest rate swap
    350       November 2008       (11 )
Pay-floating interest rate swap
    500       December 2009       (14 )
      The fair value of the interest rate swaps at December 31, 2005 represents the estimated amounts HCA would have paid upon termination of these agreements. The fair values were based on valuations obtained from the financial institutions with which HCA has the interest rate swap agreements.
Fair Value Information
      At December 31, 2005 and 2004, the fair values of cash and cash equivalents, accounts receivable and accounts payable approximated carrying values due to the short-term nature of these instruments. The

F-21


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 7 — FINANCIAL INSTRUMENTS (Continued)
Fair Value Information (Continued)
estimated fair values of other financial instruments subject to fair value disclosures are generally determined based on quoted market prices. The estimated fair values and the related carrying amounts are as follows (dollars in millions):
                                   
    2005   2004
         
    Carrying   Fair   Carrying   Fair
    Amount   Value   Amount   Value
                 
Assets:
                               
 
Investments
  $ 2,384     $ 2,384     $ 2,322     $ 2,322  
 
Interest rate swaps
                10       10  
Liabilities:
                               
 
Long-term debt
    10,475       10,733       10,530       10,789  
 
Interest rate swaps
    25       25              
NOTE 8 — LONG-TERM DEBT
      A summary of long-term debt at December 31, including related interest rates at December 31, 2005, follows (dollars in millions):
                 
    2005   2004
         
Senior collateralized debt (rates generally fixed, averaging 7.9%) payable in periodic installments through 2036
  $ 281     $ 191  
Senior debt (rates fixed, averaging 7.5%) payable in periodic installments through 2095
    7,069       7,539  
Senior debt (floating rates, averaging 6.2%) due through 2009
    1,350       1,350  
Bank term loan (floating rates, averaging 5.4%)
    1,300       750  
Bank revolving credit facility (floating rates, averaging 5.2%)
    475       700  
             
Total debt, average life of nine years (rates averaging 7.0%)
    10,475       10,530  
Less amounts due within one year
    586       486  
             
    $ 9,889     $ 10,044  
             
Bank Revolving Credit Facility
      HCA’s revolving credit facility (the “Credit Facility”) is a $1.75 billion agreement expiring November 2009. As of December 31, 2005, HCA had $475 million outstanding under the Credit Facility. As of December 2005, interest is payable generally at either a spread to LIBOR, plus 0.4% to 1.0% (depending on HCA’s credit ratings), the prime lending rate or a competitive bid rate. The Credit Facility contains customary covenants which include (i) limitations on debt levels, (ii) limitations on sales of assets, mergers and changes of ownership and (iii) maintenance of minimum interest coverage ratios. As of December 31, 2005, HCA was in compliance with all such covenants.

F-22


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 8 — LONG-TERM DEBT (Continued)
Significant Financing Activities
2006
      In February 2006, HCA issued $1.0 billion of 6.5% notes due February 2016. Proceeds of $625 million were used to refinance amounts outstanding under the term loan entered into in November 2005 and the remaining proceeds were used to pay down amounts advanced under the Credit Facility.
2005
      In November 2005, HCA entered into a $1.0 billion credit agreement with several banks, which matures in May 2006. Under this agreement, the Company borrowed $800 million (the “2005 Term Loan”). Proceeds from the 2005 Term Loan were used to partially fund the repurchase of the Company’s common stock. The 2005 Term Loan contains a mandatory prepayment clause which requires the Company to prepay amounts outstanding after receiving proceeds from the issuance of debt or equity securities or from asset sales. The proceeds of $175 million from the sale of hospitals and a portion of the proceeds from the $1.0 billion 6.5% notes issued in February 2006 were used to repay the amounts outstanding under the 2005 Term Loan. In accordance with Statement of Financial Accounting Standards No. 6, “Classification of Short-Term Obligations Expected to be Refinanced,” because the balance of the 2005 Term Loan was refinanced in February 2006, the 2005 Term Loan is classified as “long-term debt” in the December 31, 2005 consolidated balance sheet.
2004
      In March 2004, HCA issued $500 million of 5.75% notes due March 15, 2014. The proceeds from the issuance were used to repay a portion of the amounts outstanding under the Company’s previous revolving credit facility and for general corporate purposes.
      In November 2004, HCA entered into a $2.5 billion credit agreement (the “2004 Credit Agreement”) with several banks. The 2004 Credit Agreement consists of a $750 million amortizing term loan which matures in 2009 (the “2004 Term Loan”) and the Credit Facility. Proceeds from the 2004 Term Loan were used to refinance a prior bank loan and for general corporate purposes.
      During November 2004, HCA issued $500 million of 5.5% notes due December 1, 2009 and issued $750 million of 6.375% notes due January 15, 2015. Proceeds from the notes were used to repay amounts outstanding under the Credit Facility and for general corporate purposes.
      During the fourth quarter of 2004, in response to the Company’s tender offer to repurchase the Company’s common stock, Standard & Poor’s downgraded HCA’s senior debt rating from BBB- to BB+ and Fitch Ratings downgraded HCA’s senior debt rating from BBB- to BB+. Moody’s Investors Service downgraded HCA’s senior debt rating from Bal to Ba2.
      In December 2004, HCA filed a shelf registration statement and prospectus with the Securities and Exchange Commission that will allow the Company to issue, from time to time, up to $1.5 billion in debt securities. In February 2006, HCA issued $1.0 billion of debt securities under this shelf registration.
General Information
      Maturities of long-term debt in years 2007 through 2010 (excluding borrowings under the Credit Facility) are $454 million, $759 million, $897 million and $1.090 billion, respectively.
      The estimated fair value of the Company’s long-term debt was $10.733 billion and $10.789 billion at December 31, 2005 and 2004, respectively, compared to carrying amounts aggregating $10.475 billion and

F-23


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 8 — LONG-TERM DEBT (Continued)
General Information
$10.530 billion, respectively. The estimates of fair value are generally based upon the quoted market prices for the same or similar issues of long-term debt with the same maturities.
NOTE 9 — CONTINGENCIES
Significant Legal Proceedings
      HCA operates in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against the Company. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse affect on HCA’s results of operations and financial position in a given period.
      In 2005, HCA and certain of its executive officers and directors were named in various federal securities law class actions and several shareholders filed derivative lawsuits purportedly on behalf of the Company. Additionally, a former employee of HCA filed a complaint against certain of HCA’s executive officers pursuant to the Employee Retirement Income Security Act and the Company has been served with a shareholder demand letter addressed to our Board of Directors. HCA cannot predict the results of the investigations or any related lawsuits, or the effect that findings in such investigations or lawsuits may have on the Company.
General Liability Claims
      HCA is subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against HCA which may not be covered by insurance. It is management’s opinion that the ultimate resolution of these pending claims and legal proceedings will not have a material, adverse effect on HCA’s results of operations or financial position.
Investigations and Settlement of Certain Government Claims
      Commencing in 1997, HCA became aware it was the subject of governmental investigations and litigation relating to its business practices. The investigations were concluded through a series of agreements executed in 2000 and 2003. In January 2001, HCA entered into an eight-year Corporate Integrity Agreement (“CIA”) with the Office of Inspector General of the Department of Health and Human Services.
      During June 2003, HCA announced that the Company and the Centers for Medicare and Medicaid Services (“CMS”) had signed an agreement, documenting the understanding announced in March 2002, to resolve all Medicare cost report, home office cost statement and appeal issues between HCA and CMS (the “CMS Agreement”) for cost report periods ended before August 1, 2001. As a result of the CMS Agreement, HCA paid CMS $250 million in June 2003.
      During June 2003, HCA also announced that the Company and the Civil Division of the Department of Justice (the “DOJ”) had signed agreements, documenting the understanding announced in December 2002, whereby the United States would dismiss the various claims it had brought related to physician relations, cost reports and wound care issues (the “DOJ Agreement”). The DOJ Agreement received court approval in July 2003, and HCA paid the DOJ $641 million (including accrued interest of $10 million) during July 2003. HCA also finalized an agreement with a negotiating team representing states that may have claims against the Company. Under this agreement, HCA paid $17.7 million in July 2003 to state Medicaid agencies to resolve these claims. HCA also paid $33 million for legal fees of the private parties who had brought qui tam actions

F-24


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 9 — CONTINGENCIES (Continued)
Investigations and Settlement of Certain Government Claims (Continued)
against the Company. The consolidated income statement for the year ended December 31, 2003 includes a pretax favorable change in estimate of $41 million ($25 million after-tax) related to Medicaid cost report balances for cost report years ended December 31, 1997 and prior and $8 million for professional fees related to the investigations.
      In September 2005, the Company received a subpoena from the Office of the United States Attorney for the Southern District of New York seeking the production of documents. Also in September 2005, HCA was informed that the SEC had issued a formal order of investigation. Both the subpoena and the formal order of investigation relate to trading in the Company’s securities. The Company is cooperating fully with these investigations.
NOTE 10 — CAPITAL STOCK AND STOCK REPURCHASES
Capital Stock
      The terms and conditions associated with each class of HCA’s common stock are substantially identical, except for voting rights. All nonvoting common stockholders may convert their shares on a one-for-one basis into voting common stock, subject to certain limitations.
Stock Repurchase Programs
      In October 2005, HCA announced the authorization of a modified “Dutch” auction tender offer to purchase up to $2.5 billion of its common stock. In November 2005, HCA closed the tender offer and repurchased 28.7 million shares of the Company’s common stock for $1.437 billion ($50.00 per share). The shares repurchased represented approximately 6% of the Company’s outstanding shares at the time of the tender offer. During 2005, HCA also repurchased 8.0 million shares of its common stock for $412 million, through open market purchases.
      In October 2004, HCA announced the authorization of a modified “Dutch” auction tender offer to purchase up to $2.501 billion of its common stock. In November 2004, HCA closed the tender offer and repurchased 62 million shares of the Company’s common stock for $2.466 billion ($39.75 per share). The shares repurchased represented approximately 13% of the Company’s outstanding shares at the time of the tender offer. HCA also repurchased 0.9 million shares of its common stock for $35 million, through open market purchases, which completed this $2.501 billion share repurchase authorization.
      In April 2003, HCA announced an authorization to repurchase $1.5 billion of its common stock through open market purchases or privately negotiated transactions. During 2003, HCA repurchased under this authorization 25.3 million shares of its common stock for $900 million, through open market purchases. During 2004, HCA repurchased 14.5 million shares of its common stock for $600 million, through open market purchases, which completed this authorization.
      In July 2002, HCA announced an authorization to repurchase up to 12 million shares of its common stock. During 2003, HCA purchased 5.8 million shares for $214 million, through open market purchases, which completed the repurchases under this authorization.
      During 2005, 2004 and 2003, the share repurchase transactions reduced stockholders’ equity by $1.856 billion, $3.109 billion and $1.114 billion, respectively.

F-25


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 11 — STOCK BENEFIT PLANS
      In May 2005, the stockholders of HCA approved the HCA 2005 Equity Incentive Plan (the “2005 Plan”). The 2005 Plan is the primary plan under which options to purchase common stock and restricted stock may be granted to officers, employees and directors. Prior to 2005, the Company primarily utilized stock option grants for equity compensation purposes. During 2005 an increasing equity compensation emphasis was placed on restricted share grants. The restricted shares issued in 2005 are subject to back-end vesting provisions, with no shares vesting in the first two years after grant and then a third of the shares vesting in each of the third, fourth and fifth years. During 2005, compensation cost related to restricted share grants under this plan totaled $24 million. The number of options or shares authorized under the 2005 Plan is 34,000,000 (which includes 14,000,000 shares authorized under a former plan). In addition, options granted under the former plan that are cancelled become available for subsequent grants. Exercise provisions vary, but options are generally exercisable, in whole or in part, beginning one to four years after the grant date and ending ten years after the grant date.
      In December 2004, HCA accelerated the vesting of all unvested options awarded to employees and officers which had exercise prices greater than closing price of the Company’s common stock at December 14, 2004 of $40.89 per share. Options to purchase approximately 19.1 million shares became exercisable immediately as a result of the vesting acceleration.
      Options to purchase common stock have been granted to officers, employees and directors under various predecessor plans. Generally, options have been granted with exercise prices no less than the market price on the date of grant. Exercise provisions vary, but most options are exercisable in whole, or in part, beginning one to five years after the grant date and ending four to fifteen years after the grant date.
      Information regarding these option plans for 2005, 2004 and 2003 is summarized below (share amounts in thousands):
                           
    Stock   Option Price Per   Weighted Average
    Options   Share   Exercise Price
             
Balances, December 31, 2002
    48,971     $ 0.14 to $49.00     $ 28.90  
 
Granted
    9,301       31.95 to  42.36       41.86  
 
Exercised
    (4,964 )     0.14 to  41.84       22.50  
 
Cancelled
    (1,627 )     17.11 to  45.12       35.26  
                   
Balances, December 31, 2003
    51,681       0.14 to  49.00       31.64  
 
Granted
    9,306       35.00 to  45.86       45.62  
 
Exercised
    (7,208 )     0.14 to  43.66       23.79  
 
Cancelled
    (1,517 )     0.38 to  45.86       41.11  
                   
Balances, December 31, 2004
    52,262       0.14 to  49.00       34.94  
 
Granted
    2,644       44.74 to  57.67       49.25  
 
Exercised
    (27,034 )     0.14 to  49.00       34.87  
 
Cancelled
    (66 )     17.12 to  54.73       42.54  
                   
Balances, December 31, 2005
    27,806       0.14 to  57.67       36.35  
                   
                         
    2005   2004   2003
             
Weighted average fair value per option for options granted during the year
  $ 15.53     $ 12.90     $ 13.49  
Options exercisable
    24,803       50,112       31,564  
Options available for grant
    32,598       17,657       26,166  

F-26


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 11 — STOCK BENEFIT PLANS (Continued)
      The following table summarizes information regarding the options outstanding at December 31, 2005 (share amounts in thousands):
                                           
    Options Outstanding    
        Options Exercisable
        Weighted        
        Average   Weighted   Number   Weighted
    Number   Remaining   Average   Exercisable   Average
Range of   Outstanding   Contractual   Exercise   at   Exercise
Exercise Prices   at 12/31/05   Life   Price   12/31/05   Price
                     
$35.82
    211       Less than 1  year     $ 35.82       211     $ 35.82  
29.22 to 37.92
    946       1 year       36.63       946       36.63  
25.17 to 33.28
    3,000       2 years       27.08       3,000       27.08  
17.12 to 22.25
    5,005       3 years       17.65       5,005       17.65  
23.94 to 35.60
    2,197       5 years       34.13       2,026       34.99  
36.75 to 46.29
    4,236       6 years       41.75       4,234       41.75  
39.33 to 47.79
    4,055       7 years       42.18       4,024       42.19  
 
0.14
    53       8 years       0.14       53       0.14  
31.95 to 45.86
    5,184       8 years       45.37       5,014       45.68  
35.00 to 48.70
    915       9 years       43.46       245       41.06  
46.95 to 57.67
    2,004       10 years       50.51       45       50.64  
                               
      27,806                       24,803          
                               
      HCA’s amended and restated Employee Stock Purchase Plan (“ESPP”) provides an opportunity to purchase shares of its common stock at a discount (through payroll deductions over six-month periods) to substantially all employees. At December 31, 2005, 4,900,100 shares of common stock were reserved for purchase under the ESPP provisions.
      Under the Management Stock Purchase Plan (“MSPP”), HCA has made grants of restricted shares or units of HCA’s common stock to provide equity compensation to employees. The MSPP allows eligible employees to defer an elected percentage (not to exceed 25%) of their base salaries through the purchase of restricted stock at a 25% discount from the average market price. Purchases of restricted shares are made twice a year and the shares vest after three years.
      At December 31, 2005, 3,747,500 shares were subject to restrictions, which lapse between 2006 and 2009. During 2005, 2004 and 2003, grants and purchases of 3,130,900, 721,100 and 1,039,900 shares, respectively, were made at weighted-average grant or purchase date fair values of $44.97, $44.88 and $42.08 per share, respectively, related to equity compensation plans. During 2005, 2004 and 2003, grants and purchases of 145,600, 158,900 and 148,900 shares, respectively, were made at weighted-average grant or purchase date discounted (25% discount) fair values of $33.22, $29.64 and $30.21 per share, respectively, related to the MSPP.
NOTE 12 — EMPLOYEE BENEFIT PLANS
      HCA maintains noncontributory, defined contribution retirement plans covering substantially all employees. Benefits are determined as a percentage of a participant’s salary and vest over specified periods of employee service. Retirement plan expense was $216 million for 2005, $191 million for 2004 and $166 million for 2003. Amounts approximately equal to retirement plan expense are funded annually.

F-27


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 12 — EMPLOYEE BENEFIT PLANS (Continued)
      HCA maintains contributory, defined contribution benefit plans that are available to employees who meet certain minimum requirements. Certain of the plans require that HCA match specified percentages of participant contributions up to certain maximum levels (generally 50% of the first 3% of compensation deferred by participants). The cost of these plans totaled $54 million for 2005, $51 million for 2004 and $48 million for 2003. HCA’s contributions are funded periodically during each year.
      HCA maintains a Supplemental Executive Retirement Plan (“SERP”) for certain executives. The plan is designed to ensure that upon retirement the participant receives a prescribed life annuity from a combination of the SERP and HCA’s other benefit plans. Compensation expense under the plan was $9 million for 2005, $8 million for 2004 and $7 million for 2003. Accrued benefits liabilities under this plan totaled $42 million at December 31, 2005 and $52 million at December 31, 2004.
      HCA maintains defined benefit pension plans that resulted from acquisitions of certain hospitals in prior years. Compensation expense under these plans was $29 million for 2005, $26 million for 2004, and $17 million for 2003. Accrued benefits liabilities under these plans totaled $56 million at December 31, 2005 and $55 million at December 31, 2004.
NOTE 13 — SEGMENT AND GEOGRAPHIC INFORMATION
      HCA operates in one line of business, which is operating hospitals and related health care entities. During the three years ended December 31, 2005, 2004 and 2003, approximately 27%, 28% and 28%, respectively, of HCA’s revenues related to patients participating in the Medicare program.
      HCA’s operations are structured in two geographically organized groups: the Eastern Group includes 90 consolidating hospitals located in the Eastern United States and the Western Group includes 77 consolidating hospitals located in the Western United States. HCA also operates eight consolidating hospitals in England and Switzerland and these facilities are included in the Corporate and other group.
      Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, gains on sales of facilities, impairment of long-lived assets, government settlement and investigation related costs, minority interests and income taxes. HCA uses adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The

F-28


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 13 — SEGMENT AND GEOGRAPHIC INFORMATION (Continued)
geographic distributions of HCA’s revenues, equity in earnings of affiliates, adjusted segment EBITDA, depreciation and amortization, assets and goodwill are summarized in the following table (dollars in millions):
                           
    For the Years Ended December 31,
     
    2005   2004   2003
             
Revenues:
                       
 
Eastern Group
  $ 11,967     $ 11,427     $ 10,513  
 
Western Group
    11,760       11,417       10,734  
 
Corporate and other
    728       658       561  
                   
    $ 24,455     $ 23,502     $ 21,808  
                   
Equity in earnings of affiliates:
                       
 
Eastern Group
  $ (6 )   $ (7 )   $ (9 )
 
Western Group
    (215 )     (178 )     (185 )
 
Corporate and other
          (9 )     (5 )
                   
    $ (221 )   $ (194 )   $ (199 )
                   
Adjusted segment EBITDA:
                       
 
Eastern Group
  $ 2,141     $ 2,033     $ 2,053  
 
Western Group
    2,215       2,013       2,065  
 
Corporate and other
    (78 )     (80 )     (197 )
                   
    $ 4,278     $ 3,966     $ 3,921  
                   
Depreciation and amortization:
                       
 
Eastern Group
  $ 621     $ 546     $ 485  
 
Western Group
    600       550       492  
 
Corporate and other
    153       154       135  
                   
    $ 1,374     $ 1,250     $ 1,112  
                   
Adjusted segment EBITDA
  $ 4,278     $ 3,966     $ 3,921  
 
Depreciation and amortization
    1,374       1,250       1,112  
 
Interest expense
    655       563       491  
 
Gains on sales of facilities
    (78 )           (85 )
 
Impairment of long-lived assets
          12       130  
 
Government settlement and investigation related costs
                (33 )
                   
Income before minority interests and income taxes
  $ 2,327     $ 2,141     $ 2,306  
                   
                   
    As of December 31,
     
    2005   2004
         
Assets:
               
 
Eastern Group
  $ 8,026     $ 7,870  
 
Western Group
    9,000       8,704  
 
Corporate and other
    5,199       5,266  
             
    $ 22,225     $ 21,840  
             

F-29


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 13 — SEGMENT AND GEOGRAPHIC INFORMATION (Continued)
                                   
    Eastern   Western   Corporate    
    Group   Group   and Other   Total
                 
Goodwill:
                               
Balance at December 31, 2004
  $ 934     $ 1,359       $247     $ 2,540  
 
Acquisitions
    107       22             129  
 
Sales
    (3 )     (32 )           (35 )
 
Foreign currency translation
                (8 )     (8 )
                         
Balance at December 31, 2005
  $ 1,038     $ 1,349       $239     $ 2,626  
                         
NOTE 14 — OTHER COMPREHENSIVE INCOME
      The components of accumulated other comprehensive income are as follows (dollars in millions):
                                   
    Unrealized   Foreign        
    Gains on   Currency   Defined    
    Available-for-Sale   Translation   Benefit    
    Securities   Adjustments   Plans   Total
                 
Balances at December 31, 2002
  $ 46     $ 35     $ (8 )   $ 73  
 
Unrealized gains on available-for-sale securities, net of $52 of income taxes
    92                   92  
 
Foreign currency translation adjustments, net of $20 of income taxes
          11             11  
 
Defined benefit plans, net of $5 income tax benefit
                (8 )     (8 )
                         
Balances at December 31, 2003
    138       46       (16 )     168  
 
Unrealized gains on available-for-sale securities, net of $27 of income taxes
    46                   46  
 
Gains reclassified into earnings from other comprehensive income, net of $20 of income taxes
    (36 )                 (36 )
 
Foreign currency translation adjustments, net of $11 of income taxes
          21             21  
 
Defined benefit plans, net of $4 income tax benefit
                (6 )     (6 )
                         
Balances at December 31, 2004
    148       67       (22 )     193  
 
Unrealized gains on available-for-sale securities, net of $3 of income taxes
    3                   3  
 
Gains reclassified into earnings from other comprehensive income, net of $20 of income taxes
    (33 )                 (33 )
 
Foreign currency translation adjustments, net of $19 income tax benefit
          (37 )           (37 )
 
Defined benefit plans, net of $2 of income taxes
                4       4  
                         
Balances at December 31, 2005
  $ 118     $ 30     $ (18 )   $ 130  
                         

F-30


Table of Contents

HCA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 15 — ACCRUED EXPENSES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
      A summary of other accrued expenses at December 31 follows (dollars in millions):
                 
    2005   2004
         
Employee benefit plans
  $ 203     $ 186  
Taxes other than income
    166       155  
Professional liability risks
    285       310  
Interest
    149       132  
Dividends
    62       63  
Other
    399       408  
             
    $ 1,264     $ 1,254  
             
      A summary of activity in the allowance for doubtful accounts follows (dollars in millions):
                                   
        Provision   Accounts    
    Balance at   for   Written off,   Balance
    Beginning   Doubtful   Net of   at End
    of Year   Accounts   Recoveries   of Year
                 
Allowance for doubtful accounts:
                               
 
Year ended December 31, 2003
  $ 2,045     $ 2,207     $ (1,603 )   $ 2,649  
 
Year ended December 31, 2004
    2,649       2,669       (2,376 )     2,942  
 
Year ended December 31, 2005
    2,942       2,358       (2,403 )     2,897  

F-31


Table of Contents

HCA INC.
QUARTERLY CONSOLIDATED FINANCIAL INFORMATION
(UNAUDITED)
(Dollars in millions, except per share amounts)
                                   
    2005
     
    First   Second   Third   Fourth
                 
Revenues
  $ 6,182     $ 6,070     $ 6,025     $ 6,178  
Net income
  $ 414     $ 405 (a)   $ 280 (b)   $ 325 (c)
Basic earnings per share
  $ 0.97     $ 0.91 (a)   $ 0.63 (b)   $ 0.75 (c)
Diluted earnings per share
  $ 0.95     $ 0.90 (a)   $ 0.62 (b)   $ 0.74 (c)
Cash dividends declared
  $ 0.15     $ 0.15     $ 0.15     $ 0.15  
Market prices(d):
                               
 
High
  $ 54.10     $ 58.60     $ 57.17     $ 52.74  
 
Low
    38.97       52.14       45.59       45.30  
                                   
    2004
     
    First   Second   Third   Fourth
                 
Revenues
  $ 5,937     $ 5,833     $ 5,792     $ 5,940  
Net income
  $ 345     $ 352     $ 227 (e)   $ 322  
Basic earnings per share
  $ 0.71     $ 0.73     $ 0.47 (e)   $ 0.71  
Diluted earnings per share
  $ 0.69     $ 0.72     $ 0.47 (e)   $ 0.70  
Cash dividends declared
  $ 0.13     $ 0.13     $ 0.13     $ 0.13  
Market prices(d):
                               
 
High
  $ 46.60     $ 43.24     $ 42.30     $ 41.64  
 
Low
    38.98       38.00       36.44       34.70  
 
(a) Second quarter results include $18 million ($0.04 per basic and diluted share) related to the recognition of a previously deferred gain on the sale of medical office buildings (See NOTE 1 of the notes to consolidated financial statements) and $48 million ($0.11 per basic and diluted share) related to a favorable tax settlement (See NOTE 4 of the notes to consolidated financial statements).
(b) Third quarter results include $22 million ($0.05 per basic and diluted share) related to the expected repatriation of foreign earnings (see NOTE 4 of the notes to consolidated financial statements).
(c) Fourth quarter results include $19 million ($0.04 per basic and diluted share) of gains on sales of facilities (See NOTE 2 of the notes to consolidated financial statements) and an estimated tax benefit of $2 million ($0.01 per basic and diluted share) from the repatriation of foreign earnings (See NOTE 4 of the notes to consolidated financial statements).
(d) Represents high and low sales prices of the Company’s common stock which is traded on the New York Stock Exchange (ticker symbol HCA).
(e) Third quarter results include $8 million ($0.02 per basic and diluted share) related to the impairment of long-lived assets (See NOTE 3 of the notes to consolidated financial statements).

F-32 EX-12 2 g99681exv12.txt EX-12 STATEMENT RE COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES EXHIBIT 12 HCA INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (UNAUDITED) (DOLLARS IN MILLIONS)
YEAR ENDED DECEMBER 31, ------------------------------------------ 2005 2004 2003 2002 2001 ------ ------ ------ ------ ------ EARNINGS: Income before minority interests and income taxes........................................... $2,327 $2,141 $2,306 $1,603 $1,596 Fixed charges, exclusive of capitalized interest........................................ 785 686 611 558 647 ------ ------ ------ ------ ------ $3,112 $2,827 $2,917 $2,161 $2,243 ====== ====== ====== ====== ====== FIXED CHARGES: Interest charged to expense....................... $ 655 $ 563 $ 491 $ 446 $ 536 Interest portion of rental expense................ 130 123 120 112 111 ------ ------ ------ ------ ------ Fixed charges, exclusive of capitalized interest........................................ 785 686 611 558 647 Capitalized interest.............................. 25 28 49 37 15 ------ ------ ------ ------ ------ $ 810 $ 714 $ 660 $ 595 $ 662 ====== ====== ====== ====== ====== Ratio of earnings to fixed charges................ 3.84 3.96 4.42 3.63 3.39 ====== ====== ====== ====== ======
EX-21 3 g99681exv21.txt EX-21 LIST OF SUBSIDIARIES EXHIBIT 21 ALABAMA Alabama-Tennessee Health Network, Inc. CareOne Home Health Services, Inc. Four Rivers Medical Center PHO, Inc. Selma Medical Center Hospital, Inc. ALASKA Chugach PT, Inc. Columbia Behavioral Healthcare, Inc. Columbia North Alaska Healthcare, Inc. ARKANSAS Central Arkansas Provider Network, Inc. Columbia Health System of Arkansas, Inc. BERMUDA Parthenon Insurance Company, Limited CALIFORNIA Birthing Facility of Beverly Hills, Inc. C.H.L.H., Inc. CFC Investments, Inc. CH Systems Chino Community Hospital Corporation, Inc. Columbia ASC Management, L.P. Columbia Fallbrook, Inc. Columbia Riverside, Inc. Columbia/HCA San Clemente, Inc. Community Hospital of Gardena Corporation, Inc. Encino Hospital Corporation, Inc. Far West Division, Inc. Galen-Soch, Inc. Good Samaritan Surgery Center, L.P. HCA Allied Health Services of San Diego, Inc. HCA Health Services of California, Inc. HCA Hospital Services of San Diego, Inc. Healdsburg General Hospital, Inc. L E Corporation Las Encinas Hospital Los Gatos Surgical Center, a California Limited Partnership Los Gatos Surgical Center Los Robles Regional Medical Center Los Robles Hospital & Medical Center Los Robles Surgicenter JV Los Robles SurgiCenter MCA Investment Company Mission Bay Memorial Hospital, Inc. Neuro Affiliates Company Psychiatric Company of California, Inc. Riverside Healthcare System, L.P. Riverside Community Hospital Riverside Holdings, Inc. Riverside Surgicenter, L.P. San Joaquin Surgical Center, Inc. San Jose Healthcare System, Inc. San Jose Pathology Outreach, LLC Southwest Surgical Clinic, Inc. Surgicare of Beverly Hills, Inc. Surgicare of Good Samaritan, LLC Surgicare of Los Gatos, Inc. Surgicare of Montebello, Inc. Surgicare of Riverside, LLC Surgicare of West Hills, Inc. Ukiah Hospital Corporation Visalia Community Hospital, Inc. VMC Management, Inc. VMC-GP, Inc. West Hills Hospital West Hills Hospital & Medical Center West Hills Surgical Center, Ltd. West Hills Surgical Center West Los Angeles Physicians' Hospital, Inc. Westminster Community Hospital Westside Hospital Limited Partnership Windsor Health Group Medical Building, LLC CAYMAN ISLANDS Health Midwest Insurance Company, Ltd. COLORADO Arapahoe Orthopedic Associates, LLC Aspen Family Medicine at Lowry Medical Center, LLC Aspenwood Internal Medicine, LLC Bethesda Psychealth Ventures, Inc. Breckenridge Medical Center, LLC Centennial MOB II, LLC Centrum Surgery Center, Ltd. Centrum Surgical Center Clear Creek Surgery Center, LLC Colorado Health Systems, Inc. Colorado Healthcare Management, LLC Colorado Neurology Specialists, LLC Columbine Psychiatric Center, Inc. Continental Division I, Inc. Denver Mid-Town Surgery Center, Ltd. Midtown Surgical Center Denver Orthopedics and Sports Medicine, LLC Diagnostic Imaging Associates Diagnostic Mammography Services, G.P. Endocrine Associates of the Rockies, LLC Galen of Aurora, Inc. HCA-HealthONE, LLC North Suburban Medical Center Presbyterian/St. Luke's Medical Center Rose Medical Center Sky Ridge Medical Center Swedish Medical Center The Medical Center of Aurora Health Care Indemnity, Inc. HealthONE Clear Creek, Inc. HealthONE Clinic Services, LLC HealthONE Lowry, LLC HealthONE of Denver, Inc. HealthONE Trauma Services, LLC HealthONE Urologic, LLC Hospital-Based CRNA Services, Inc. Lakewood Outpatient Surgical Center, Ltd. Lakewood Surgicare, Inc. Medical Imaging of Colorado, LLC MOVCO, Inc. New Rose Holding Company, Inc. North Suburban Surgery Center, L.P. North Suburban Surgery Center Outpatient Surgery Center of Lakewood, L.P. Lakewood Surgical Center Rose Ambulatory Surgery Center, L.P. Rose Health Partners, LLC Rose Medical Plaza, Ltd. Rose POB, Inc. Sky Ridge Surgery Center, L.P. Sky Ridge Surgical Center Southwest MedPro, Ltd. Surgicare of Denver Mid-Town, Inc. Surgicare of North Suburban, LLC Surgicare of Rose, LLC Surgicare of Sky Ridge, LLC Surgicare of Southeast Denver, Inc. Surgicare of Swedish, LLC Swedish Medpro, Inc. Swedish MOB I, Ltd. Swedish MOB II, Inc. Swedish MOB II, LLC Swedish MOB III, Inc. Swedish MOB IV, Inc. Swedish MOB, LLC DELAWARE AC Med, LLC Aligned Business Consortium Group, L.P. Alpharetta Imaging Services, LLC Alternaco, LLC American Medicorp Development Co. Ami-Point GA, LLC AOGN, LLC Arkansas Medical Park, LLC ASD Shared Services, LLC Atlanta Healthcare Management, L.P. Atlanta Market GP, Inc. Atlanta Orthopaedic Surgical Center, Inc. Aventura EFL Imaging Center, LLC Bayshore Partner, LLC Belton Family Practice Clinic, LLC Blake Imaging, LLC BNA Associates, Inc. Boynton Beach EFL Imaging Center, LLC Brunswick Hospital, LLC C/HCA Capital, Inc. C/HCA, Inc. Cancer Centers of North Florida, LLC Central Florida Diagnostic Cardiology Center, LLC Central Florida Imaging Services, LLC Central Health Holding Company, Inc. Central Health Services Hospice, Inc. Chattanooga ASC, LLC CHC Finance Co. CHC Payroll Agent, Inc. CHCA Bayshore, L.P. Bayshore Medical Center CHCA Clear Lake L.P. Clear Lake Regional Medical Center CHCA Conroe, L.P. Conroe Regional Medical Center CHCA East Houston, L.P. East Houston Regional Medical Center CHCA Hospital LP, Inc. CHCA Mainland, L.P. Mainland Medical Center CHCA Palmyra Partner, Inc. CHCA West Houston, L.P. West Houston Medical Center CHCA Woman's Hospital, L.P. Woman's Hospital of Texas Cheray and Samuels, LLC Clear Lake Merger, LLC Clear Lake Regional Partner, LLC Clearwater GP, LLC ClinicServ, LLC CMS GP, LLC Coastal Bend Hospital, Inc. Coastal Healthcare Services, Inc. Cobb Imaging Services, LLC Coliseum Health Group, LLC Coliseum Medical Center, LLC Coliseum Medical Centers Coliseum Psychiatric Center, LLC Coliseum Psychiatric Center Coliseum Surgery Center, L.L.C. Columbia Behavioral Health, LLC Columbia EFL Imaging Center, LLC Columbia Homecare Group, Inc. Columbia Hospital (Palm Beaches) Limited Partnership Columbia Hospital Columbia Hospital Corporation of Fort Worth Columbia Hospital Corporation of Houston Columbia Hospital Corporation - Delaware Columbia Management Companies, Inc. Columbia Mesquite Health System, L.P. Columbia Palm Beach GP, LLC Columbia Palms West Hospital Limited Partnership Palms West Hospital Columbia Rio Grande Healthcare, L.P. Rio Grande Regional Hospital Columbia Valley Healthcare System, L.P. Valley Regional Medical Center Columbia Westbank Healthcare, L.P. Columbia/HCA Middle East Management Company Columbia-SDH Holdings, Inc. Columbus Cath Lab, Inc. Columbus Cath Lab, LLC Concept EFL Imaging Center, LLC Concept West EFL Imaging Center, LLC Conroe Partner, LLC CoralStone Management, Inc. COSCORP, LLC CPS TN Processor 1, Inc. CRMC-M, LLC Dallas/Ft. Worth Physicians, LLC Danforth Hospital, Inc. Delray EFL Imaging Center, LLC Delta Division, Inc. DeSoto Family Practice, LLC Doctors Hospital of Augusta, LLC Doctors Hospital Drake Development Company Drake Development Company II Drake Development Company III Drake Development Company IV Drake Development Company V Drake Development Company VI Drake Management Company EarthStone HomeHealth Company East Florida Imaging Holdings, LLC East Houston Partner, LLC Edmond Regional Medical Center, LLC Edmond Medical Center Electa Health Network, LLC EMMC, LLC EP Health, LLC EP Holdco, LLC EPIC Development, Inc. EPIC Diagnostic Centers, Inc. EPIC Healthcare Management Company EPIC Surgery Centers, Inc. Extendicare Properties, Inc. Fairview Park GP, LLC Fairview Partner, LLC Family Care of E. Jackson County, LLC FHAL, LLC Forest Park Surgery Pavilion, Inc. Forest Park Surgery Pavilion, L.P. Fort Bend Hospital, Inc. Galen (Kansas) Merger, LLC Galen BH, Inc. Galen Finance, Inc. Galen Global Finance, Inc. Galen GOK, LLC Galen Holdco, LLC Galen Hospital Alaska, Inc. Alaska Regional Hospital Galen International Capital, Inc. Galen International Holdings, Inc. Galen KY, LLC Galen LA, LLC Galen MCS, LLC Galen Medical Corporation Galen MRMC, LLC Galen NMC, LLC Galen NSH, LLC Galen SOM, LLC Galen SSH, LLC Galendeco, Inc. GalTex, LLC Garden Park Community Hospital Limited Partnership Gardens EFL Imaging Center, LLC Gary Berger, DO, LLC General Healthserv, LLC Georgia Health Holdings, Inc. Georgia, L.P. GHC - Galen Health Care, LLC GKI Lawrence, LLC Glendale Surgical, LLC Good Samaritan Hospital, L.P. Good Samaritan Hospital Good Samaritan Hospital, LLC Goppert-Trinity Family Care, LLC GPCH-GP, Inc. Garden Park Medical Center Grand Strand Regional Medical Center, LLC Grand Strand Regional Medical Center Grandview Health Care Clinic, LLC H.H.U.K., Inc. HCA Health Services of Midwest, Inc. HCA Holdco, LLC HCA Imaging Services of North Florida, Inc. HCA Management Services, L.P. HCA Outpatient Imaging Services Group, Inc. HCA Property GP, LLC HCA Psychiatric Company HCA Squared, LLC HCA Wesley Rehabilitation Hospital, Inc. Health Services (Delaware), Inc. Health Services Merger, Inc. Healthcare Technology Assessment Corporation Healthco, LLC Healthnet of Kentucky, LLC Healthserv Acquisition, LLC Healthtrust MOB Tennessee, LLC Healthtrust MOB, LLC Healthtrust Purchasing Group, L.P. Healthtrust, Inc. - The Hospital Company Hearthstone Home Health, Inc. Heloma Operations, LLC Hendersonville ODC, LLC HHNC, LLC HM EHS, LLC HM NKCH, LLC HM OMCOS, LLC Holden Family Health Care, LLC Hospital Corp., LLC Hospital Development Properties, Inc. Hospital of South Valley, LLC Hospital Partners Merger, LLC Houston Healthcare Holdings, Inc. Houston Woman's Hospital Partner, LLC HSS Holdco, LLC HSS Systems VA, LLC HSS Systems, LLC HTI Hospital Holdings, Inc. Independence Regional Medical Group, LLC Indian Path, LLC Indianapolis Hospital Partner, LLC Integrated Regional Laboratories, LLP Internal Medicine Associates of Lee's Summit, LLC Jackson County Medical Group, LLC JCSH, LLC JCSHLP, LLC JFK Medical Center Limited Partnership JFK Medical Center Jupiter EFL Imaging Center, LLC JV Investor, LLC Kansas Healthserv, LLC Katy Medical Center, Inc. Kendall EFL Imaging Center, LLC Kendall Regional Medical Center, LLC Lake City Health Centers, Inc. Lake Hearn Imaging Services, LLC Lakeland Medical Center, LLC Lakeside Radiology, LLC Lakeview Medical Center, LLC Lakeview Regional Medical Center Laredo Medco, LLC Lawrence Amdeco, LLC Lawrence Medical, LLC Lee's Summit Family Care, LLC Lewis-Gale Medical Center, LLC Lewis-Gale Medical Center Louisiana Hospital Holdings, Inc. Low Country Health Services, Inc. of the Southeast Macon Healthcare, LLC Macon Northside Health Group, LLC Macon Northside Hospital, LLC Coliseum Northside Hospital Mainland Partner, LLC Management Services Holdings, Inc. Management Services LP, LLC McKinley & Associates, LLC Medical Arts Hospital of Texarkana, Inc. Medical Care America, LLC Medical Care Financial Services Corp. Medical Care Real Estate Finance, Inc. Medical Center of Plano Partner, LLC Medical Centers of Oklahoma, LLC Medical City Dallas Partner, LLC Medical Corporation of America Medical Office Buildings of Kansas, LLC Medical Specialties, Inc. Medistone Healthcare Ventures, Inc. MediVision of Mecklenburg County, Inc. MediVision of Tampa, Inc. MediVision, Inc. Memorial Southside Cancer Center, LLC Miami Beach EFL Imaging Center, LLC Mid-Continent Health Services, Inc. MidAmerica Oncology, LLC Middle Georgia Hospital, LLC Midtown ID Clinic, LLC Midwest Division - ACH, LLC Allen County Hospital Midwest Division - BLMC, LLC Baptist-Lutheran Medical Center Midwest Division - CMC, LLC Midwest Division - IRHC, LLC Independence Regional Health Center Midwest Division - LRHC, LLC Lafayette Regional Health Center Midwest Division - LSH, LLC Lee's Summit Hospital Midwest Division - MCI, LLC Medical Center of Independence Midwest Division - MII, LLC Midwest Division - MMC, LLC Menorah Medical Center Midwest Division - OPRMC, LLC Overland Park Regional Medical Center Midwest Division - PFC, LLC Midwest Division - RMC, LLC Research Medical Center Midwest Division - RPC, LLC Research Psychiatric Center Midwest Division - TLM, LLC Midwest Holdings, Inc. Midwest Medicine Associates, LLC Midwest Physician Services Lab, LLC Mobile Corps., Inc. MRT&C, Inc. Nashville Shared Services General Partnership North Brandon Imaging, LLC North Florida Cancer Center Lake City, LLC North Florida Cancer Center Live Oak, LLC North Florida Cancer Center Tallahassee, LLC North Miami Beach Surgery Center Limited Partnership North Miami Beach Surgical Center North Miami Beach Surgical Center, LLC North Tampa Imaging, LLC North Texas Medical Center, Inc. Northeast Florida Cancer Services, LLC Northwest Fla. Home Health Agency, Inc. Notami Hospitals, LLC Notami Louisiana Holdings, Inc. Notami, LLC Notco, LLC NTGP, Inc. NTMC Ambulatory Surgery Center, L.P. NTMC Management Company NTMC Venture, Inc. Ocala Stereotactic Radiosurgery Partner, LLC Ocala Stereotactic Radiosurgery, LLC OMI Management, LLC OneSource Med Acquisition Company Orange City Imaging Services, LLC Orlando Outpatient Surgical Center, Inc. Outpatient Cardiovascular Center of Central Florida, LLC Outpatient GP, LLC Outpatient LP, LLC Outpatient Services - LAD, LLC Outpatient Services - River Oaks Imaging - Clear Lake, L.P. Outpatient Services - River Oaks Imaging - Conroe, L.P. Outpatient Services - River Oaks Imaging - East Houston, L.P. Outpatient Services - River Oaks Imaging - Houston, L.P. Outpatient Services - River Oaks Imaging - Humble, L.P. Outpatient Services - River Oaks Imaging - Medical Center, L.P. Outpatient Services - River Oaks Imaging - Pasadena, L.P. Outpatient Services - River Oaks Imaging - Sugar Land, L.P. Outpatient Services - River Oaks Imaging - West Houston, L.P. Outpatient Services - River Oaks Imaging - Willowbrook, L.P. Outpatient Services Holdings, Inc. Palm Beach EFL Imaging Center, LLC Palmyra Park GP, Inc. Paragon SDS, Inc. Paragon WSC, Inc. Parkway Hospital, Inc. Pearland Partner, LLC Pinellas Medical, LLC Pioneer Medical, LLC Plano Heart Institute, L.P. Plano Heart Management, LLC Plantation General Hospital Limited Partnership Plantation General Hospital PMM, Inc. POH Holdings, LLC Portsmouth Regional Ambulatory Surgery Center, LLC Portsmouth Regional Ambulatory Surgery Center Preferred Works WC, LLC Primary Care Acquisition, Inc. Primary Medical Management, Inc. RCH, LLC Reston Hospital Center, LLC Reston Hospital Center RHA MSO, LLC Richmond Imaging Merger, LLC Riverside Hospital, Inc. RMC HBP, LLC Rockhill General Surgery, LLC Round Rock Hospital, Inc. Samaritan, LLC San Jose Healthcare System, L.P. Regional Medical Center of San Jose San Jose Hospital, L.P. San Jose Medical Center, LLC San Jose, LLC San Pablo ASC, LLC Sarah Cannon Research Institute, LLC SCRI Holdings, LLC SJMC, LLC SMCH, LLC South Bay Imaging, LLC South Brandon Imaging, LLC South Dade GP, LLC South Valley Hospital, L.P. Southtown Women's Clinic, LLC Spalding Rehabilitation L.L.C. Spalding Rehabilitation Hospital Spring Branch GP, LLC Spring Branch LP, LLC Spring Hill Imaging, LLC Springview KY, LLC SR Medical Center, LLC State Line Medical Group, LLC State Line Urgent Care, LLC Stones River Hospital, LLC Suburban Medical Center at Hoffman Estates, Inc. Summit General Partner, Inc. Summit Medical Assoc., LLC Summit Outpatient Diagnostic Center, LLC Sun Bay Medical Office Building, Inc. Sun City Imaging, LLC Sun-Med, LLC Suncoast Physician Practice, LLC Sunrise Hospital and Medical Center, LLC Sunrise Hospital and Medical Center Surgicare of Denton, Inc. Surgicare of Plano, Inc. Surgico, LLC SVH, LLC Swedish MOB Acquisition, Inc. Terre Haute Hospital GP, Inc. Terre Haute Hospital Holdings, Inc. Terre Haute Regional Hospital, L.P. Terre Haute Regional Hospital The Medical Group of Kansas City, LLC Town Plaza Family Practice, LLC Trident Medical Center, LLC Trident Medical Center Tuckahoe Surgery Center, LP Tuckahoe Surgery Center Ultra Imaging Management Services, LLC Ultra Imaging of Tampa, LLC Utah Medco, LLC Value Health Management, Inc. VHSC Plantation, LLC VHSC Pompano Beach, LLC Vicksburg Diagnostic Services, L.P. Washington Holdco, LLC Wesley Cath Lab, LLC Wesley Manager, LLC Wesley Medical Center, LLC Wesley Medical Center West Florida Imaging Services, LLC West Florida PET Services, LLC West Houston, LLC Westbury Hospital, Inc. Westside EFL Imaging Center, LLC WHG Medical, LLC WJHC, LLC Woman's Hospital Merger, LLC Women's Hospital Indianapolis GP, Inc. Women's Hospital Indianapolis, L.P. WPPC, LLC Yates Center Family Health, LLC FLORIDA AAL Holdings, Inc. All About Learning, LLC All About Staffing, Inc. Ambulatory Laser Associates, GP Ambulatory Surgery Center Group, Ltd. Ambulatory Surgery Center Aventura Cardiovascular Surgeons, LLC Aventura Comprehensive Cancer Research Group of Florida, Inc. Aventura Neurosurgery, LLC BAMI Property, LLC Bay Hospital, Inc. Gulf Coast Medical Center Bayonet Point Imaging, LLC Bayonet Point Surgery Center, Ltd. Bayonet Point Surgery and Endoscopy Center Beach Primary Care, LLC Belleair Surgery Center, Ltd. Belleair Surgery Center Big Cypress Medical Center, Inc. Bonita Bay Surgery Center, Inc. Bonita Bay Surgery Center, Ltd. Brandon Surgi-Center, Ltd. Brandon Surgery Center Bridges Surgical Group, LLC Broward Healthcare System, Inc. Broward Neurosurgeons, LLC Broward Physician Practices, Ltd. Cape Coral Surgery Center, Inc. Cape Coral Surgery Center, Ltd. CCH-GP, Inc. Cedarcare, Inc. Cedars BTW Program, Inc. Cedars Cardiovascular Surgeons, LLC Cedars Gastroenterologists, LLC Cedars Healthcare Group, Ltd. Cedars Medical Center Cedars International Cardiology Consultants, LLC Cedars Medical Center Hospitalists, LLC Cedars Neurosurgery, LLC Central Florida Cardiology Interpretations, LLC Central Florida Division Practice, Inc. Central Florida Radiology, LLC Central Florida Regional Hospital, Inc. Central Florida Regional Hospital Central Florida Regional Obstetrics and Gynecology, LLC Clearwater Community Hospital Limited Partnership Coastal Cardiac Diagnostics, Ltd. Collier County Home Health Agency, Inc. Columbia Behavioral Health, Ltd. Columbia Behavioral Healthcare of South Florida, Inc. Columbia Central Florida Division, Inc. Columbia Development of Florida, Inc. Columbia Eye and Specialty Surgery Center, Ltd. Tampa Eye & Specialty Surgery Center Columbia Florida Group, Inc. Columbia Homecare - Central Florida, Inc. Columbia Homecare - North Florida Division, Inc. Columbia Hospital Corporation of Central Miami Columbia Hospital Corporation of Kendall Columbia Hospital Corporation of Miami Columbia Hospital Corporation of Miami Beach Columbia Hospital Corporation of North Miami Beach Columbia Hospital Corporation of South Broward Westside Regional Medical Center Columbia Hospital Corporation of South Dade Columbia Hospital Corporation of South Florida Columbia Hospital Corporation of South Miami Columbia Hospital Corporation of Tamarac Columbia Hospital Corporation - SMM Columbia Jacksonville Healthcare System, Inc. Columbia Lake Worth Surgical Center Limited Partnership Columbia Midtown Joint Venture Columbia North Central Florida Health System Limited Partnership Columbia North Florida Regional Medical Center Limited Partnership Columbia Ocala Regional Medical Center Physician Group, Inc. Columbia Palm Beach Healthcare System Limited Partnership Columbia Park Healthcare System, Inc. Columbia Park Medical Center, Inc. Columbia Physician Services - Florida Group, Inc. Columbia Primary Care, LLC Columbia Resource Network, Inc. Columbia South Florida Division, Inc. Columbia Tampa Bay Division, Inc. Columbia-Osceola Imaging Center, Inc. Community Orthopedics and Hand Surgery, LLC Coral Springs Surgi-Center, Ltd. Surgery Center at Coral Springs Countryside Surgery Center, Ltd. Countryside Surgery Center Cypress Physician Group, LLC Dade Physician Practices, Ltd. Daytona Medical Center, Inc. Diagnostic Breast Center, Inc. Doctors Imaging, LLC Doctors Osteopathic Medical Center, Inc. Gulf Coast Hospital Doctors Same Day Surgery Center, Inc. Doctors Same Day Surgery Center, Ltd. Doctors Same Day Surgery Center Doctors' Special Surgery Center of Jacksonville, Ltd. DOMC Property, LLC East Florida Division, Inc. East Pointe Hospital, Inc. Edward White Hospital, Inc. Edward White Hospital Englewood Community Hospital, Inc. Englewood Community Hospital Fawcett Memorial Hospital, Inc. Fawcett Memorial Hospital Florida Home Health Services - Private Care, Inc. Florida Outpatient Surgery Center, Ltd. Florida Surgery Center Florida Primary Physicians, Inc. Fort Myers Market, Inc. Fort Pierce Immediate Care Center, Inc. Fort Pierce Surgery Center, Ltd. Fort Walton Beach Medical Center, Inc. Fort Walton Beach Medical Center Ft. Pierce Surgicare, LLC Ft. Walton Beach General Surgery, LLC Ft. Walton Beach Medical Practices, LLC Galen Diagnostic Multicenter, Ltd. Galen Hospital - Pembroke Pines, Inc. Galen of Florida, Inc. St. Petersburg General Hospital Galencare, Inc. Brandon Regional Hospital Northside Hospital Gateway Internal Medicine, LLC Gateway Surgical Group, LLC Grant Center Hospital of Ocala, Inc. Greater Ft. Myers Physician Practices, Ltd. Gulf Coast Health Technologies, Inc. Gulf Coast Physicians, Inc. Hamilton Memorial Hospital, Inc. HCA Family Care Center, Inc. HCA Health Services of Florida, Inc. Blake Medical Center Oak Hill Hospital Regional Medical Center Bayonet Point St. Lucie Medical Center HD&S Corp. Successor, Inc. Homecare North, Inc. Hospital Corporation of Lake Worth Imaging and Surgery Centers of Florida, Inc. Imaging Corp. of the Palm Beaches Imaging Services of Orlando, LLC Integrated Regional Lab, LLC Internal Medicine of Tallahassee, LLC Jacksonville Market, Inc. Jacksonville Physician Practices, Ltd. Jacksonville Surgery Center, Ltd. Jacksonville Surgery Center JFK Occupational Medicine, LLC JFK Real Properties, Ltd. Kendall Healthcare Group, Ltd. Kendall Regional Medical Center Kendall Therapy Center, Ltd. Kingsley Family Care, LLC Kissimmee Surgicare, Ltd. Kissimmee Surgery Center LAD Imaging, LLC Lake Mary Imaging, LLC Lakewood Park Walk-In Clinic, LLC Largo Medical Center, Inc. Largo Medical Center Lawnwood Medical Center, Inc. Lawnwood Regional Medical Center & Heart Institute Lawnwood Neurosurgery, LLC Lawnwood Pavilion Physician Services, LLC Lawnwood Regional Cancer Center Limited Partnership Lehigh Physician Practice, Ltd. M & M of Ocala, Inc. Manatee Surgicare, Ltd. Gulf Coast Surgery Center Marion Community Hospital, Inc. Ocala Regional Medical Center Medical Center of Port St. Lucie, Inc. Medical Center of Santa Rosa, Inc. Medical Imaging Center of Ocala Memorial Diagnostic Services, Inc. Memorial Family Practice Associates, LLC Memorial Healthcare Group, Inc. Memorial Hospital Jacksonville Specialty Hospital Jacksonville Memorial Surgicare, Ltd. Plaza Surgery Center Memorial Urgent Care - Mandarin, LLC MHS Partnership Holdings JSC, Inc. MHS Partnership Holdings SDS, Inc. Miami Beach Healthcare Group, Ltd. Aventura Hospital and Medical Center Miami Lakes Surgery Center, Ltd. Naples Physician Practices, Ltd. Network MS of Florida, Inc. New Belleair Surgery Center, Ltd. New Port Richey Hospital, Inc. Community Hospital New Port Richey Surgery Center, Ltd. New Port Richey Surgery Center North Central Florida Health System, Inc. North Central Florida Physician Practices, Ltd. North Florida Division I, Inc. North Florida Division Practice, Inc. North Florida GI Center GP, Inc. North Florida GI Center, Ltd. North Florida Immediate Care Center - Springhill, LLC North Florida Immediate Care Center, Inc. North Florida Infusion Corporation North Florida Outpatient Imaging Center, Ltd. North Florida Physician Services, Inc. North Florida Practice Management, Inc. North Florida Regional Imaging Center, Ltd. North Florida Regional Investments, Inc. North Florida Regional Medical Center, Inc. North Florida Regional Medical Center North Florida Surgical Associates, LLC North Palm Beach County Surgery Center, Ltd. North County Surgicenter North Tampa Physician Practices, Ltd. Northside Imaging, LLC Northside MRI, Inc. Northwest Florida Healthcare Systems, Inc. Northwest Medical Center, Inc. Northwest Medical Center Notami Hospitals of Florida, Inc. Lake City Medical Center Oak Hill Acquisition, Inc. Oak Hill Family Care, LLC Ocala Regional Outpatient Services, Inc. Okaloosa Hospital, Inc. Twin Cities Hospital Okeechobee Hospital, Inc. Raulerson Hospital OneSource Health Network of South Florida, Inc. Orange Park Hospitalists, LLC Orange Park Medical Center, Inc. Orange Park Medical Center Orlando Physician Practices, Ltd. Orlando Surgicare, Ltd. Same Day Surgicenter of Orlando Osceola Neurological Associates, LLC Osceola Regional Hospital, Inc. Osceola Regional Medical Center Outpatient Surgical Services, Ltd. Outpatient Surgical Services P&L Associates Pace Obstetrics and Gynecology, LLC Palm Beach Healthcare System, Inc. Palm Beach Hospitalists Program, LLC Palm Beach Neurosurgery, LLC Palm Beach Physician Practices, Ltd. Palms West Pediatric Neurosurgery, Inc. Palms West Surgery Center, Ltd. Panhandle Physician Practices, Ltd. Park South Imaging Center, Ltd. PCMC Physician Group, Inc. Pensacola Primary Care, Inc. Pinellas Surgery Center, Ltd. Center for Special Surgery Plantation Diabetes and Metabolism Clinic, LLC Plantation Ortho, LLC Plantation Pediatric Neurosurgery, LLC Port St. Lucie Surgery Center, Ltd. St. Lucie Surgery Center Premier Medical Management, Ltd. Primary Care Medical Associates, Inc. Pulmonary Specialists of Lake City, LLC Putnam Hospital, Inc. Raulerson General Surgery Group, LLC Roosevelt Family Care, LLC San Pablo Surgery Center, Ltd. Sarasota Doctors Hospital, Inc. Doctors Hospital of Sarasota South Bay Physician Clinics, Inc. South Broward Medical Practice Partners, Ltd. South Broward Practices, Inc. South Dade Healthcare Group, Ltd. South Florida Division Practice, Inc. South Tampa Physician Practices, Ltd. Southwest Florida Division Practice, Inc. Southwest Florida Health System, Inc. Southwest Florida Regional Medical Center, Inc. Southwest Florida Regional Medical Center Space Coast Surgical Center, Ltd. Merritt Island Surgery Center Spinal Disorder and Pain Treatment Institute, LLC Spine Care Centers of West Florida, LLC St. Lucie West Primary Care, LLC Sun City Hospital, Inc. South Bay Hospital Surgery Center of Aventura, Ltd. Surgery Center of Aventura Surgery Center of Ft. Pierce, Ltd. Surgery Center of Ft. Pierce Surgery Center of Port Charlotte, Ltd. Surgical Park Center, Ltd. Surgical Park Center Surgicare America - Winter Park, Inc. Surgicare of Altamonte Springs, Inc. Surgicare of Aventura, LLC Surgicare of Bayonet Point, Inc. Surgicare of Brandon, Inc. Surgicare of Central Florida, Inc. Surgicare of Central Florida, Ltd. Central Florida Surgicenter Surgicare of Countryside, Inc. Surgicare of Florida, Inc. Surgicare of Ft. Pierce, Inc. Surgicare of Kissimmee, Inc. Surgicare of Manatee, Inc. Surgicare of Merritt Island, Inc. Surgicare of Miami Lakes, LLC Surgicare of New Port Richey, Inc. Surgicare of Orange Park, Inc. Surgicare of Orange Park, Ltd. Orange Park Surgery Center Surgicare of Orlando, Inc. Surgicare of Palms West, LLC Surgicare of Pinellas, Inc. Surgicare of Plantation, Inc. Surgicare of Port Charlotte, LLC Surgicare of Port St. Lucie, Inc. Surgicare of St. Andrews, Inc. Surgicare of St. Andrews, Ltd. Surgery Center at St. Andrews Surgicare of Stuart, Inc. Surgicare of Tallahassee, Inc. Surgicare of West Palm Beach, Ltd. Tallahassee Community Network, Inc. Tallahassee Gyn-Oncology, LLC Tallahassee Imaging Services, LLC Tallahassee Medical Center, Inc. Capital Regional Medical Center Tallahassee Orthopaedic Surgery Partners, Ltd. Tallahassee Outpatient Surgery Center Tallahassee Physician Practices, Ltd. Tampa Bay Division Practice, Inc. Tampa Bay Health System, Inc. Tampa Surgi-Centre, Inc. TCH Physician Group, Inc. The Neurohealth Sciences Center, LLC The Tallahassee Diagnostic Imaging Center Partnership The Urology Center at Central Florida Regional Hospital, LLC Thoracic & Cardiovascular Surgeons, LLC Travel Medicine and Infections, Inc. Treasure Coast Physician Practices, Ltd. Twin Cities Primary Care, LLC University Hospital, Ltd. University Hospital and Medical Center Volusia Healthcare Network, Inc. West Broward Hand & Ortho, LLC West Florida Behavioral Health, Inc. West Florida Division, Inc. West Florida HealthWorks, LLC West Florida Regional Medical Center, Inc. West Florida Hospital Westside Surgery Center, Ltd. Parkside Surgery Center Winter Park Healthcare Group, Ltd. Women's Health Center of Central Florida, LLC Wound and Hyperbaric Center, LLC GEORGIA Acworth Imaging Center, LLC Albany Family Practice, LLC Albany Neurosurgery Center, LLC AOSC Sports Medicine, Inc. Atlanta Home Care, L.P. Atlanta Outpatient Surgery Center, Inc. Atlanta Surgery Center, Ltd. Atlanta Outpatient Surgery Center Atlanta Outpatient Peachtree Dunwoody Center Augusta Physician Practice Company Buckhead Surgical Services, L.P. Buckhead Ambulatory Surgery Center Byron Family Practice, LLC Cartersville Medical Center, LLC Cartersville Medical Center Cartersville Occupational Medicine Center, LLC Cartersville Physician Practice I, LLC Cartersville Physician Practice Network, Inc. Cartersville Urgent Care, LLC Center for Colorectal Care, LLC Central Health Services, Inc. Chatsworth Hospital Corp. CHHC of Chattanooga, Inc. Church Street Partners Coliseum Health Group, Inc. Coliseum Park Hospital, Inc. Coliseum Primary Healthcare - Macon, LLC Coliseum Primary Healthcare - Riverside, LLC Coliseum Same Day Surgery Center, L.P. Coliseum Same Day Surgery Center Coliseum-Houston ASC, L.P. Coliseum-Houston GP, LLC Columbia Coliseum Same Day Surgery Center, Inc. Columbia Physicians Services, Inc. [GA] Columbia Polk General Hospital, Inc. Polk Medical Center Columbia Redmond Occupational Health, Inc. Columbia Surgicare of Augusta, Ltd. Augusta Surgical Center Columbia-Georgia PT, Inc. Columbus Cardiology, Inc. Columbus Doctors Hospital, Inc. Community Home Nursing Care, Inc. Dekalb Home Health Services, Inc. Diagnostic Services, G.P. Doctors Hospital Center for Occupational Medicine, LLC Doctors Hospital Columbus GA-Joint Venture Doctors Hospital Doctors Hospital Surgery Center, L.P. Doctors Hospital Surgery Center Doctors-I, Inc. Doctors-II, Inc. Doctors-III, Inc. Doctors-IV, Inc. Doctors-IX, Inc. Doctors-V, Inc. Doctors-VI, Inc. Doctors-VII, Inc. Doctors-VIII, Inc. Doctors-X, Inc. Dublin Community Hospital, LLC Dunwoody Physician Practice Network, Inc. Eagle Springs Primary Care, LLC Eastside Medicine, LLC EHCA Diagnostics, LLC EHCA Dunwoody, LLC Emory Dunwoody Medical Center EHCA Eastside Occupational Medicine Center, LLC EHCA Eastside, LLC Emory Eastside Medical Center EHCA Johns Creek, LLC EHCA Metropolitan, LLC EHCA Parkway, LLC EHCA Peachtree, LLC EHCA West Paces, LLC EHCA, LLC Evans Diagnostic Imaging Center, LLC Fairview Park, Limited Partnership Fairview Park Hospital Fairview Physician Practice Company Gainesville Cardiology, Inc. Georgia Psychiatric Company, Inc. Grace Family Practice, LLC Grayson Primary Care, LLC Greater Gwinnett Internal Medicine Associates, LLC Greater Gwinnett Physician Corporation Gwinnett Community Hospital, Inc. HCA Health Services of Georgia, Inc. Hughston Orthopedic Hospital HCOL, Inc. Health Care Management Corporation LPOM, LLC LPPN, Inc. LPS, Inc. Marietta Outpatient Medical Building, Inc. Marietta Outpatient Surgery, Ltd. Marietta Surgical Center, Inc. Marietta Surgical Center Med Corp., Inc. MedFirst, Inc. Medical Center- West, Inc. MGIM, LLC MOSC Sports Medicine, Inc. Newnan Hospitals I, L.L.C. North Cobb Physical Therapy, Inc. North Georgia Primary Care Group, LLC Northlake Medical Center, LLC Northlake Medical Center Northlake MultiSpecialty Associates, LLC Northlake Physician Practice Network, Inc. Northlake Surgical Center, L.P. Northlake Surgical Center Northlake Surgicare, Inc. Orthopaedic Specialty Associates, L.P. Orthopaedic Sports Specialty Associates, Inc. Palmyra Park Hospital, Inc. Palmyra Medical Centers Palmyra Park, Limited Partnership Palmyra Professional Fees, LLC Parkway Physician Practice Company Parkway Surgery Center, L.P. Peachtree Corners Surgery Center, Ltd. Peachtree Occupational Medicine Center, LLC Peachtree Physician Practice Network, Inc. Pediatric Surgery Center, L.P. Pediatric Surgicare of Atlanta, LLC Polk Physician Practice Network, Inc. Redmond ER Services, Inc. Redmond Hospital-Based Services, LLC Redmond P.D.N., Inc. Redmond Park Health Services, Inc. Redmond Park Hospital, LLC Redmond Regional Medical Center Redmond Physician Practice Company Redmond Physician Practice Company II Redmond Physician Practice Company III Redmond Physician Practice Company IV Redmond Physician Practice Company V Redmond Physician Practice Company VI Redmond Physician Practice VIII, LLC Redmond Physician Practice X, LLC Redmond Physician Practice XI, LLC Rockbridge Primary Care, LLC Rome Imaging Center Limited Partnership S.O.R., Inc. SCNG, LLC Southeast Division, Inc. Surgery Center of Rome, L.P. The Surgery Center of Rome Surgicare of Augusta, Inc. Surgicare of Buckhead, LLC Surgicare of Evans, Inc. Surgicare of Rome, Inc. The Rankin Foundation Urology Center of North Georgia, LLC West Paces Services, Inc. IDAHO Eastern Idaho Health Services, Inc. Eastern Idaho Regional Medical Center Eastern Idaho OB Clinic, LLC Eastern Idaho Regional Medical Center Physician Services, LLC West Valley Medical Center, Inc. West Valley Medical Center West Valley Professional Fee Billing, LLC ILLINOIS Chicago Grant Hospital, Inc. Columbia Chicago Division, Inc. Columbia Chicago Homecare, Inc. Columbia Chicago Northside Hospital, Inc. Columbia LaGrange Hospital, Inc. Columbia Surgicare - North Michigan Ave., L.P. Galen Hospital Illinois, Inc. Galen of Illinois, Inc. Illinois Psychiatric Hospital Company, Inc. Smith Laboratories, Inc. INDIANA All About Staffing, Inc. BAMI-COL, Inc. Basic American Medical, Inc. Columbia PhysicianCare Outpatient Surgery Center, Ltd. Jeffersonville MediVision, Inc. Physician Practices of Terre Haute, Inc. Surgicare of Indianapolis, Inc. Terre Haute Heart Lung Vascular Associates, LLC Terre Haute Hospitalists Service, LLC Terre Haute MOB, L.P. Terre Haute Regional Physician Hospital Organization, Inc. Wabash Valley Hospitalists, LLC Women's Management Services, Inc. KANSAS Galichia Laboratories, Inc. HealthPlus Physical Therapy, LLC Johnson County Surgery Center, L.P. Johnson County Surgicenter, L.L.C. Surgicenter of Johnson County Kansas Trauma and Critical Care Specialists, LLC Mid-America Surgery Center, LLC Mid-America Surgery Institute, LLC Midwest Division, Inc. OB-GYN Diagnostics, Inc. Overland Park Cardiovascular, Inc. Quivira Internal Medicine, Inc. Surgery Center of Overland Park, L.P. Surgicare of Overland Park, LLC Surgicare of Wichita, Inc. Surgicare of Wichita, Ltd. Surgicare of Wichita Surgicenter of Johnson County, Ltd. Trauma Institute at Overland Park Regional Medical Center, LLC Wesley Physician Services, LLC KENTUCKY Bowling Green Medical Clinic - Greenview, LLC Capel Surgical Associates, LLC CHCK, Inc. Columbia Behavioral Health Network, Inc. Columbia Kentucky Division, Inc. Columbia Medical Group - Frankfort, Inc. Columbia Medical Group - Greenview, Inc. Frankfort Hospital, Inc. Frankfort Regional Medical Center Frankfort Orthopedics, LLC Franklin Surgical, LLC Galen of Kentucky, Inc. GALENCO, Inc. Greenview Hospital, Inc. Greenview Regional Hospital Physicians Medical Management, LLC South Central Kentucky Corp. Southern Kentucky Urology, LLC Spring View Health Alliance, Inc. Subco of Kentucky, Inc. Tri-County Community Hospital, Inc. Western Kentucky Gastroenterology, LLC Frankfort Hospital, Inc. LOUISIANA Acadiana Care Center, Inc. Acadiana Practice Management, Inc. Acadiana Regional Pharmacy, Inc. BRASS East Surgery Center Partnership in Commendam Center for Digestive Diseases, LLC Center for Digestive Disorders, LLC Columbia Healthcare System of Louisiana, Inc. Columbia Lakeview Surgery Center, LP Columbia West Bank Hospital, Inc. Columbia/HCA Healthcare Corporation of Central Louisiana, Inc. Columbia/HCA of Baton Rouge, Inc. Columbia/HCA of New Orleans, Inc. Columbia/Lakeview, Inc. Dauterive Hospital Corporation Dauterive Hospital Dauterive Professionals Management, L.L.C. Doctors Hospital of Opelousas Limited Partnership Hamilton Medical Center, Inc. Southwest Medical Center HCA Health Services of Louisiana, Inc. HCA Highland Hospital, Inc. Lafayette Surgery Center Limited Partnership Lafayette Surgicare, Inc. Lafayette Surgicare Lake Charles Surgery Center, Inc. Lakeview Radiation Oncology, L.L.C Louisiana Psychiatric Company, Inc. Medical Center of Baton Rouge, Inc. Medical Center of Southwest Louisiana Professionals Management, L.L.C. Metairie Primary Care Associates, LLC Notami (Opelousas), Inc. Notami Hospitals of Louisiana, Inc. Pediatric Heart Center (A Medical Limited Liability Company) Rapides Healthcare System, L.L.C. Avoyelles Hospital Oakdale Community Hospital Rapides Regional Medical Center Savoy Medical Center Winn Parish Medical Center Rapides Physicians Management, LLC Surgicare Merger Company of Louisiana Surgicare of Lakeview, Inc. Surgicare Outpatient Center of Baton Rouge, Inc. Surgicenter of East Jefferson, Inc. TUHC Anesthesiology Group, LLC TUHC Primary Care and Pediatrics Group, LLC TUHC Radiology Group, LLC TUHC Specialty Group, LLC Tulane Primary Care, LLC Tulane Professionals Management, L.L.C. University Healthcare System, L.C. DePaul-Tulane Behavioral Health Center Tulane University Hospital and Clinic Uptown Primary Care Associates, LLC WGH, Inc. Women's and Children's Hospital, Inc. Women's and Children's Hospital Women's and Children's Professional Management, L.L.C. MASSACHUSETTS Columbia Hospital Corporation of Massachusetts, Inc. Orlando Outpatient Surgical Center, Ltd. MISSISSIPPI Brookwood Medical Center of Gulfport, Inc. Coastal Imaging Center of Gulfport, Inc. Coastal Imaging Center, L.P. Galen of Mississippi, Inc. Garden Park Investments, L.P. Garden Park Physician Services Corporation Garden Park Professional Services, LLC Garden Park Professionals Management, LLC GOSC, L.P. Gulfport Outpatient Surgical Center GOSC-GP, Inc. Gulf Coast Medical Ventures, Inc. HTI Health Services, Inc. Southern Urology Associates, LLC VIP, Inc. MISSOURI Baptist Lutheran Endoscopy Center, L.P. Baptist Lutheran HBP, LLC Baptist Lutheran Surgery Center, L.P. Belton HBP, LLC Cedar Creek Medical Group, LLC Clinishare, Inc. Columbia/HCA Kansas City Medical Management, Inc. EHS Remainco, Inc. Eye Care Surgicare, Ltd. Eye Surgicare of Independence, LLC Family Care at Arbor Walk, LLC Family Health Specialists of Lee's Summit, LLC Foot & Ankle Specialty Services, LLC Galen Sale Corporation HCA Midwest Comprehensive Care, Inc. Health Midwest Medical Group, Inc. Health Midwest Office Facilities Corporation Health Midwest Ventures Group, Inc. HEI Missouri, Inc. HM Acquisition, LLC Independence Neurosurgery Services, LLC Independence Surgicare, Inc. Kansas City Perfusion Services, Inc. Kansas City Surgicenter, Ltd. Lee's Summit Medical Imaging, Inc. Medical Center Imaging, Inc. Metropolitan OB-GYN Associates, LLC Metropolitan Providers Alliance, Inc. Mid-States Financial Services, Inc. Midwest Cardiovascular & Thoracic Surgery, LLC Midwest Division - RBH, LLC Research Belton Hospital Midwest Infectious Disease Specialists, LLC Midwest Multispeciality Physicians Group, Inc. Midwest Newborn Care, LLC Midwest Trauma Services, LLC Missouri Healthcare System, L.P. Notami Hospitals of Missouri, Inc. Nuclear Diagnosis, Inc. Ozarks Medical Services, Inc. Panorama Park Occupational Medicine, LLC Precise Imaging, Inc. Raymore Medical Group, LLC Research Family Physicians, LLC Research GYN/Oncology Associates, LLC Research Psychiatric - 1500, LLC RMC - Pulmonary, LLC RMC Transplant Physicians, LLC Surgery Center of Independence, L.P. Surgicare of Antioch Hills, Inc. Surgicare of Baptist Lutheran Endoscopy, LLC Surgicare of Baptist Lutheran, LLC Surgicenter of Kansas City, L.L.C. NEVADA CHC Holdings, Inc. CHC Venture Co. CIS Holdings, Inc. Columbia Hospital Corporation of West Houston Columbia Southwest Division, Inc. Consolidated Las Vegas Medical Centers, A Nevada Limited Partnership Desert Physical Therapy, Inc. Green Valley Surgery Center, L.P. Health Service Partners, Inc. Las Vegas ASC, LLC Las Vegas Physical Therapy, Inc. Las Vegas Surgical Center, a Nevada limited partnership Las Vegas Surgicare, Inc. Las Vegas Surgicare, Ltd. Las Vegas Surgery Center Nevada Psychiatric Company, Inc. Nevada Surgery Center of Southern Hills, L.P. Nevada Surgicare of Southern Hills, LLC Rhodes Limited-Liability Company Sahara Outpatient Surgery Center, Ltd. Sahara Surgery Center Southern Hills Medical Center, LLC Southern Hills Hospital & Medical Center Specialty Surgicare of Las Vegas, LP Specialty Surgery Center Sunrise Anesthesia Services, LLC Sunrise Clinical Research Institute, Inc. Sunrise Flamingo Surgery Center, Limited Partnership Flamingo Surgery Center Sunrise Mountainview Hospital, Inc. MountainView Hospital Sunrise Outpatient Services, Inc. Sunrise Physician Services, LLC Sunrise Trauma Services, LLC Surgicare of Henderson, Inc. Surgicare of Las Vegas, Inc. Value Health Holdings, Inc. VH Holdco, Inc. VH Holdings, Inc. Western Plains Capital, Inc. NEW HAMPSHIRE Appledore Medical Group II, Inc. Appledore Medical Group, Inc. Coastline Cancer Center, LLC Derry ASC, Inc. Derry Surgery Center, Limited Partnership Fieldstone Health Network, Inc. HCA Health Services of New Hampshire, Inc. Parkland Medical Center Portsmouth Regional Hospital Med-Point of New Hampshire, Inc. Occupational Health Services of PRH, LLC Parkland Oncology, LLC Parkland Physician Services, Inc. PRH Oncology, LLC Salem Surgery Center, Limited Partnership Salem Surgery Center Seacoast Oncology, LLC Surgicare of Salem, LLC NEW MEXICO New Mexico Psychiatric Company, Inc. NORTH CAROLINA Brunswick Anesthesia, LLC Brunswick Primary Care, LLC Brunswick Surgical Associates I, LLC CareOne Home Health Services, Inc. Columbia Cape Fear Healthcare System, Limited Partnership Columbia North Carolina Division, Inc. Columbia-CFMH, Inc. Cumberland Medical Center, Inc. HCA - Raleigh Community Hospital, Inc. Heritage Hospital, Inc. Hospital Corporation of North Carolina HTI Health Services of North Carolina, Inc. Mecklenburg Surgical Land Development, Ltd. North Carolina Physician Network, Inc. Raleigh Community Medical Office Building, Ltd. Wake Psychiatric Hospital, Inc. OHIO AHN Holdings, Inc. Columbia Beachwood Surgery Center, Ltd. Columbia Dayton Surgery Center, Ltd. Columbia Ohio Division, Inc. Columbia/HCA Healthcare Corporation of Northern Ohio Columbia-CSA/HS Greater Canton Area Healthcare System, L.P. Columbia-CSA/HS Greater Cleveland Area Healthcare System, L.P. E.N.T. Services, Inc. Lorain County Surgery Center, Ltd. Surgicare of Lorain County, Inc. Surgicare of North Cincinnati, Inc. Surgicare of Westlake, Inc. Westlake Surgicare, L.P. OKLAHOMA Columbia Doctors Hospital of Tulsa, Inc. Columbia Oklahoma Division, Inc. Columbia/Edge Mobile Medical, L.L.C. Edmond General Surgery, LLC Edmond Physician Hospital Organization, Inc. Edmond Physician Services, LLC Edmond Spine and Orthopedic Services, LLC Green Country Anesthesiology Group, Inc. HCA Health Services of Oklahoma, Inc. OU Medical Center Healthcare Oklahoma, Inc. Integrated Management Services of Oklahoma, Inc. Lake Region Health Alliance Corporation Medi Flight of Oklahoma, LLC Medical Imaging, Inc. Millenium Health Care of Oklahoma, Inc. Oklahoma Outpatient Surgery Limited Partnership Oklahoma Surgicare Oklahoma Surgicare, Inc. Plains Healthcare System, Inc. Presbyterian Office Building, Ltd. Rogers County PHO, Inc. Stephenson Laser Center, L.L.C. Surgicare of Northwest Oklahoma Limited Partnership Surgicare of Oklahoma City-Midtown, L.P. Surgicare of Tulsa, Inc. SWMC, Inc. Wagoner Medical Group, Inc. PENNSYLVANIA Basic American Medical Equipment Company, Inc. Surgicare of Philadelphia, Inc. SOUTH CAROLINA C/HCA Development, Inc. Carolina Forest Imaging Center, LLC Carolina Regional Surgery Center, Inc. Carolina Regional Surgery Center, Ltd. Grande Dunes Surgery Center Coastal Carolina Home Care, Inc. Coastal Carolina MultiSpecialty Associates, LLC Colleton Ambulatory Care, LLC Colleton Ambulatory Surgery Center Colleton Diagnostic Center, LLC Colleton Medical Anesthesia, LLC Colleton Medical Hospitalists, LLC Colleton Neurology Associates, LLC Columbia/HCA Healthcare Corporation of South Carolina Columbia-CSA/HS Greater Columbia Area Healthcare System, LP Community Medical Center - South Strand Ambulatory Surgery Center, LLC Community Medical Centers, LLC Doctor's Memorial Hospital of Spartanburg, L.P. Edisto Multispecialty Associates, Inc. Grand Strand Senior Health Center, LLC North Charleston Diagnostic Imaging Center, LLC Providence Eye Care, Inc. South Carolina Market, Inc. Trident Behavioral Health Services, LLC Trident Eye Surgery Center, L.P. Trident Eye Surgery Center Trident Medical Services, Inc. Trident MRI Associates, L.P. Trident Neonatology Services, LLC Walterboro Community Hospital, Inc. Colleton Medical Center SWITZERLAND CDRC Centre de Diagnostic Radiologique de Carouge SA Clinique de Carouge CMCC SA Clinique de Carouge Glemm SA La Tour Healthcare Holding SARL La Tour S.A. Hopital de la Tour Permanence de la Clinique de Carouge SA Permanence La Tour S.A. Physiotherapie S. Pidancet Sport Multitherapies La Tour SA TENNESSEE America's Group, Inc. Appalachian OB/GYN Associates, Inc. Arthritis Specialists of Nashville, Inc. Athens Community Hospital, Inc. Atrium Memorial Surgery Center Joint Venture Atrium Memorial Surgery Center Atrium Memorial Surgical Center, Ltd. Centennial Surgery Center, L.P. Centennial Surgery Center Central Tennessee Hospital Corporation Horizon Medical Center Chattanooga Healthcare Network Partner, Inc. Chattanooga Healthcare Network, L.P. Columbia Health Management, Inc. Columbia Healthcare Network of Tri-Cities, Inc. Columbia Healthcare Network of West Tennessee, Inc. Columbia Integrated Health Systems, Inc. Columbia Medical Group - Athens, Inc. Columbia Medical Group - Centennial, Inc. Columbia Medical Group - Daystar, Inc. Columbia Medical Group - Eastridge, Inc. Columbia Medical Group - Franklin Medical Clinic, Inc. Columbia Medical Group - Hendersonville, Inc. Columbia Medical Group - Nashville Memorial, Inc. Columbia Medical Group - Parkridge, Inc. Columbia Medical Group - River Park, Inc. Columbia Medical Group - Southern Hills, Inc. Columbia Medical Group - Southern Medical Group, Inc. Columbia Medical Group - The Frist Clinic, Inc. Columbia Mid-Atlantic Division, Inc. Columbia Nashville Division, Inc. Columbia Northeast Division, Inc. Cool Springs Surgery Center, LLC Cumberland Division, Inc. Dickson Corporate Health Services, LLC Dickson Diagnostic Imaging Center, LLC Dickson Surgery Center, L.P. Eastern Tennessee Medical Services, Inc. Florida Primary Physicians, L.P. Goodlettsville Primary Care, LLC HCA - Information Technology & Services, Inc. HCA Central Group, Inc. HCA Chattanooga Market, Inc. HCA Development Company, Inc. HCA Eastern Group, Inc. HCA Health Services of Tennessee, Inc. Centennial Medical Center Centennial Medical Center at Ashland City Southern Hills Medical Center StoneCrest Medical Center Summit Medical Center HCA Home and Clinical Services, Inc. HCA Medical Services, Inc. HCA Physician Services, Inc. HCA Psychiatric Company HCA Realty, Inc. Healthtrust, Inc. - The Hospital Company Hendersonville Hospital Corporation Hendersonville Medical Center Hendersonville Hospitalist Services, Inc. Hendersonville OB-GYN, LLC Hermitage Primary Care, LLC Holly Hill/Charter Behavioral Health System, L.L.C. Hometrust Management Services, Inc. Horizon Orthopedics, LLC Hospital Corporation of Tennessee Hospital Realty Corporation Hospitalists at Centennial Medical Center, LLC Hospitalists at Parkridge, LLC HTI Memorial Hospital Corporation Skyline Medical Center HTI Tri-Cities Rehabilitation, Inc. Indian Path Hospital, Inc. Indian Path Rehabilitation Center, Inc. Judy's Foods, Inc. Lookout Valley Medical Center, LLC Madison Anesthesiology, LLC Madison Behavioral Health, LLC Madison Internal Medicine, LLC Madison Primary Care, LLC McMinnville Cardiology, LLC Med Group - Southern Hills Hospitalists, LLC Medical Group - Dickson, Inc. Medical Group - Stonecrest FP, Inc. Medical Group - Stonecrest Pulmonology, LLC Medical Group - StoneCrest, Inc. Medical Group - Summit, Inc. Medical Plaza Ambulatory Surgery Center Associates, L.P. Plaza Day Surgery Medical Plaza MRI, L.P. Medical Resource Group, Inc. Middle Tennessee Medical Services Corporation Mid-State Physicians, LLC Nashville Psychiatric Company, Inc. Network Management Services, Inc. North Florida Regional Freestanding Surgery Center, L.P. North Florida Surgical Pavilion North Nashville Family Health Center, LLC Old Fort Village, LLC OneSourceMed, Inc. Palmer Medical Center, LLC Parkridge East Specialty Associates, LLC Parkridge Hospitalists, Inc. Parkridge Medical Associates, LLC Parkridge Medical Center, Inc. Parkridge Medical Center Parkridge Professionals, Inc. Parkside Surgery Center, Inc. Plano Ambulatory Surgery Associates, L.P. Surgery Center of Plano Portland Primary Care, LLC Portland Surgical, LLC Pulmonary Medicine of Dickson, LLC Quantum Innovations, Inc. Rio Grande Surgery Center Associates, L.P. Rio Grande Surgery Center Signal Mountain Primary Care, LLC Skyline Hospitalists, LLC Skyline Medical Group, LLC Skyline Neuroscience Associates, LLC Skyline Primary Care, LLC Skyline Riverside Medical Group, LLC Southern Hills Surgery Center, L.P. Southern Hills Surgery Center Spring Hill Physicians, LLC SRS Acquisition, Inc. St. Mark's Ambulatory Surgery Associates, L.P. St. Mark's Outpatient Surgery Center Stonecrest Medical Group - Family Practice of Murfreesboro, LLC Stonecrest Medical Group - SC Murfreesboro Family Practice, LLC Sullins Surgical Center, Inc. Summit Research Solutions, LLC Summit Surgery Center, L.P. Summit Surgery Center Surgery Center of Chattanooga, L.P. Surgery Center of Chattanooga Surgicare of Chattanooga, LLC Surgicare of Dickson, LLC Surgicare of Madison, Inc. Surgicare of Southern Hills, Inc. Surgicare of Wilson County, LLC Surgicare Outpatient Center of Jackson, Inc. Sycamore Shoals Hospital, Inc. TCMC Madison-Portland, Inc. Tennessee Healthcare Management, Inc. Tennessee Valley Outpatient Diagnostic Center, LLC Tennessee Valley Surgery Center, L.P. The Charter Cypress Behavioral Health System, L.L.C. Trident Ambulatory Surgery Center, L.P. Trident Ambulatory Surgery Center TriStar Cath Management, LLC TriStar Health System Inc. TriStar Outpatient Cardiac Catheterization Center, LLC Troop and Jacobs, Inc. Wilson County Outpatient Surgery Center, L.P. TEXAS All About Staffing of Texas, Inc. Ambulatory Endoscopy Clinic of Dallas, Ltd. Arlington Diagnostic South, Inc. Austin Medical Center, Inc. Bailey Square Ambulatory Surgical Center, Ltd. Bailey Square Surgery Center Bailey Square Outpatient Surgical Center, Inc. Barrow Medical Center CT Services, Ltd. Bay Area Healthcare Group, Ltd. Corpus Christi Medical Center Bay Area Surgical Center Investors, Ltd. Bay Area Surgicare Center, Inc. Bayshore Surgery Center, Ltd. Bayshore Surgery Center Beaumont Healthcare System, Inc. Bedford-Northeast Community Hospital, Inc. Bellaire Imaging, Inc. Brownsville-Valley Regional Medical Center, Inc. Calloway Creek Surgery Center, L.P. Calloway Creek Surgicare, LLC Central San Antonio Surgical Center Investors, Ltd. CHC Management, Ltd. CHC Payroll Company CHC Realty Company CHCA Pearland, L.P. CHC-El Paso Corp. CHC-Miami Corp. Clear Lake Regional Medical Center, Inc. Clear Lake Surgicare, Ltd. Bay Area Surgicare Center Coastal Bend Hospital CT Services, Ltd. COL-NAMC Holdings, Inc. Columbia Ambulatory Surgery Division, Inc. Columbia Bay Area Realty, Ltd. Columbia Call Center, Inc. Columbia Central Group, Inc. Columbia Central Verification Services, Inc. Columbia Champions Treatment Center, Inc. Columbia GP of Mesquite, Inc. Columbia Greater Houston Division Healthcare Network, Inc. Columbia Hospital at Medical City Dallas Subsidiary, L.P. Medical City Dallas Hospital Columbia Hospital Corporation at the Medical Center Columbia Hospital Corporation of Arlington Columbia Hospital Corporation of Bay Area Columbia Hospital Corporation of Corpus Christi Columbia Hospital Securities Corporation Columbia Hospital-Arlington (WC), Ltd. Columbia Hospital-El Paso, Ltd. Columbia Lone Star/Arkansas Division, Inc. Columbia Medical Arts Hospital Subsidiary, L.P. Columbia Medical Center at Lancaster Subsidiary, L.P. Columbia Medical Center Dallas Southwest Subsidiary, L.P. Columbia Medical Center of Arlington Subsidiary, L.P. Medical Center of Arlington Columbia Medical Center of Denton Subsidiary, L.P. Denton Regional Medical Center Columbia Medical Center of Las Colinas, Inc. Las Colinas Medical Center Columbia Medical Center of Lewisville Subsidiary, L.P. Medical Center of Lewisville Columbia Medical Center of McKinney Subsidiary, L.P. Medical Center of McKinney Columbia Medical Center of Plano Subsidiary, L.P. Medical Center of Plano Columbia North Hills Hospital Subsidiary, L.P. North Hills Hospital Columbia North Texas Healthcare System, L.P. Columbia North Texas Subsidiary GP, LLC Columbia North Texas Surgery Center Subsidiary, L.P. Columbia Northwest Medical Center Partners, Ltd. Columbia Northwest Medical Center, Inc. Columbia Plaza Medical Center of Fort Worth Subsidiary, L.P. Plaza Medical Center of Fort Worth Columbia Psychiatric Management Co. Columbia South Texas Division, Inc. Columbia Specialty Hospital of Dallas Subsidiary, L.P. Columbia Specialty Hospitals, Inc. Columbia Surgery Group, Inc. Columbia/HCA Healthcare Corporation of Central Texas Columbia/HCA Heartcare of Corpus Christi, Inc. Columbia/HCA International Group, Inc. Columbia/HCA of Houston, Inc. Columbia/HCA of North Texas, Inc. Columbia/HCA Physician Hospital Organization Medical Center Hospital Columbia/Pasadena Healthcare System, L.P. Columbia-Quantum, Inc. Comprehensive Radiology Management Services, Ltd. Conroe Hospital Corporation Corpus Christi Healthcare Group, Ltd. Corpus Christi Surgery Center, L.P. Corpus Christi Surgery, Ltd. Surgicare of Corpus Christi Corpus Surgicare, Inc. Denton Regional Ambulatory Surgery Center, L.P. Day Surgery Center at Denton Regional Medical Center Doctors Bay Area Physician Hospital Organization Doctors Hospital (Conroe), Inc. E.P. Physical Therapy Centers, Inc. El Paso Healthcare System, Ltd. Del Sol Medical Center Las Palmas Medical Center El Paso Nurses Unlimited, Inc. El Paso Physical Therapy Centers, Ltd. El Paso Surgery Centers, L.P. East El Paso Surgery Center Surgical Center of El Paso El Paso Surgicenter, Inc. Endoscopy Clinic of Dallas, Inc. Endoscopy of Plano, L.P. Endoscopy Surgicare of Plano, LLC EPIC Properties, Inc. EPSC, L.P. Flower Mound Surgery Center, Ltd. Fort Worth Investments, Inc. Frisco Warren Parkway 91, Inc. Galen Hospital of Baytown, Inc. Gramercy Surgery Center, Ltd. Gramercy Outpatient Surgery Center Greater Houston Preferred Provider Option, Inc. Green Oaks Hospital Subsidiary, L.P. Green Oaks Hospital Gulf Coast Division, Inc. Gulf Coast Physician Administrators, Inc. HCA Health Services of Texas, Inc. HCA Pearland GP, Inc. HCA Plano Imaging, Inc. HCA Western Group, Inc. Heart Center of Fort Worth, Ltd. Heartcare of Texas, Ltd. HEI Sealy, Inc. Houston Northwest Surgical Partners, Inc. HPG Energy, L.P. HPG GP, LLC HTI Gulf Coast, Inc. Kingwood Surgery Center, Ltd. KPH-Consolidation, Inc. Kingwood Medical Center Las Colinas Surgery Center, Ltd. Las Colinas Surgery Center Leadership Healthcare Holdings L.P., L.L.P. Leadership Healthcare Holdings II L.P., L.L.P. Longview Regional Physician Hospital Organization, Inc. Med City Dallas Outpatient Surgery Center, L.P. Medical City Ambulatory Surgery Center Med Plus of El Paso, Inc. Med-Center Hosp./Houston, Inc. Medical Care Surgery Center, Inc. Medical City Dallas Hospital, Inc. MediPurchase, Inc. Methodist Healthcare System of San Antonio, Ltd., L.L.P. Methodist Ambulatory Surgery Center - North Central Methodist Ambulatory Surgery Center - Northeast Methodist Ambulatory Surgery Hospital - Northwest Methodist Children's Hospital of South Texas Methodist Hospital Metropolitan Methodist Hospital Methodist Specialty & Transplant Hospital Northeast Methodist Hospital Methodist Medical Center ASC, L.P. Methodist Ambulatory Surgery Center - Medical Center Metroplex Surgicenters, Inc. MGH Medical, Inc. MHS SC Partner, L.L.C. MHS Surgery Centers, L.P. Mid-Cities Surgi-Center, Inc. National Patient Account Services, Inc. Navarro Memorial Hospital, Inc. North Austin Surgery Center, L.P. North Austin Surgery Center North Central Methodist ASC, L.P. North Hills Cardiac Catheterization Center, L.P. North Hills Catheterization Lab, LLC North Hills Surgicare, L.P. Texas Pediatric Surgery Center North Texas Division, Inc. North Texas General, L.P. North Texas Technologies, Ltd. Northeast Methodist Surgicare, Ltd. Northeast PHO, Inc. Oakwood Surgery Center, Ltd., LLP Oakwood Surgery Center Occupational and Family Medicine of South Texas Orthopedic Hospital, Ltd. Texas Orthopedic Hospital Outpatient Services - River Oaks Imaging, L.P. Outpatient Women's and Children's Surgery Center, Ltd. Paragon of Texas Health Properties, Inc. Paragon Physicians Hospital Organization of South Texas, Inc. Paragon Surgery Centers of Texas, Inc. Park Central Surgical Center, Ltd. Park Central Surgical Center Parkway Cardiac Center, Ltd. Parkway Surgery Services, Ltd. Pasadena Bayshore Hospital, Inc. Pediatric Surgicare, Inc. Primary Health Network of South Texas Qualitycare Network of Greater Houston, Inc. Quantum/Bellaire Imaging, Ltd. Rim Building Partners, L.P. Rio Grande Healthcare MSO, Inc. Rio Grande NP, Inc. Rio Grande Regional Hospital, Inc. Rio Grande Regional Investments, Inc. Rosewood Medical Center, Inc. Rosewood Professional Building, Ltd. Royal Oaks Surgery Center, L.P. S.A. Medical Center, Inc. San Antonio Division, Inc. San Antonio Regional Hospital, Inc. South Austin Surgery Center, Ltd. Surgicare of South Austin South Texas Surgicare, Inc. Southwest Houston Surgicare, Inc. Spring Branch Medical Center, Inc. Spring Branch Medical Center St. David's Healthcare Partnership, L.P., LLP North Austin Medical Center Round Rock Medical Center South Austin Hospital St. David's Medical Center STPN Manager, LLC Sugar Land Surgery Center, Ltd. Sun Towers/Vista Hills Holding Co. Sunbelt Regional Medical Center, Inc. Surgical Center of Irving, Inc. Surgical Facility of West Houston, L.P. Surgicare of Arlington, LLC Surgicare of Central San Antonio, Inc. Surgicare of Flower Mound, Inc. Surgicare of Fort Worth Co-GP, LLC Surgicare of Fort Worth, Inc. Surgicare of Gramercy, Inc. Surgicare of Houston Women's, Inc. Surgicare of Kingwood, Inc. Surgicare of McKinney, Inc. Surgicare of Medical City Dallas, LLC Surgicare of North Austin, LLC Surgicare of North San Antonio, Inc. Surgicare of Northeast San Antonio, Inc. Surgicare of Pasadena, Inc. Surgicare of Round Rock, Inc. Surgicare of Royal Oaks, LLC Surgicare of South Austin, Inc. Surgicare of Sugar Land, Inc. Surgicare of Travis Center, Inc. Tarrant County Surgery Center, L.P. Texas Medical Technologies, Inc. Texas Psychiatric Company, Inc. The Family Birth Center, Ltd. The West Texas Division of Columbia, Inc. THN Physicians Association, Inc. Travis Surgery Center, L.P. Village Oaks Medical Center, Inc. W & C Hospital, Inc. West Houston ASC, Inc. West Houston Healthcare Group, Ltd. West Houston Outpatient Medical Facility, Inc. West Houston Surgicare, Inc. West McKinney Imaging Services, LLC West Park Surgery Center, L.P. McKinney Surgery Center WHMC, Inc. Willow Creek Hospital, Ltd. Woman's Hospital of Texas, Incorporated UNITED KINGDOM Columbia U.K. Finance Limited HCA Finance, LP HCA International Holdings Limited HCA International Limited Princess Grace Hospital The Harley Street Clinic The Portland Hospital for Women and Children The Wellington Hospital HCA Staffing Limited HCA UK Capital Limited HCA UK Holdings Limited HCA UK Investments Limited HCA UK Services, Ltd. HCA United Kingdom Limited La Tour Finance Limited Partnership London Radiography & Radiotherapy Services Limited St. Martins Healthcare Limited Lister Hospital London Bridge Hospital St. Martins Ltd. The Harley Street Cancer Clinic Limited UTAH Bountiful Surgery Center, LLC Brigham City Community Hospital Physician Services, LLC Brigham City Community Hospital, Inc. Brigham City Community Hospital Brigham City Health Plan, Inc. Columbia Ogden Medical Center, Inc. Ogden Regional Medical Center Columbia Utah Division, Inc. East Layton Internal Medicine, LLC General Hospitals of Galen, Inc. Healthtrust Utah Management Services, Inc. Hospital Corporation of Utah Lakeview Hospital HTI Physician Services of Utah, Inc. Lakeview Hospital Physician Services, LLC Lakeview Neurosurgery Clinic, LLC Lakeview Professional Billing, LLC Maternal Fetal Services of Utah, LLC Mountain Division, Inc. Mountain View Hospital, Inc. Mountain View Hospital Mountain View Medical Office Building, Ltd. Northern Utah Healthcare Corporation St. Mark's Hospital Northern Utah Imaging, L.P. Ogden CV Surgery, LLC Ogden Regional Health Plan, Inc. Ogden Regional Medical Center Professional Billing, LLC Ogden Senior Center, LLC Salt Lake City Surgicare, Inc. St. Mark's Investments, Inc. St. Mark's Lone Peak Hospital, Inc. St. Mark's Physicians, Inc. St. Mark's Professional Services, LLC Surgicare of Bountiful, LLC Surgicare of Salt Lake City, LLC Synergies Surgery Center, L.P. The Wasatch Endoscopy Center, Ltd. Timpanogos Regional Medical Services, Inc. Timpanogos Regional Hospital Utah Imaging GP, LLC West Jordan Hospital Corporation VIRGINIA Alleghany General and Bariatric Services, LLC. Alleghany Primary Care, Inc. Ambulatory Services Management Corporation of Chesterfield County, Inc. Arlington Surgery Center, L.P. Arlington Surgicare, LLC Ashburn Imaging, LLC Atrium Surgery Center, L.P. Atrium Surgicare, LLC Behavioral Health of Virginia Corporation Buford Road Imaging, L.L.C. Capital Division, Inc. Central Shared Services, LLC Chesterfield Imaging, LLC Chippenham & Johnston-Willis Hospitals, Inc. CJW Medical Center Chippenham & Johnston-Willis Sports Medicine, LLC Christiansburg Internal Medicine, LLC Clinch Valley Endocrinology, LLC Clinch Valley Pulmonology, LLC Clinch Valley Urology, LLC Colonial Heights Ambulatory Surgery Center, L.P. Colonial Heights Surgicare, LLC Columbia Arlington Healthcare System, L.L.C. Columbia Healthcare of Central Virginia, Inc. Columbia Medical Group - Southwest Virginia, Inc. Columbia Pentagon City Hospital, L.L.C. Columbia Physicians Services, Inc. [VA] Columbia Primary Care Associates, Ltd. Columbia/Alleghany Regional Hospital, Incorporated Alleghany Regional Hospital Columbia/HCA John Randolph, Inc. John Randolph Medical Center Community Healthcare of Dublin, LLC CVMC Property, LLC Fairfax Surgical Center, L.P. Fairfax Surgical Center Family Practice at Retreat, LLC Foot & Ankle Center, LLC Fort Chiswell Family Practice, LLC Galen of Virginia, Inc. Galen Property, LLC Galen Virginia Hospital Corporation Galen-Med, Inc. Clinch Valley Medical Center Generations Family Practice, Inc. GYN-Oncology of Southwest Virginia, LLC Hanover Outpatient Surgery Center, L.P. Hanover Outpatient Surgery Center HCA Health Services of Virginia, Inc. Henrico Doctors' Hospital HCA Richmond Division, Inc. Hopewell Nursing Home, LLC HSS Virginia, L.P. Imaging Services of Richmond, LLC Internal Medicine of Blacksburg, LLC John Randolph Family Practice, LLC John Randolph OB/GYN, LLC Lewis-Gale Hospital, Incorporated Lewis-Gale Physicians, LLC Loudoun Surgery Center, L.P. Loudoun Surgery Center, LLC Management Services of the Virginias, Inc. Montgomery Cancer Center, LLC Montgomery Regional Hospital, Inc. Montgomery Regional Hospital Montgomery Surgery Associates, LLC MOS Temps, Inc. NOCO, Inc. Northern Virginia Community Hospital, LLC Northern Virginia Community Hospital Northern Virginia Hospital Corporation Orthopedics of Southwest Virginia, LLC Orthopedics Specialists, LLC Preferred Hospitals, Inc. Primary Health Group, Inc. Pulaski Community Hospital, Inc. Pulaski Community Hospital Pulaski Radiologists, LLC Pulaski Urology, LLC Reston Surgery Center, L.P. Reston Surgery Center Retreat Hospital, Inc. Retreat Hospital Richmond Pediatric Surgeon's, LLC Roanoke Neurosurgery, LLC Roanoke Surgery Center, L.P. Blue Ridge Surgery Center Roanoke Valley Gynecology, LLC Robious Wellness Associates, L.L.P. Short Pump Imaging, LLC Southwest Virginia Fertility Center, LLC Spotsylvania Medical Center, Inc. Stafford Imaging, LLC Surgical Associates of Southwest Virginia, LLC Surgicare of Fairfax, Inc. Surgicare of Hanover, Inc. Surgicare of Reston, Inc. Surgicare of Roanoke, LLC Surgicare of Tuckahoe, Inc. Tri Medical, LLC Virginia Gynecologic Oncology, LLC Virginia Hematology & Oncology Associates, Inc. Virginia Hospitalists, Inc. Virginia Psychiatric Company, Inc. Dominion Hospital WASHINGTON ACH, Inc. Capital Network Services, Inc. WEST VIRGINIA Charleston Hospital, Inc. Saint Francis Hospital Columbia Parkersburg Healthcare System, LLC Columbia/HCA WVMS Member, Inc. Columbia-S.J. Ventures Properties, Limited Partnership Columbia-St. Joseph's Healthcare System, Limited Partnership St. Joseph's Hospital Galen of West Virginia, Inc. HCA Health Services of West Virginia, Inc. Hospital Corporation of America Parkersburg SJ Holdings, Inc. Raleigh General Hospital, LLC Raleigh General Hospital St. Francis Sleep Lab Professional Services, LLC St. Francis Surgery Center, L.P. Surgicare of Charleston, Inc. Teays Valley Health Services, LLC Putnam General Hospital Tri Cities Health Services Corp. West Virginia Management Services Organization, Inc. Zone, Incorporated EX-23.1 4 g99681exv23w1.txt EX-23.1 CONSENT OF ERNST & YOUNG LLP EXHIBIT 23 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements on Forms S-3 (File Nos. 333-121520 and 333-107536) and Forms S-8 (File Nos. 333-125404, 333-61930, 333-51112, 333-48254, 333-48246, 333-82207, 333-64479, 333-33881, 333-18169, 33-62309, 33-62303, 33-55511, 33-55509, 33-53788, 33-55272, 33-55270, 33-52253, 33-51114, 33-51052, 33-50151, 33-50147, 33-49783 and 33-36571) of HCA Inc. of our reports dated March 8, 2006, with respect to the consolidated financial statements of HCA Inc., HCA Inc. management's assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of HCA Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2005. Nashville, Tennessee /s/ Ernst & Young LLP March 8, 2006 EX-31.1 5 g99681exv31w1.txt EX-31.1 SECTION 302 CERTIFICATION OF THE CEO EXHIBIT 31.1 CERTIFICATIONS I, Jack O. Bovender, Jr., certify that: 1. I have reviewed this annual report on Form 10-K of HCA Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. By: /s/ JACK O. BOVENDER, JR. ------------------------------------ Jack O. Bovender, Jr. Chairman of the Board and Chief Executive Officer Date: March 14, 2006 EX-31.2 6 g99681exv31w2.txt EX-31.2 SECTION 302 CERTIFICATION OF THE CFO EXHIBIT 31.2 CERTIFICATIONS I, R. Milton Johnson, certify that: 1. I have reviewed this annual report of Form 10-K of HCA Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. By: /s/ R. MILTON JOHNSON ------------------------------------ R. Milton Johnson Executive Vice President and Chief Financial Officer Date: March 14, 2006 EX-32 7 g99681exv32.txt EX-32 SECTION 906 CERTIFICATIONS OF THE CEO & CFO EXHIBIT 32 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of HCA Inc. (the "Company") on Form 10-K for the year ended December 31, 2005, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. By: /s/ JACK O. BOVENDER, JR. ------------------------------------ Jack O. Bovender, Jr. Chairman of the Board and Chief Executive Officer March 14, 2006 By: /s/ R. MILTON JOHNSON ------------------------------------ R. Milton Johnson Executive Vice President and Chief Financial Officer March 14, 2006 -----END PRIVACY-ENHANCED MESSAGE-----